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ABSTRACT 
RNA is a widely utilized and integrated component of core cellular function because of 
its abilities to recognize and hybridize to nucleic acid templates, spatially localize to 
different compartments within the cell, bind combinatorially to effector molecules, and in 
some cases directly catalyze chemical reactions. In this thesis, I describe three cases, 
illustrating the biomolecule’s unique importance in several different aspects of cellular 
homeostasis.  Chapter 1 provides historical context for studying RNA-protein interactions 
within RNA biology and Virology. Chapter 2 details experiments in which we explored 
RNA as a central target of host cell takeover by SARS-CoV-2. In the process, we 
highlight the importance of RNA in many integral complexes within the cell, including 
components of the spliceosome, the eukaryotic ribosome, and signal recognition particle. 
Chapter 3 presents data from our consideration of RNA within the context of cis gene 
regulation. We specifically focus on a model RNA-binding protein, SMRT/HDAC1 
Associated Repressor Protein (SHARP), and the paternally imprinted long non-coding 
RNA, Kcnq1ot1, as case studies. Chapter 4 describes our dissection of a transcriptional 
circuit involving SHARP and discusses implications of RNA-binding to developmentally 
sensitive circuits and processes. Finally, Chapter 5 poses new questions raised by these 
studies. Together these data emphasize the diverse and unique role RNA plays in cellular 
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C h a p t e r  1  
ESTABLISHING CONTEXT AND RAISING OPEN QUESTIONS 
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Since the first documented isolation of nucleic acid in 1869 by Friedrich Miescher, RNA has 
been recognized as a widely utilized and integrated component of core cellular function. In this 
Chapter, I provide a historical overview of key advances within RNA biology, with emphasis on 
the diversity of non-coding RNA. I discuss three types of mechanisms used broadly by non-
coding RNAs in the cell, including sponge activities, direct RNA-mediated catalytic activity, and 
protein scaffolding. In addition, I introduce the paradigm of long non-coding RNAs as spatially 
concentrating protein scaffolds within the cell and discuss limitations in current methods used to 
evaluate RNA-protein interactions. Finally, I conclude by discussing the relevance of Virology 
towards advances in RNA biology and overall provide context for the investigation of RNA-
protein interactions during SARS-CoV-2 infection in Chapter 2, genomic imprinting in Chapter 
3, and transcriptional circuits and auto-regulation in Chapter 4. 
2.0 INTRODUCTION 
2.1 DISCOVERY, NON-CODING DIVERSITY, AND THE LENS OF CENTRAL DOGMA 
Nucleic acid was first isolated in 1869 by Friedrich Miescher, terming the highly acidic material 
as nuclein1-2. Several forms of nucleic acid were reported over the next few decades, varying as a 
result of purification method, primary source material, and research laboratory, and later 
resolved to two main groups: phytonucleic acid (yeast nucleic acid, thought to be typical of 
plants) and thymonucleic acid (also referred to as zoonucleic acid, thought to be typical of 
animals)3-4. It was later determined that differences between these two classes of nucleic acid 




thymonucleic acid) and sugar (pentose in yeast versus what was thought to be a hexose in 
animal), ultimately resolving to RNA and DNA respectively3-4. 
The connection between RNA and DNA was gradually established over the mid to late 20th 
century. In the late 1950s, Volkin and Astrachan described RNA as a DNA-like molecule 
synthesized from DNA5-6,2. Coupled with X-ray crystallography studies from Rosalind Franklin 
and the publication of the DNA double helix structure by Watson and Crick in 1953, RNA was 
later proposed to be an intermediate molecule in the flow of biological information from DNA to 
protein in a model called the Central Dogma of Molecular Biology7-9,2. This model was 
additionally supported by evidence from Caspersson and Brachet in 1939, who demonstrated that 
cells producing high amounts of protein also contained abundant RNA, and Jacob and Monod in 
1960, who (among others described in Section 2.4) identified the messenger RNA intermediate 
during protein synthesis10,2. 
In parallel to these coding RNA advances, non-coding RNA also emerged to the forefront. Key 
discoveries included: ribosomal RNA (rRNA), RNA components of the ribosome; transfer RNAs 
(tRNA), responsible for translation of RNA nucleotides to amino acids during protein assembly 
first identified in 1958 by Hoagland and Zamecnik; small nuclear RNAs, components of the 
spliceosome; small nucleolar RNAs, responsible for processing ribosomal RNA within the 
nucleolus; microRNAs (miRNAs), 20mer RNAs responsible for post-transcriptional gene 
silencing; and long non-coding RNA (lncRNA), non-coding RNAs greater than 200 nucleotides 
in length initially associated with gene regulation; among other types11-23,2.  
Central Dogma has been an invaluable paradigm for understanding the flow of biological 




Central Dogma (rRNA and tRNA) and illustrate the diversity of molecular processes within the 
cell. For better or worse, due to associations between non-coding RNA and regulatory activity 
(as a result of miRNAs, lncRNAs, and bacterial regulatory RNAs termed small RNAs), Central 
Dogma has unintentionally established a dichotomy within RNA biology: that is coding mRNA 
and regulatory non-coding RNA are mutually exclusive24,2. We later question this dichotomy in 
Chapters 3 and 5. 
2.2 REINING IN LONG NON-CODING RNAS AND CONSIDERATIONS OF CAUSALITY 
Recent reports have demonstrated that the mammalian genome is pervasively transcribed, 
producing upwards of 27,000 lncRNAs according to some estimates25-29. Coupled with the 
observations that 93% of the human genome is actively transcribed but only 1% contains protein-
coding gene exons, lncRNAs have become an exciting ‘new’ area of RNA biology research30-31, 
18-20,2. It is important, however, to take these newly reported lncRNAs with healthy skepticism 
because several lncRNAs have been reported to exert their function in an RNA-independent 
manner (that is, through activity as a cis regulatory DNA element or through the act of 
transcription itself)27,32. 
For example, Lockd (lncRNA downstream of Cdkn1b) is a mouse erythroblast lncRNA, 
associated with positive regulation of its neighbor, Cdkn1b33-34. Using a combination of 
CRISPR/Cas9-mediated excision of the Lockd gene body (which reduces neighbor Cdkn1b 
expression), as well as lncRNA transcript truncation via a pre-mature polyA termination signal 
(which does not effect Cdkn1b transcription), the authors demonstrated that a cis DNA element 
within the promoter of the Lockd locus, rather than the lncRNA itself, was responsible for its 




of Cdkn1a36. Through a combination of a Linc-p21 mouse knockout model, tissue-specific gene 
expression patterns, and a massively parallel reporter assay for enhancer activity, Groff et al. 
demonstrated that in vivo cis regulatory effects associated with Linc-p21 are due to DNA 
enhancer activity within the locus itself rather than the RNA molecule35-37.  
In contrast to DNA regulatory elements harbored within a lncRNA gene, the act of transcription 
can be responsible for a given behavior. An example of this is the Ftx RNA, a non-coding RNA 
associated with Xist lncRNA activation38-39. In their 2018 study, Furlan et al. demonstrated that 
deletion of the Ftx promoter resulted in impaired Xist activation. They additionally demonstrated 
that the Ftx transcript was not strictly required for this phenotype through LNA-Gapmer (locked 
nucleic acid oligonucleotides antisense to target RNAs) knockdown targeting mature Ftx. The 
authors later demonstrated that transcription of Ftx is functionally responsible for Xist activation 
using CRISPR-interference38. Ftx aside, groups have also documented that intense transcriptional 
activity can lead to expression of neighboring genes through a process termed transcriptional 
ripples40. Therefore, transcription of the lncRNA itself may lead to permissive changes in 
chromatin structure, with the produced RNA molecule ultimately dispensable towards an 
observed behavior in the laboratory32.  
Although certain lncRNAs may be ‘merely’ associated with a given behavior or disease, these 
associations can nevertheless be leveraged for diagnostic or prognostic purposes41-43. That said, 
lncRNA research demands additional experimental rigor to distinguish between the possibilities 
of RNA-independent and RNA-dependent mechanisms of action, particularly when claiming the 





2.3 REINING IN LONG NON-CODING RNAS AND RNA-PROTEIN INTERACTIONS 
Assuming a lncRNA molecule is functionally responsible for a given behavior, how are lncRNAs 
thought to work? The first reported class of mechanisms includes decoy and sponge activities2. A 
well-cited example of a lncRNA decoy is the GAS5 (growth arrest-specific 5) lncRNA, 
responsible for binding to glucocorticoid receptor by mimicking the nucleotide sequence of a 
glucocorticoid response element (GRE) and preventing the receptor from recognizing GREs 
within DNA to effect gene expression44,2. Another example includes the pseudogene derived 
lncRNA PTENP1. PTENP1 was shown to compete for miRNA binding with PTEN, effectively 
releasing PTEN from miRNA repression in a DICER-dependent manner45-47,2.  
A second mechanism, applicable to non-coding RNA more generally, is direct RNA-mediated 
catalytic activity48. Examples include self-cleaving group I introns, intronic RNA structures 
responsible for binding to guanosine and removal of 5’ RNA splice sites; RNase P, a tRNA 
processing enzyme responsible for cleaving off 5’ leader sequences to produce mature tRNAs; 
and the large subunit of ribosome, responsible for protein synthesis; among other examples48-57.  
The third and most prevailing mechanism is protein scaffolding51,58,21,27. One example is the 
human telomerase RNA; while its 5’ terminal domain binds to TERT protein-binding elements, 
stem loops within the 3’ half bind to dyskerin complexes and TCAB159-61,51. Another well-
established example is the Xist lncRNA, responsible for initiation of X-chromosome inactivation 
(XCI), the process by which one of the two female X-chromosomes is transcriptionally silenced 
to establish dosage compensation in early mammalian development21. During XCI, the Xist 
lncRNA recruits several regulatory proteins to the inactive X-chromosome, ultimately resulting 




lncRNA remains an important tool for understanding how lncRNAs can directly interact and 
spatially concentrate effector proteins within the nucleus21,27. As a result of the paradigm 
established by Xist lncRNA and the repertoire of effector RNA-binding proteins within the cell, 
this dissertation examines RNA-protein interactions in several different contexts, including 
SARS-CoV-2 viral infection (Chapter 2), genomic imprinting (Chapter 3), and transcriptional 
circuits and auto-regulation (Chapter 4). 
RNA-protein interaction studies have historically relied on in vitro binding techniques or 
immunoprecipitation-based techniques, which include RNA Immunoprecipitation and 
Crosslinking Immunoprecipitation (CLIP)68-70. CLIP has been used successfully to identify 
precise RNA-binding sites for numerous RNA-binding proteins71,62. However, CLIP has also led 
to claims of direct RNA interactions by non-canonical RNA-binding proteins, including 
metabolic proteins and chromatin regulators72-73. Mili and Steitz previously showed that 
immunoprecipitation methods can identify RNA-protein interactions that do not occur in vivo, 
but rather form in solution post cell lysis (in vitro associations)74. Given discrepancies between 
CLIP-based biochemical evidence (supporting specific RNA-protein interactions) and genetic 
evidence (demonstrating that these same interactions are often dispensable), CLIP-based 
methods need to be reevaluated in light of possible in vitro association artifacts62,75-83. We 
discuss this reevaluation in greater detail in Chapter 2. 
2.4 LESSONS FROM VIROLOGY 
The fields of Virology and RNA biology are fundamentally linked. Insights from viruses have 
led to key discoveries within basic RNA biology, processing, gene regulation, and disease 




how RNA can carry genetic information, from tobacco mosaic virus; discovery of the retroviral 
reverse transcriptase from Rous sarcoma virus and Rauscher mouse leukaemia virus; the 
discovery of mRNA capping from simian vacuolating virus 40 (SV40) and vaccinia virus; the 
discovery of RNA-splicing from adenovirus; the discovery of the polyadenylation signal from 
SV40; and early discoveries of RNA-interference using various plant-viruses; among others10,84-
100. Vice versa as discussed in Chapter 2 with Covalent Linkage Affinity Purification, RNA 
biology methods development can also lead to insights in Virology. The two go hand-in-hand. 
The term ‘virus’ is derived from the Latin word for poison; given their associations with 
numerous debilitating diseases in man and detrimental effects on agriculture, livestock, and the 
food-supply, viruses justifiably remain the target of translational research efforts and 
application101-114. Translational application aside, viruses are an ideal basic science model 
system, owing to their limited coding capacity, rapid growth and replication cycle, and robust 
associated phenotypes (with notable exceptions in all three categories to be sure)115. Viruses 
enable researchers to frame every experimental hypothesis within the context of a simpler 
guiding question: “how does this interaction promote viral fitness and replication?” This 
interpretation may not necessarily be entirely intuitive or correct however, particularly with 
systems-level understanding of host-virus dynamics, as later discussed in Chapters 2 and 5. Still, 
viruses have increased our understanding of basic RNA biology, with clear ramifications for 
studies of non-coding RNA and RNA-protein interactions. 
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SARS-CoV-2 is a novel coronavirus that causes the respiratory disease known as COVID-19. 
Despite the urgent need, we still do not fully understand the molecular basis of SARS-CoV-2 
pathogenesis. Here, we comprehensively define the interactions between SARS-CoV-2 proteins 
and human RNAs using Covalent Linkage Affinity Purification, a technique capable of 
identifying bona fide RNA-protein interactions while reducing deleterious in vitro association 
artifacts. We show that NSP16 binds to the mRNA recognition domains of the U1 and U2 
splicing RNAs and acts to suppress global mRNA splicing upon SARS-CoV-2 infection. We 
find that NSP1 binds to 18S ribosomal RNA in the mRNA entry channel of the ribosome and 
leads to global inhibition of mRNA translation upon infection. Finally, we find that NSP8 and 
NSP9 bind to the 7SL RNA in the Signal Recognition Particle and interfere with protein 
trafficking upon infection. Disruption of these cellular functions suppresses the interferon 
response to viral infection. Our results uncover a multipronged strategy utilized by SARS-CoV-2 
to antagonize essential cellular processes to suppress host defenses. 
 
2.0 INTRODUCTION 
Coronaviruses are a family of viruses with notably large single-stranded RNA genomes and 
broad species tropism among mammals1. Recently, a new coronavirus, SARS-CoV-2, was 
discovered to cause the severe respiratory disease known as COVID-19. It is highly transmissible 
within human populations and its spread has resulted in a global pandemic with nearly a million 




this virus in human cells. Accordingly, there is an urgent need to understand these mechanisms 
to guide the development of therapeutics. 
 
SARS-CoV-2 encodes 27 proteins with diverse functional roles in viral replication and 
packaging4-5. These include 4 structural proteins: the nucleocapsid (N, which binds the viral 
RNA), and the envelope (E), membrane (M), and spike (S) proteins, which are integral 
membrane proteins. In addition, there are 16 non-structural proteins (NSP1-16) which encode the 
RNA-directed RNA polymerase, helicase, and other components required for viral replication6. 
Finally, there are 7 accessory proteins (ORF3a-8) whose function in viral replication or 
packaging remain largely uncharacterized7-8. 
  
As obligate intracellular parasites, viruses require host cell components to translate and transport 
their proteins and to assemble and secrete viral particles9. Upon viral infection, the mammalian 
innate immune system acts to rapidly detect and block viral infection at all stages of the viral life 
cycle10-12. The primary form of intracellular viral surveillance engages the interferon pathway, 
which amplifies signals resulting from detection of intracellular viral components to induce a 
systemic type I interferon response upon infection13. Specifically, cells contain various RNA 
sensors (such as RIG-I and MDA5) that detect the presence of viral RNAs, promote nuclear 
translocation of the transcription factor IRF3 leading to transcription, translation, and secretion 
of interferon (e.g. IFN-a and IFN-b). Binding of interferon to cognate cell-surface receptors leads 
to transcription and translation of hundreds of antiviral genes. In order to successfully replicate, 




In addition to their essential roles in the viral life cycle, many viral proteins also antagonize core 
cellular functions in human cells to evade host immune responses. For example, human 
cytomegalovirus (HCMV) encodes proteins that inhibit class 1 Major Histocompatibility (MHC) 
display on the cell surface by retaining MHC proteins in the endoplasmic reticulum15, 
polioviruses encode proteins that degrade translation initiation factors (eIF4G) to prevent 
translation of 5’-capped host mRNAs16-17, and influenza A encodes a protein that modulates 
mRNA splicing to degrade the mRNA that encodes RIG-I18-19. 
 
Suppression of the interferon response has recently emerged as a major clinical determinant of 
COVID-19 severity20, with almost complete loss of secreted IFN characterizing the most severe 
cases21. The extent to which SARS-CoV-2 suppresses the interferon response is a key 
characteristic that distinguishes COVID-19 from SARS and MERS22. Several strategies have 
been proposed for how the related SARS- and MERS-causing viruses may hijack host cell 
machinery and evade immune detection, including repression of host mRNA transcription in the 
nucleus23, degradation of host mRNA in the nucleus and cytoplasm24-25, and inhibition of host 
translation26. Nonetheless, the extent to which SARS-CoV-2 uses these or other strategies, and 
how they may be executed at a molecular level remains unclear. 
 
Understanding the interactions between viral proteins and components of human cells is essential 
for elucidating their pathogenic mechanisms and for development of effective therapeutics. 
Because SARS-CoV-2 is an RNA virus and many of its encoded proteins are known to bind 




intermediates in protein production) or non-coding RNAs (critical structural components of 
diverse cellular machines) to promote viral propagation.  
  
To date, most studies of RNA-protein interactions have relied on in vitro binding assays or 
immunoprecipitation experiments (e.g. RNA Immunoprecipitation, RIP, or Crosslinking 
Immunoprecipitation, CLIP)28-30. However in a classic experiment, Mili and Steitz showed that 
immunoprecipitation methods can identify RNA-protein interactions that do not occur in vivo, 
but rather form in solution after cell lysis, which may be problematic for screens with potential 
therapeutic implications31. To address this issue, we developed a new method called Covalent 
Linkage and Affinity Purification (CLAP) that enables purification of RNA-protein interactions 
using fully-denaturing conditions. 
 
Using CLAP, we comprehensively define the interactions between each SARS-CoV-2 protein 
and human RNAs. We show that 10 viral proteins form highly specific interactions with mRNAs 
or ncRNAs, including those involved in progressive steps of host cell protein production. We 
show that NSP16 binds to the mRNA recognition domains of the U1 and U2 RNA components 
of the spliceosome and acts to suppress global mRNA splicing in SARS-CoV-2-infected human 
cells. We find that NSP1 binds to a precise region on the 18S ribosomal RNA that resides in the 
mRNA entry channel of the initiating 40S ribosome. This interaction leads to global inhibition of 
mRNA translation upon SARS-CoV-2 infection of human cells. Finally, we find that NSP8 and 
NSP9 bind to discrete regions on the 7SL RNA component of the Signal Recognition Particle 
(SRP) and interfere with protein trafficking to the cell membrane upon infection. We show that 




response to viral infection. Together, our results uncover a multipronged strategy utilized by 
SARS-CoV-2 to antagonize essential cellular processes and robustly suppress host immune 
defenses. 
3.0 RESULTS 
3.1 CLIP IDENTIFIES MANY PRC2-RNA INTERACTIONS THAT FORM IN SOLUTION 
AFTER CELL LYSIS 
CLIP methods are the gold-standard for defining in vivo RNA-protein interactions and have been 
successfully used to define the precise RNA binding sites of numerous RNA binding proteins32. 
Briefly, CLIP utilizes UV crosslinking to form covalent interactions in cells between directly 
interacting RNA and protein, followed by immunoprecipitation, subsequent separation through a 
denaturing SDS-PAGE gel, transfer to a nitrocellulose membrane, size extraction of the RNA-
protein complex, and sequencing of the associated RNAs32-34. Given critical discrepancies 
between biochemical evidence (supporting specific chromatin-RNA interactions) and genetic 
evidence (demonstrating that these same interactions are often dispensable), we wanted to 
examine the specificity of CLIP and if it were subject to in vitro association artifacts prior to 
examining RNA-protein interactions in SARS-CoV-235-44. 
 
Based on the abundance of literature characterizing interactions between RNA and the chromatin 
regulatory complex Polycomb Repressive Complex 2 (PRC2), we specifically focused on PRC2 
complex components EZH2, EED, and SUZ12 as test cases45-48,36. To determine whether any 
observed PRC2-RNA interactions might represent associations that occur in solution, we 




an RNA binding protein (HuR) in one cell, its known RNA target (fos mRNA) in a separate cell, 
and measured RNA-protein associations that occur after mixing these distinct cells31. We 
extended this framework to enable quantitative measurements of in solution association by 
generating V5-tagged versions of all three PRC2 components (EED, EZH2, and SUZ12) and 
transfecting them into human HEK293T cells, followed by UV-crosslinking these cells to form 
covalent interactions between RNA and proteins that directly interact in vivo (+tag sample). We 
then mixed these human cells with UV-crosslinked mouse ES cells that do not express the V5-
tagged protein (-tag sample). We performed CLIP in these mixed samples using an antibody 
against the V5-tagged PRC2 proteins and only analyzed sequencing reads that mapped uniquely 
and unambiguously to either the human or mouse genomes (Figure 1A). In this system, any 
detected mouse RNA must represent an RNA-protein interaction that occurred after cell lysis 
because the immunoprecipitated V5-tagged protein is not expressed in mouse cells. 
 
We find that the majority of expressed RNAs are significantly enriched for all 3 PRC2 
components in the +tag samples (~65%, p<10-6, Figure 1B). For example, we observe strong 
enrichment for all 3 PRC2 components across several lncRNAs that have previously been 
reported to bind to PRC2 including XIST, HOTAIR, KCNQ1ot1, and TUG1 (Figure 1B)49-
52,48,39,43-44. We also observed PRC2 binding in the –tag samples, suggesting CLIP methods are 
subject to in vitro association artifacts (Figure 1B).  
  
In order to directly compare protein binding to the same RNAs in the +tag and -tag experiments, 
we transfected each of the 3 PRC2 components into a human cell line (+tag[Human]) and mixed 




cell line and mixed them with untransfected human cells (-tag[Human]). We performed CLIP in 
these two sets of mixed samples and directly compared PRC2 binding to the same human RNAs 
in the +tag[Human] and -tag[Human] experiments. We observed a strong global correlation between 
RNA regions that are highly enriched in the -tag[Human]  samples and those that are enriched in the 
+tag[Human] samples (Pearson correlation = 0.43, Figures 1C and 1E). For example, when 
focusing on XIST, we observed that the 3 PRC2 components showed highly comparable profiles 
in both the +tag[Human] and -tag[Human] samples and display broad enrichment across the RNA with 
the strongest enrichment being over the A-repeat region as previously reported (Figures 1D and 
1E)35,50. Notably, these binding profiles are highly similar to those observed across XIST when 
performing CLIP using antibodies that recognize the endogenous PRC2 components (Figure 
1D).  
 
These results demonstrate that thousands of PRC2-RNA interactions can be detected by CLIP 
even when they do not occur in vivo.   
 
3.2 COVALENT LINKAGE AFFINITY PURIFICATION REMOVES RNA-PROTEIN 
INTERACTIONS THAT DO NOT OCCUR IN VIVO 
While the presence of strong PRC2-RNA binding in solution does not preclude the possibility 
that these PRC2 components also bind to RNA in vivo, it highlights the challenge in accurately 
determining which of the detected PRC2-RNA represent bona fide interactions that occur in vivo. 
Because CLIP is the current gold standard approach for studying RNA-protein interactions, there 
are currently no methods available that allow us to confidently assess in vivo interactions 




We considered several possibilities that could lead to the detection of RNA-protein interactions 
that do not occur in vivo: (i) the captured protein may interact directly with RNA in solution and 
this RNA could even be crosslinked to a distinct protein, (ii) the captured protein may associate 
in solution with other proteins that are crosslinked to RNA, or (iii) other proteins that are 
crosslinked to RNA may still be retained after immunoprecipitation (Figure 2A). Any of these 
non-specific interactions that remain after immunoprecipitation would be detected because the 
protein purification (immunoprecipitation) and denaturation steps (gel electrophoresis) are 
decoupled in the CLIP procedure (Figure 2B). These sources of protein-specific background 
binding would be especially problematic when the captured protein does not actually bind to 
RNA, or binds to rare RNA targets in vivo, because non-specific RNA targets will be present in 
vast excess relative to bona fide targets.  
 
To address these issues, we developed a new method called Covalent Linkage and Affinity 
Purification (CLAP) that enables purification of RNA-protein interactions using fully-denaturing 
conditions (Figure 2B). CLAP integrates an epitope tag into a protein of interest that enables 
covalent coupling of the tagged protein to a resin (e.g. HaloTag, SpyTag)53-54. Because the 
tagged protein is covalently coupled to the resin, rather than captured through an antibody, we 
can use a purification procedure that employs fully denaturing conditions – including high 
temperatures, high concentrations of denaturants and detergents, and chaotropic salts – that 
disrupt protein folding and RNA folding. This procedure directly couples protein purification 
and denaturation and accordingly the only RNA-protein interactions that should remain are those 





To test whether CLAP reduces RNA-protein associations that occur in solution, we performed a 
mixing experiment where we expressed proteins fused to both Halo and V5 tags in human cells 
(+tag) and mixed them with untransfected mouse cells (-tag). We then split the lysate and 
performed CLIP and CLAP captures from the same mixture allowing us to directly compare the 
contribution of in solution associations in each experiment (Figure 2B). In the –tag samples, 
CLAP led to greatly reduced levels of background associated RNA for all 3 of the PRC2 proteins 
relative to V5 CLIP (Figure 2C and 2D). These results demonstrate that CLAP accurately 
removes RNA-protein interactions that do not occur in vivo.  
 
3.3 CLAPS ACCURATELY MAPS RNA-PROTEIN INTERACTIONS FOR A WIDE-RANGE 
OF RBPS IN VIVO 
To ensure that CLAP can identify bona fide RNA-protein interactions that occur in vivo, we 
performed CLAP on seven well-characterized RNA binding proteins (RBPs) that are known to 
interact with distinct classes of RNAs to mediate well-defined functions (e.g. mRNA splicing, 
translational regulation). These include (i) proteins that bind predominately within intronic 
regions and have high selectivity towards precise RNA sequence motifs (PTBP1, hnRNPC, 
hnRNPH1), (ii) proteins that bind to nascent pre-mRNA with broad affinity and a promiscuous 
binding profile (SAF-A and SRSF9), and (iii) proteins that bind to mature mRNAs in the 
cytoplasm (FMR1 and IGF2BP1)55-61. In all cases, we observed RNA binding profiles by CLAP 
that are highly comparable to those observed in previously reported CLIP experiments (Figures 
3A-C). For example, we find that hnRNPC binds specifically to intronic regions, SRSF9 binds 




strong bias towards the 3’ end (Figures 3A-B). Importantly, for all proteins, the observed RNA 
binding profiles are markedly different from the distribution of RNA present in the total input 
sample (Figure 3A).  
 
Because these 7 well-characterized RBPs bind to many different RNAs, we wanted to ensure that 
the CLAP method would have the sensitivity to define RNA-protein interactions that might 
occur if a protein only binds to very few, highly specific RNA targets in vivo. To test this, we 
expressed a Halo-tagged GFP fused to a λN bacteriophage RNA binding protein, which does not 
have any endogenous RNA targets in animal cells, but is known to interact with high affinity in 
vivo to RNAs containing a BoxB RNA aptamer62 . We co-transfected these cells with an MBP-
BoxB RNA. Using CLAP, we found that GFP-λN was enriched exclusively over the co-
expressed MBP-BoxB RNA, but not over any endogenously expressed RNAs (Figure 3D). 
CLAP reads were enriched specifically over the BoxB containing portion of the RNA and 
comparatively depleted over the MBP RNA (Figure 3E).  Moreover, by exploiting the well-
described tendency for reverse transcriptase to preferentially terminate at the site of a UV-
crosslinked RNA-protein binding site, we find that the cDNA induced truncation sites 
correspond precisely to the location of the BoxB RNA sequences (Figure 3E)33. 
 
These results demonstrate that CLAP accurately identifies RNA-protein interactions that are 






3.4 COMPREHENSIVE MAPPING OF SARS-COV-2 PROTEIN BINDING TO HUMAN 
RNAS 
We cloned all 27 of the known SARS-CoV-2 viral proteins into mammalian expression vectors 
containing an N-terminal HaloTag53, expressed each in HEK293T cells, and exposed them to UV 
light to covalently crosslink proteins to their bound RNAs. We then lysed the cells and purified 
each viral protein using stringent, denaturing conditions to disrupt any non-covalent associations 
and capture those with a UV-mediated interaction (Figure 4A, Methods). As positive and 
negative controls, we purified a known human RNA binding protein (PTBP1) and a metabolic 
protein (GAPDH) (Figures 5A-E). We successfully purified 26 of the 27 viral proteins (Figure 
5A; full-length Spike was not soluble when expressed). We found that 10 viral proteins (NSP1, 
NSP4, NSP8, NSP9, NSP12, NSP15, NSP16, ORF3b, N, and E protein) bind to specific host 
RNAs (p-value < 0.001, Figure 4B, Table S1), including 6 structural ncRNAs and 142 mRNAs 
(Table S1). These include mRNAs involved in protein translation (e.g. COPS5, EIF1, and 
RPS12), protein transport (ATP6V1G1, SLC25A6, and TOMM20), protein folding (HSPA5, 
HSPA6, and HSPA1B), transcriptional regulation (YY1, ID4, and IER5), and immune response 
(JUN, AEN, and RACK1) (FDR < 0.05, Figures 4B and 5F). Importantly, the observed 
interactions are highly specific for each viral protein, and each protein binds to a precise region 
within each RNA (Figures 4C and 5F). 
 
Using these data, we identified several viral proteins that interact with structural ncRNA 
components of the spliceosome (U1 and U2 snRNA), the ribosome (18S and 28S rRNA), and the 
Signal Recognition Particle (7SL) (Figure 4B). Because these molecular machines are essential 




trafficking – we focused on their interactions with viral proteins to understand their functions and 
mechanisms in SARS-CoV-2 pathogenesis. 
3.5 NSP16 BINDS TO THE PRE-MRNA RECOGNITION DOMAINS OF THE U1 AND U2 
SNRNAS 
After transcription in the nucleus, nascent pre-mRNAs are spliced to generate mature mRNAs 
which are translated into protein. Splicing is mediated by a complex of ncRNAs and proteins 
known as the spliceosome. Specifically, the U1 small nuclear RNA (snRNA) hybridizes to the 5’ 
splice site at the exon-intron junction and the U2 snRNA hybridizes to the branchpoint site 
within the intron to initiate splicing of virtually all human mRNAs65. We identified a highly 
specific interaction between the NSP16 viral protein and the U1 and U2 snRNAs (Figure 4B). 
 
Because U1 and U2 are small RNAs (164 and 188 nucleotides, respectively), we noticed strong 
enrichment of NSP16-associated reads across the entire length of each. To more precisely define 
the binding sites, we exploited the well-described tendency of reverse transcriptase to 
preferentially terminate when it encounters a UV-crosslinked protein on RNA (Figures 4A and 
5D)33. We determined that NSP16 binds to the 5’ splice site recognition sequence of U1 (Figures 
6A-B and 7A-B) and the branch point recognition site of U2 (Figures 6C-D and 7C-D). These 
binding sites are highly specific to NSP16 relative to all of the other viral and human proteins 
(Figures 4B, 7A, and 7C). Consistent with its interaction with U1/U2, we observed that NSP16 
localizes within the nucleus upon SARS-CoV-2 infection (Figures 6E and 7E-F) and when 






3.6 NSP16 DISRUPTS GLOBAL MRNA SPLICING UPON SARS-COV-2 INFECTION 
Based on the locations of the NSP16 binding sites relative to the mRNA recognition domains of 
the U1/U2 spliceosomal components, we hypothesized that NSP16 might disrupt splicing of 
newly transcribed genes (Figure 6F). To test this, we co-expressed NSP16 in human cells along 
with a splicing reporter derived from IRF7 (an exon-intron-exon minigene) fused to GFP66. In 
this system, if the reporter is spliced, then GFP is made; if not, translation is terminated (via a 
stop codon present within the first intron) and GFP is not produced (Figure 8A). We observed a 
>3-fold reduction in GFP levels in the presence of NSP16 compared to a control human protein 
(Figures 8B and 9A). 
 
To explore whether NSP16 has a global impact on splicing of endogenous mRNAs, we measured 
the splicing ratio of each gene using nascent RNA sequencing. Specifically, we metabolically 
labeled nascent RNA by feeding cells for 20 minutes with 5-ethynyl uridine (5EU), purified and 
sequenced 5EU-labeled RNA, and quantified the proportion of unspliced fragments spanning the 
3’ splice site of each gene (Figures 8C, 9B). We observed a global increase in the fraction of 
unspliced genes in the presence of NSP16 compared to controls (Figures 8D, 9C, 9D). 
 
Given that NSP16 is sufficient to suppress global mRNA splicing, we expect that its expression 
in SARS-CoV-2-infected cells would result in a global mRNA splicing deficit. To test this, we 
infected human lung epithelial cells (Calu3) with SARS-CoV-2 and measured splicing levels of 
newly transcribed mRNAs compared to a mock infected control. As expected, we observed a 




of measured genes showing increased intron retention (Figures 8E, 9E). Together these results 
indicate that NSP16 binds to the splice site and branch point sites of U1/U2 to suppress global 
mRNA splicing in SARS-CoV-2 infected cells (Figure 8F). Although NSP16 is known to act as 
an enzyme that deposits 2’-O-methyl modifications on viral RNAs67, our results demonstrate that 
it also acts as a host virulence factor. Global disruption of mRNA splicing may act to decrease 
host protein and mRNA levels by triggering nonsense-mediated decay of improperly spliced 
mRNAs68. Consistent with this, we observed a strong global decrease in steady-state mRNA 
levels (relative to ncRNA levels) upon SARS-CoV-2 infection (Figure 9F). 
 
3.7 INHIBITION OF MRNA SPLICING SUPPRESSES HOST INTERFERON RESPONSE TO 
VIRAL INFECTION 
Because many of the key genes stimulated by interferon (IFN) are spliced, we reasoned that 
mRNA splicing would be critical for a robust IFN response. To test this, we utilized a reporter 
line engineered to express alkaline phosphatase upon IFN signaling (mimicking an antiviral 
response gene). This IFN Stimulated Gene (ISG) reporter line can be stimulated using IFN-b and 
assayed for reporter induction. We observed strong repression of this IFN responsive gene upon 
expression of NSP16 (Figure 8G) and upon addition of a small molecule that interferes with 
spliceosomal assembly (Figure 9G). These results demonstrate that one outcome of NSP16- 
mediated inhibition of mRNA splicing is to reduce the host cells’ innate immune response to 
viral recognition. Consistent with such a role, we observed an increase in intron retention within 
multiple IFN-responsive genes (such as ISG15 and RIG-I) upon SARS-CoV-2 infection 





3.8 NSP1 BINDS TO 18S RIBOSOMAL RNA IN THE MRNA ENTRY CHANNEL OF THE 
40S SUBUNIT 
Once exported to the cytoplasm, spliced mRNA is translated into protein on the ribosome. 
Initiation of translation begins with recognition of the 5’ cap by the small 40S subunit (which 
scans the mRNA to find the first start codon). We observed that NSP1 binds exclusively to the 
18S ribosomal RNA (Figures 4B and 10A) – the structural RNA component of the 40S 
ribosomal subunit. 
 
Several roles for NSP1 have been reported in SARS-CoV and MERS-CoV including roles in 
viral replication, translational inhibition, transcriptional inhibition, mRNA degradation, and cell 
cycle arrest69-70, 24-25. One of the reported roles for NSP1 in SARS-CoV is that it can associate 
with the 40S ribosome to inhibit host mRNA translation24,71, yet it remains unknown whether 
this association is due to interaction with the ribosomal RNA, protein components of the 
ribosome, or other auxiliary ribosomal factors. Accordingly, the mechanisms by which NSP1 
acts to suppress protein production remain elusive. 
 
We mapped the location of NSP1 binding to a 37 nucleotide region corresponding to Helix 18 
(Figure 11A), adjacent to the mRNA entry channel (Figure 11B)72. The interaction would 
position NSP1 to disrupt 40S mRNA scanning and prevent translation initiation (Figure 11B), 
and disrupt tRNA recruitment to the 80S ribosome and block protein production (Figure 10B). 
Interestingly, the NSP1 binding site includes the highly conserved G626 nucleotide which 
monitors the minor groove of the codon-anticodon helix for tRNA binding fidelity73. We noticed 




known ribosome inhibitors that bind within the mRNA entry channel to preclude mRNA access 
(Figure 10C). Consistent with this, a recent cryo-EM structure confirms that NSP1 binds to 
these same nucleotides of 18S within the mRNA entry channel76. 
 
3.9 NSP1 SUPPRESSES GLOBAL TRANSLATION OF HOST MRNAS UPON SARS-COV-2 
INFECTION 
Given the location of NSP1 binding on the 40S ribosome, we hypothesized that it could suppress 
global initiation of mRNA translation. To test this, we performed in vitro translation assays of a 
GFP reporter in HeLa cell lysates and found that addition of NSP1 led to potent inhibition of 
translation (Figure 10D). We observed a similar NSP1-mediated translational repression when 
we co-expressed NSP1 and a GFP reporter gene in HEK293T cells (Figures 11C-D). In contrast, 
we did not observe this inhibition when we expressed other SARS-CoV-2 proteins (NSP8, 
NSP9, M) or human proteins (GAPDH) (Figure 11D). 
 
To determine if NSP1 leads to translational inhibition of endogenous proteins in human cells, we 
used a technique called Surface Sensing of Translation (SUnSET) to measure global protein 
production levels77. In this assay, translational activity is measured by the level of puromycin 
incorporation into elongating polypeptides (Figure 10E). We observed a strong reduction in the 
level of global puromycin integration in cells expressing NSP1 compared to cells expressing 
GFP (Figures 10F-G). 
 
Because NSP1 expression is sufficient to suppress global mRNA translation in human cells, we 




infected a human lung epithelial (Calu3) or monkey kidney (Vero) cell line with SARS-CoV-2 
and measured nascent protein synthesis levels using SUnSET. We observed a strong reduction of 
global puromycin integration upon SARS-CoV-2 infection in both cell types (Figures 11E-F, 
10H-I). 
 
To explore whether NSP1 binding to 18S rRNA is critical for translational repression, we 
generated a mutant NSP1 in which two positively charged amino acids (K164 and H165) in the 
C-terminal domain were replaced with alanine residues (Figure 10C)78. We observed a complete 
loss of in vivo contacts with 18S (Figure 11G); because this mutant disrupts ribosome contact, 
we refer to it as NSP1 Delta RC. We co-expressed GFP and NSP1 Delta RC in HEK293T cells 
and found that the mutant fails to inhibit translation (Figures 11H and 10J). In contrast, 
mutations to the positively charged amino acids at positions 124/125 do not impact 18S binding 
(Figure 11G) or the ability to inhibit translation (Figure 11H). 
 
Together, these results demonstrate that NSP1 binds within the mRNA entry channel of the 
ribosome and that this interaction is required for translational inhibition of host mRNAs upon 
SARS-CoV-2 infection. 
3.10 NSP1-MEDIATED TRANSLATIONAL INHIBITION SUPPRESSES HOST 
INFERFERON RESPONSE 
We explored whether NSP1 binding to 18S rRNA suppresses the ability of cells to respond to 
IFN-b stimulation upon viral infection. We transfected ISG reporter cells with NSP1, stimulated 
with IFN-b, and observed robust repression of the IFN responsive gene (>6-fold, Figure 11I). To 




stranded RNA (dsRNA)-sensing pathways typically triggered by viral infection, we treated a 
human lung epithelial cell line (A549) with poly(I:C), a molecule that is structurally similar to 
dsRNA and known to induce an antiviral innate immune response(Figure 10K)79-80. We 
observed a marked downregulation of IFN-b protein and endogenous IFN-b responsive mRNAs 
in the presence of NSP1, but not in the presence of NSP1 Delta RC (Figures 10L-M). These 
results demonstrate that NSP1, through its interaction with 18S rRNA, suppresses the innate 
immune response to viral recognition (Figure 11J). 
 
3.11 THE VIRAL 5’ LEADER PROTECTS MRNA FROM NSP1-MEDIATED 
TRANSLATIONAL INHIBITION 
Because NSP1 blocking the mRNA entry channel would impact both host and viral mRNA 
translation, we explored how translation of viral mRNAs is protected from NSP1-mediated 
translational inhibition. Many viruses contain 5’ untranslated regions that regulate viral gene 
expression and translation81; all SARS-CoV-2 encoded subgenomic RNAs contain a common 5’ 
leader sequence that is added during negative strand synthesis82. We explored whether the leader 
sequence protects viral mRNAs from translational inhibition by fusing the viral leader sequence 
to the 5’ end of GFP or mCherry reporter genes (Figure 12A). We found that NSP1 fails to 
suppress translation of these leader-containing mRNAs (Figures 13A-B, 12B). We dissected the 
leader sequence and found that the first stem loop (SL1) is sufficient to prevent translational 
suppression upon NSP1 expression (Figure 13C) or SARS-CoV-2 infection (Figure 13D). 
 
We considered three models for how the leader could protect viral mRNAs: (i) it could compete 




could bind to the leader independently of its ribosome interaction to allosterically modulate the 
NSP1-ribosome interaction. We reasoned that if the leader competes for NSP1 binding or 
directly recruits free ribosomes, then the presence of SL1 should be sufficient for protection, 
regardless of its precise position in the 5’ UTR. In contrast, if the leader allosterically modulates 
ribosome binding then the spacing between the 5’ cap (which is bound to NSP1-40S) and SL1 
would be critical for protection. To distinguish between these models, we swapped the location 
of SL1 and SL2 in the 5’ leader or inserted 5 nucleotides between the 5’ cap and SL1 (Figure 
S5C) and found that both mutants ablate protection (Figures 13E and 12D). 
 
These results indicate that an mRNA requires the 5’ leader to be precisely positioned relative to 
the NSP1-bound 40S ribosome to enable translational initiation (Figure 13F). While many 
aspects of this allosteric model remain to be explored, it would explain how leader-mediated 
protection can occur on an mRNA only when present in cis. Moreover, this model suggests that 
NSP1 might also act to further increase viral mRNA translation by actively recruiting the 
ribosome to its own mRNAs. Consistent with this, we observe a consistent ~20% increase in 
translation of leader-containing reporter levels upon viral infection (Figure 13D) or expression 
of NSP1 (Figure 12E). 
 
3.12 NSP8 AND NSP9 BIND TO THE 7SL RNA COMPONENT OF THE SIGNAL 
RECOGNITION PARTICLE 
Upon engaging the start codon in an mRNA, the 60S subunit of the ribosome is recruited to form 
the 80S ribosome which translates mRNA. The Signal Recognition Particle (SRP) is a 




the nascent peptide to identify hydrophobic signal peptides present in integral membrane proteins 
and proteins secreted from the plasma membrane83. When these are identified, SRP triggers 
ribosome translocation to the endoplasmic reticulum (ER) to ensure proper folding and 
trafficking of these proteins to the cell membrane83. 
 
We identified two viral proteins – NSP8 and NSP9 – that bind at distinct and highly specific 
regions within the S-domain of the 7SL RNA scaffold of SRP (Figures 14A and 15A). NSP8 
interacts with 7SL in the region bound by SRP54 (the protein responsible for signal peptide 
recognition, SRP-receptor binding, and ribosome translocation) (Figure 14B)83-84. NSP9 binds to 
7SL in the region that is bound by the SRP19 protein (Figure 14B), which is required for proper 
folding and assembly of SRP (including proper loading of SRP54)83. 
 
Because SRP scans nascent peptides co-translationally, we were intrigued to find that NSP8 also 
forms a highly specific interaction with 28S rRNA (the structural component of the 60S subunit) 
(Figures 14C and 15B). The binding site on 28S rRNA corresponds to the largest human-
specific expansion segment within the ribosome, referred to as ES2785. ES27 is highly dynamic, 
and thus has not been resolved in most ribosome structures86. However, when engaged by 
specific factors, ES27 can become ordered, and was recently shown to be capable of interacting 
with the ribosome exit tunnel, adjacent to the 60S binding site of SRP (Figures 14D and 15C)87.  
 
Together, these observations suggest that NSP8 and NSP9 bind to the co-translational SRP 
complex. Consistent with this, we find that NSP8 and NSP9 localize broadly throughout the 





3.13 NSP8 AND NSP9 SUPPRESS PROTEIN INTEGRATION INTO THE CELL 
MEMBRANE 
Because NSP8 and NSP9 binding on 7SL are positioned to disrupt SRP function, we 
hypothesized that they may alter translocation of secreted and integral membrane proteins 
(Figure 16A). To test this, we expressed an SRP-dependent membrane protein (Nerve Growth 
Factor Receptor, NGFR88) fused via an Internal Ribosome Entry Site (IRES) to a non-membrane 
GFP (Figure 16F). In this system, if a perturbation specifically affects membrane protein levels 
we expect to see a decrease in the ratio of membrane to non-membrane protein levels. To ensure 
that the NGFR reporter accurately reports on SRP function, we treated HEK293T cells with 
siRNAs against SRP54 or SRP19 and found that both lead to a dramatic reduction of the NGFR 
membrane protein relative to the non-membrane GFP protein (Figure 16B). Similarly, we found 
that expression of NSP8 and NSP9 (alone or together) lead to a striking reduction in expression 
of NGFR relative to GFP (Figure 17A). Expression of control proteins did not specifically 
impact NGFR levels (Figures 17A and 16B). 
 
To determine if there is a global effect on membrane protein levels, we utilized the SUnSET 
method to measure puromycin levels in membrane proteins using flow cytometry (see Methods). 
We confirmed that disruption of SRP leads to a global reduction in puromycin levels in the cell 
membrane (Figure 16C). We observed a comparable global reduction of puromycin-labeled 
membrane proteins upon expression of NSP8 or NSP9 individually or together, but not with 




3.14 SARS-COV-2 INFECTION SUPPRESSES PROTEIN INTEGRATION INTO THE CELL 
MEMBRANE 
Because NSP8 and NSP9 are each sufficient to suppress protein integration into the cell 
membrane, we anticipate that SARS-CoV-2 infection would lead to similar suppression. 
However, determining whether SARS-CoV-2 infection specifically impacts membrane protein 
expression is confounded by the fact that NSP1 inhibits translation of membrane and 
nonmembrane proteins upon infection. 
 
To address this, we co-expressed a membrane protein reporter (NGFR) containing the 5’ viral 
leader along with a non-membrane GFP reporter containing the viral leader. Upon viral 
infection, we observed a strong reduction of membrane protein levels (Figure 17C), but no 
reduction in non-membrane GFP levels (Figure 13D). To ensure that these effects are specific to 
SARS-CoV-2 infected cells, we separated individual cells within the infected population into 
those expressing the viral Spike protein (S+) and those not expressing the protein (S-). We found 
that the shift in membrane protein levels only occurs in S+ cells (Figure 17D), while the S- 
population resembled the mock infected samples (Figure 17C). We observed a strong 
relationship between the level of Spike protein – likely reflecting the amount of viral replication 
within each cell – and the level of membrane protein suppression (Figure 17C). We observed 
this membrane protein-specific decrease upon infection of human lung epithelial (Calu3, Figure 
16D) and monkey kidney (Vero, Figures 17C-D) cell lines. 
 
Together, these results demonstrate that NSP8 and NSP9 bind to 7SL to disrupt SRP function 




NSP9 are thought to be components of the viral replication machinery89, our results indicate that 
they play an additional role as host virulence factors. Because viral membrane proteins also 
require trafficking to the ER, viral disruption of SRP might negatively impact viral propagation, 
unless viral proteins are trafficked in an SRP-independent manner (Figure 16E) or if NSP8/9 
selectively impacts host (but not viral) proteins. 
 
3.15 VIRAL DISRUPTION OF PROTEIN TRAFFICKING SUPPRESSES INTERFERON 
RESPONSE 
Next we explored how disruption of SRP might be advantageous for viral propagation. Because 
secretion of IFN and other cytokines is dependent on the SRP complex for secretion (Figure 
16F), a central component of the IFN response is dependent on SRP. Accordingly, we 
hypothesized that NSP8/9-mediated viral suppression of SRP would act to suppress the IFN 
response upon infection. To test this, we co-expressed NSP8 and NSP9 and observed a 
significant reduction in the IFN response relative to a control protein (Figure 16G). 
Together, these results suggest that SARS-CoV-2 mediated suppression of SRP-dependent 
protein secretion enables suppression of host immune defenses (Figure 17E). Interestingly, 
many proteins involved in anti-viral immunity – including most cytokines and class I major 
histocompatibility complex – are membrane-anchored or secreted, and are known to use the SRP 
pathway for transport (Figure 16F), suggesting that there may be other effects of SRP pathway 
inhibition on SARS-CoV-2 pathogenesis90. 
 
4.0 DISCUSSION  




global inhibition of host mRNA splicing, protein translation, and membrane protein trafficking – 
and described the molecular mechanisms by which the virus acts to disrupt these essential cell 
processes. Interestingly, all of the viral proteins involved (NSP1, NSP8, NSP9, and NSP16) are 
produced in the first stage of the viral life cycle, prior to generation of double stranded RNA 
(dsRNA) products during viral genome replication. Because dsRNA is detected by host immune 
sensors and triggers the type I interferon response, disruption of these cellular processes would 
allow the virus to replicate its genome while minimizing the host innate immune response. 
Disruption of these three non-overlapping steps of protein production may represent a 
multipronged mechanism that synergistically acts to suppress the host antiviral response (Figure 
17F). Specifically, the IFN response is usually boosted >1,000-fold upon viral detection (through 
amplification and feedback, Figure 11K), yet each individual mechanism impacts IFN levels on 
the order of ~5-10-fold. Accordingly, if each independent mechanism impacts IFN levels 
moderately, the three together may be able to achieve dramatic suppression of IFN (103=1,000- 
fold). This multi-pronged mechanism may explain the molecular basis for the potent suppression 
of IFN observed in severe COVID-19 patients. 
 
Interferon is emerging not only as a determinant of disease severity, but also a potential 
treatment option91. As such, our work identifies several therapeutic opportunities for boosting 
IFN levels upon SARS-CoV-2 infection. For example, disrupting the interaction between NSP1 
and 18S rRNA could allow cells to detect and respond to viral infection. Because many small-
molecule drugs target ribosomal RNAs92, it may be possible to develop drugs to block the NSP1-
18S and other interactions. Additionally, disrupting the 5’ viral leader may be a potent antiviral 




it may be possible to design small molecules that specifically bind this structure to suppress viral 
protein production93. 
 
Viral suppression of these cellular functions is not exclusive to the IFN response and will also 
impact other spliced, translated, secreted, and membrane proteins. Many proteins involved in 
anti-viral immunity are spliced and/or membrane-anchored or secreted. For example, class I 
major histocompatibility complex (MHC), which is critical for antigen presentation to CD8 T 
cells at the cell surface of infected cells94. By antagonizing membrane trafficking, SARS-CoV-2 
may prevent viral antigens from being presented on MHC and allow infected cells to escape T-
cell recognition and clearance. In this way, interference with these essential cellular processes 
might further aid SARS-CoV-2 in evading the host immune response. 
 
More generally, we expect that insights gained from the SARS-CoV-2 protein-RNA binding 
maps will be critical for exploring additional viral mechanisms. Specifically, we identified many 
other interactions, including highly specific interactions with mRNAs. For example, NSP12 
binds to the JUN mRNA (Figure 5E) which encodes the critical immune transcription factor c- 
Jun which is activated in response to multiple cytokines and immune signaling pathways95. We 
also identified an interaction between NSP9 and the start codon of the mRNA that encodes 
COPS5 (Figure 4C), the enzymatic subunit of the COP9 Signalosome complex which regulates 
protein homeostasis96, suggesting that it might disrupt its translation. Interestingly, COPS5 (also 
known as JAB1) is known to bind and stabilize c-Jun protein levels97 and several viruses are 




play in virally infected cells, the specificity suggests that they may provide a selective advantage 
for viral propagation.  
 
Together, our results demonstrate that global mapping of RNA binding by viral proteins could 
enable rapid characterization of mechanisms for newly emerging pathogenic RNA viruses. 
 
4.1 LIMITATIONS OF STUDY  
We note several limitations of our current study that will need to be explored in future work. (i) 
Our mapping experiments were performed in uninfected human cells expressing tagged viral 
proteins. Accordingly, it remains possible that our maps may not fully capture all of the 
interactions that occur when human cells are infected, such as interactions that occur with viral 
induced RNAs, in specific viral compartments, or that require multiple viral proteins. (ii) While 
we characterized the functional and mechanistic roles of several viral proteins and structural 
ncRNAs, we did not explore what roles viral protein interactions with mRNAs might play. (iii) 
How the virus disrupts fundamental cellular processes while still maintaining its own production 
is still largely undefined. While we showed that the 5' leader is sufficient to relieve translational 
inhibition by NSP1, we still do not fully understand how this protection occurs and specifically 
how NSP1 might interact with the viral leader or allosterically modulate ribosome binding. 
Similarly, viral membrane proteins are dependent on trafficking to the ER and how NSP8/9 
might selectively impact ER translocation of host – but not viral – proteins remains to be 
explored. (iv) While we showed that viral disruption of these essential cellular functions can 
suppress IFN, what other roles host cell shutdown might play in viral pathogenesis and in 




responses, have not been explored. 
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6.0 MATERIALS AND METHODS 
Cell lines and culture conditions 
Cell lines used in this study. We used the following cell lines in this study: (i) HEK293T, a 
female human embryonic kidney cell line obtained from ATCC. (ii) HEK-Blue™ ISG, 
Interferon regulatory factor (IRF)-inducible Secreted Alkaline Phosphatase (SEAP) reporter 
HEK293 cells of female origin (Invivogen). (iii) A549, a male human lung epithelial cell line 
obtained from ATCC. (iii) Calu3, a male human lung epithelial cell line obtained from ATCC, 
(iv) Vero E6, a female African green monkey kidney cell line, kindly provided by J.L. Whitton 




Cell culture conditions. A549s, HEK293T cells and derivatives were cultured in complete media 
consisting of DMEM (GIBCO, Thermo Fisher Scientific) supplemented with 10% FBS 
(Seradigm Premium Grade HI FBS, VWR), 1X penicillin-streptomycin (GIBCO, Thermo Fisher 
Scientific), 1X MEM non-essential amino acids (GIBCO, Thermo Fisher Scientific), 1 mM 
sodium pyruvate (GIBCO, Thermo Fisher Scientific) and maintained at 37C under 5% CO2. For 
maintenance, 800,000 cells were seeded into 10 mL of complete media every 3-4 days in 10 cm 
dishes. Vero E6 cells were maintained in complete DMEM (Thermo Fisher Scientific, 11965–
092) containing 10% fetal bovine serum (FBS) (Thermo Fisher Scientific, 16140–071), 1% 
HEPES Buffer Solution (Thermo Fisher Scientific, 15630–130), and 1% penicillin-streptomycin 
(Thermo Fisher Scientific, 15140–122). Calu3 cells were maintained in Eagles’s Minimal 
Essential Medium (ATCC) containing 10% FBS and 1% penicillin-streptomycin purchased from 
Thermo Fisher Scientific. All cell lines were maintained at 37C under 5% CO2. Cells were grown 
in a humidified incubator at 37C with 5% CO2. 
 
SARS-CoV-2 Viral Infection conditions 
All experiments using infectious SARS-CoV-2 conducted at the UVM BSL-3 facility were 
performed under an approved Institutional Biosafety protocol. SARS-CoV-2 strain 2019- 
nCoV/USA_USA WA1/2020 (WA1) was generously provided by Kenneth Plante and the World 
Reference Center for Emerging Viruses and Arboviruses (WRCEVA) at the University of Texas 
Medical Branch and propagated in Vero E6 cells. Viral infections were performed at the 
indicated multiplicity of infection in a low volume of normal cellular maintenance media 
containing 2% FBS for one hour at 37.C, inoculum was removed and then overlaid in the 




Experiments performed to visualize the location of viral NSP proteins (and associated antibody 
validation) were performed in a Containment Level 3 facility at the MRC-University of Glasgow 
Centre for Virus Research using SARS-CoV-2 strain England-02 (from Public Health England 
[now called National Institute for Health Protection], GISAID: EPI_ISL_407073) using a MOI 
of 0.1 or 1 (as indicated). 
 
Crosslinking and Immunoprecipitation (CLIP) 
 
Purifications. Cells were lysed in 1 ml lysis buffer (50 mM Tris pH 7.5, 100mM NaCl, 1% NP-
40, 0.5% Sodium Deoxycholate, 1x Promega protease inhibitor cocktail). RNA was digested 
with Ambion RNase I (1:3000 dilution) to achieve a size range of 100-500 nucleotides in length. 
Lysate preparations were precleared by mixing with Protein G beads for 30 min at 4C. Target 
proteins were immunoprecipitated from 5 million cells with 10µg of antibody and 75µl of 
Protein G beads in 100µL lysis buffer. The antibodies were pre-coupled to the beads for 1 hour 
at room temperature with mixing and unbound antibodies removed with 3 washes of lysis buffer. 
The precleared lysate was added to the Protein G coupled antibody beads overnight at 4C. After 
the immunoprecipitation, the beads were washed four times with High salt wash buffer (50 mM 
TrisHCl pH 7.4, 1 M NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate) 
and four times with Wash buffer (20 mM Tris-HCl pH 7.4, 10 mM MgCl2, 0.2% Tween-20). 
RNA and protein were eluted by incubating at 50C in NLS elution buffer (20 mM Tris-HCl pH 
7.5, 10 mM EDTA, 2% N-lauroylsacrosine, 2.5 mM TCEP) supplemented with 100 mM DTT 
for 20 minutes. Samples were then run through an SDS-PAGE gel and transferred to a 
nitrocellulose membrane using the iBLOT transfer system, and a region 70 kDa above the 




followed by buffer exchange and concentration with RNA Clean & Concentrator™-5 (Zymo). 
RNA sequencing libraries from these samples were constructed as previously described102,119-121. 
We used the following antibodies: V5 antibody (Bethyl, A190-120A), EZH2 (Active Motif, 
39933), SUZ12 (Active Motif, 39357), PTBP1 (Abcam, ab5642), and SAFA/hnRNPU (Santa 
Cruz, SC-32315). 
 
CLIP Library Construction. CLIP samples were treated as previously described102,120. Briefly, 
after immunoprecipitation and wash steps, the RNA was dephosphorylated (Fast AP) and cyclic 
phosphates removed (T4 PNK) and then ligated on Protein G beads with an RNA adapter 
containing a RT primer binding site. The ligated protein-bound RNA was then run through a 
denaturing PAGE gel and transferred to nitrocellulose membrane (as described above). The RNA 
was then extracted by proteinase K and purified using a spin column (Zymo). The RNA was 
reverse transcribed into single stranded cDNA. After RT, the RNA was degraded and a second 
adapter was ligated to the single stranded DNA. PCR amplification is achieved using primers 
that target the 3’ and 5’ adapters. Input total RNA libraries were constructed using the same steps 
as outlined above except that the dephosphorylation, cyclic phosphate removal, and ligation were 
performed in solution rather than on Protein-G beads.   
 
Read processing and Alignment. Sequencing reads were trimmed to remove adaptor sequences 
and any bases containing a quality scores <10 using Trimmomatic122. We filtered out all read-
pairs where either read was trimmed to <25 nucleotides. We excluded PCR duplicates using the 
FastUniq tool123. The remaining reads were then aligned to Ribosomal RNAs (rRNAs) using the 




because it allowed more permissive alignments to rRNA reads that contained mismatches and 
indels due to RT errors induced by rRNA post-transcriptional modifications. The remaining 
reads were then aligned to a combined genome reference containing the mouse (mm9) and 
human (hg19) genomes using STAR aligner125. Only reads that mapped uniquely in the genome 
and unambiguously to the human or mouse genomes were kept for further analysis.  
 
Gene Window Enrichment calculations. All human (hg19) and mouse (mm9) annotated genes 
(RefSeq, downloaded from UCSC Hg19 and MM9, respectively) were used as a reference set 
except for the genes encoding the 6 transfected proteins. In addition, we added all human 
lncRNAs as annotated by Genecode (release 26). For each gene, we enumerated 100 nucleotide 
windows that span across the exons and introns of each gene. For each window, we calculated 
the enrichment by computing the number of reads overlapping the window in the protein elution 
sample divided by the number of reads in the input sample. Because all windows overlapping a 
gene should have the same expression level in the input sample, we estimated the number of 
reads in the input as the maximum of either (i) the number of reads over the window or (ii) the 
median read count over all windows within the gene. This approach provides a conservative 
estimation of enrichment because it prevents windows from being scored as enriched if the input 
values over a given window are artificially low, while at the same time accounting for any non-
random issues that lead to increases in read counts over a given window (i.e. alignment artifacts 
leading to non-random assignment or pileups).  
 
We normalized this observed ratio by the expected number of reads in a window defined as the 




the sample. This normalization estimates the expected read coverage for each window and 
accounts for the redistribution of reads that occur because of the fixed sequencing depth used and 
possible “drop out” of specific RNA regions during the enrichment process. The total number of 
reads in the protein elution or input samples was calculated by adding the total number of 
human-specific reads, mouse-specific reads, and ribosomal RNA reads. Nominal p-values were 
calculated for each window using a binomial test where k (number of successes) is defined as the 
number of reads in the protein elution samples within the window, N (number of trials) is the 
sum of the number of reads in the protein elution and input samples, and p (probability of 
success) is the expected number of reads per window in the elution divided by the sum of the 
expected number of reads per window in elution and input samples. (The expected number of 
reads is defined as the total number of reads divided by the number of windows). For plotting 
and reporting purposes, we considered all regions with a nominal binomial p-value< 10-6 as 
significant. However, the overall results reported are robust to the precise p-value cutoff used. 
 
Plotting and visualization. IGV plots for specific RNAs were generated by computing 
enrichments (as described above) across 100 nucleotide windows and the enrichment value was 
plotted at the midpoint of each window.  
 
Generation of SARS-CoV-2 RNA binding maps 
 




Nsp11) were a gift from Fritz Roth (see Table S3 for Addgene information)101 and were LR-
cloned (Invitrogen Gateway Cloning, Thermo Fisher Scientific) into mammalian expression 
destination vector pCAG-Halo-TEV-DEST-V5-IRES-puroR. Note that following LR 
cloning, proteins were not V5-tagged because all entry clones contained stop codons. For 
NSP11, an entry clone was generated by BP cloning (Invitrogen Gateway Cloning, Thermo 
Fisher Scientific) a PCR amplicon (primers: 
ggGGACAAGTTTGTACAAAAAAGCAGGCTTTtcagctgatgcacaatcgtttttaaacgg and 
gGGGACCACTTTGTACAAGAAAGCTGGGTTttacaccgcaaacccgtttaaaaacgattg; template: 
pGBW-m4133457 a gift from Ginkgo Bioworks) into pDONR221. 
 
Expression and lysis. For each viral protein capture, we transfected 10 µg of these expression 
vectors into HEK293T cells grown on a 15cm dish using BioT transfection reagent (Bioland) 
according to manufacturer’s recommendations. 24-48 hours post-transfection, cells were washed 
once with PBS and then crosslinked on ice using 0.25 J cm−2 (UV2.5k) of UV at 254 nm in a 
Spectrolinker UV Crosslinker. Cells were then scraped from culture dishes, washed once with 
PBS, pelleted by centrifugation at 1,000 X g for 5 min, and flash-frozen in liquid nitrogen for 
storage at –80C. We lysed batches of 5 million cells by completely resuspending frozen cell 
pellets in 1 mL of ice cold lysis buffer (50 mM Hepes, pH 7.4, 100 mM NaCl, 1% NP-40, 0.1% 
SDS, 0.5% Sodium Deoxycholate) supplemented with 1X Protease Inhibitor Cocktail (Promega), 
200 U of Ribolock (Thermo Fisher Scientific), 20 U Turbo DNase (Ambion), and 1X 
Manganese/Calcium Mix (0.5mM CaCl2, 2.5 mM MnCl2). Samples were incubated on ice for 10 
minutes to allow lysis to proceed. The lysates were then incubated at 37C for 10 minutes at 700 




g for 2 minutes. The supernatant was collected and kept on ice until bound to the HaloLink Resin 
(Promega). Of the 1mL lysis volume, 50uL was set aside for input, 20uL used for protein 
expression confirmation, and the rest for capture on HaloLink Resin as described below. 
 
Protein capture. We used 200 µL of 25% HaloLink Resin slurry (50 µL of HaloLink Resin total) 
per 5 million cells. Resin was washed three times with 2 mL of 1X PBS-T (1x PBS + 0.1% 
Triton X-100) and incubated in 1X Blocking Buffer (50 mM HEPES, pH 7.4, 100 µg/mL BSA) 
for 20 minutes at room temperature with continuous rotation. After the incubation, resin was 
washed three times with 1X PBS-T. The cleared lysate was mixed with 50µl of HaloLink Resin 
and incubated at 4C for 3-16 hrs with continuous rotation. The captured protein bound to resin 
was washed three times with lysis buffer at room temperature and then washed three times at 
90C for 3 minutes while shaking on a Thermomixer at 1200 rpm with each of the following 
buffers: 1X NLS buffer (1xPBS, 2% NLS, 10 mM EDTA), High Salt Buffer (50 mM HEPES, 
pH 7.4, 0.1% NP-40, 1M NaCl), 8M Urea Buffer (50 mM HEPES, pH 7.5, 0.1% NP-40, 8 M 
Urea), Tween buffer (50 mM HEPES, pH 7.4, 0.1% Tween 20) and TEV buffer (50 mM HEPES, 
pH 7.4, 1 mM EDTA, 0.1% NP-40). The extended incubation of the bound RNA with the wash 
buffers leads to chemical fragmentation of the RNA yielding sizes that are suitable for RNA 
library preparation and binding site resolution. Between each wash, samples were centrifuged at 
1,000 X g for 30 seconds and supernatant was removed. After the last wash, samples were 
centrifuged at 7,500 X g for 30 seconds and supernatant was discarded. For elution, the resin was 
resuspended in 100 µL of NLS Buffer and 10 µL of Proteinase K (NEB) and the sample was 
incubated at 50C for 30 minutes while shaking at 1200 rpm. Input samples were similarly 




Scientific), centrifuged at 2,000 X g for 30 seconds, and elutions used for RNA purification by 
RNA Clean and Concentrate-5 kits (Zymo, >17nt protocol). 
 
For qPCR analysis, cDNA was generated from purified RNA using Maxima H- reverse 
transcriptase (Thermo Fisher Scientific) following manufacturer’s recommendations. 
Amplification reactions were assembled with primer sets indicated in Table S2 and 
LightCycler. 480 SYBR Green I Master (Roche) following manufacturer’s protocols and read 
out in a Roche Lightcycler 480. 
 
Library construction. RNA-Seq libraries were constructed from purified RNA as previously 
described102. Briefly, after proteinase K elution, the RNA was dephosphorylated (Fast AP) and 
cyclic phosphates removed (T4 PNK) and then cleaned using Silane beads as previously 
described102. An RNA adapter containing a RT primer binding site was ligated to the 3’ end of 
the cleaned and end-repaired RNA. The ligated RNA was reverse transcribed (RT) into cDNA, 
the RNA was degraded using NaOH, and a second adapter was ligated to the single stranded 
cDNA. Library preparation was the same for input samples except that an initial chemical 
fragmentation step (90C for 2 min 30 s in 1X FastAP buffer) was included prior to FastAP 
treatment. This chemical fragmentation step was designed to be similar to the fragmentation 
conditions used for purified Halo bound samples. The DNA was amplified and Illumina 
sequencing adaptors were added by PCR using primers that are complementary to the 3’ and 5’ 
adapters. The molarity of PCR amplified libraries were measured by Agilent Tapestation High 
Sensitivity DNA screentapes and all samples were pooled at equal molarity. The pool was then 




were measured by Agilent Bioanalyzer and Qubit high sensitivity DNA to determine the loading 
density of the final pooled sample. Pooled samples were paired-end sequenced on an Illumina 
HiSeq 2500 with read length 35 x 35nts. 
 
Sequence alignment and analysis. For Halo purifications and RNA binding mapping sequencing 
reads were aligned to a combined genome reference containing the sequences of structural RNAs 
(ribosomal RNAs, snRNAs, snoRNAs, 45S pre-rRNA) and annotated mRNAs (RefSeq hg38) 
using Bowtie2. To distinguish between the nascent pre-ribosomal RNA and mature 18S, 28S, 
and 5.8S rRNA, we separated each of the components of the 45S into separate sequence units for 
alignment (e.g. ITS, ETS). We excluded all low quality alignments (MAPQ < 2) from the 
analysis. For mRNA analysis, we removed PCR duplicates using the Picard MarkDuplicates 
function (https://broadinstitute.github.io/picard/). 
 
For each RNA, we enumerated 100 nucleotide windows across the entire RNA. For each 
window, we calculated the enrichment by computing the number of reads overlapping the 
window in the protein elution sample divided by the total number of reads within the protein 
elution sample. We normalized this ratio by the number of reads in the input sample divided by 
the total number of reads in the input sample. Because all windows overlapping a gene should 
have the same expression level in the input sample (which represents RNA expression), we 
estimated the number of reads in the input as the maximum of either (i) the number of reads over 
the window or (ii) the median read count over all windows within the gene. This approach 
provides a conservative estimation of enrichment because it prevents windows from being scored 




accounting for any non-random issues that lead to increases in read counts over a given window 
(e.g. fragmentation biases or alignment artifacts leading to non-random assignment or pileups). 
 
We calculated a multiple testing corrected p-value using a scan statistic, as previously 
described103-104. Briefly, n was defined as the number of reads in the protein elution plus the 
number of reads in the control sample. p was defined as the total number of reads in the protein 
elution sample divided by the sum of the protein elution sample total reads and total reads in the 
control sample. w was the size of the window used for the analysis (100 nucleotides). The scan 
statistic p-value was defined using the Poisson estimations based on standard distributions 
previously described105. 
 
Because RNA within input samples are fragmented differently than the protein elution samples, 
we noticed that the overall positional distribution of protein elution samples was distinct from 
Input distributions. Accordingly, we used the remaining protein elution samples (rather than 
Input) as controls for each protein. Specifically, this enabled us to test whether a given protein is 
enriched within a given window relative to all other viral and control proteins. Enrichments were 
computed as described above. These values are plotted in Figure 1 and Table 1. 
 
Plotting and visualization. Enrichment plots for specific RNAs were visualized in IGV107 and 
were generated by either: (i) computing the enrichment for each nucleotide as described above. 
In this case, the read count for each nucleotide was computed as the total number of reads that 
overlapped the nucleotide. (ii) Counting the number of RT stop sites at a given nucleotide. In this 




each nucleotide. We normalized this count by the total number of reads in the sample to account 
for sequencing depth generated. We then normalized this ratio by the same ratio computed for 
the control sample (merge of all other protein samples) for each nucleotide. Heatmaps were 
generated using Morpheus (https://software.broadinstitute.org/morpheus/). All values were 
included if they contained a significant 100nt window with a p-value<0.001 (see above) and 
minimum enrichment of 3-fold above the control sample. 
 
Gene ontology analysis. The 66 non-N enriched mRNAs were analyzed against the Gene 
Ontology Biological Processes and Reactome gene sets using the Molecular Signatures Database 
(MSigDB)107. Significantly enriched gene sets with an FDR<0.05 were used. To ensure that 
significant gene sets were not being driven by the multiple ribosomal proteins or histone 
proteins, these analyses were also carried out excluding these proteins. 
 
Antibody Generation 
To generate the sheep polyclonal anti-NSP1, anti-NSP8, anti-NSP9, and anti-NSP16 antibodies 
utilized in this study, NSP1, NSP8, NSP9 and NSP16 (using QHD43415.1 as reference) were 
cloned into pGex (GST-tagged) and pMex (MBP-tagged), in order to produce GST- and MBP-
tagged respective NSP proteins. The N-terminal GST fusions were then used as antigens to 
immunize sheep. A bleed from the sheep was taken 7 days later, after which the MBP-tagged 
NSP proteins were used for serum affinity purification of the antibodies. To validate expression 
of the antibodies, Vero E6 cells were uninfected (mock) or infected with SARS-CoV-2 England- 
02 using a MOI of 0.1 or 1 (as indicated). At 72 hours post infection, the samples were 




NSP or mouse anti-actin (Developmental Studies Hybridoma Bank JLA20, antibody registry ID: 
AB_528068) primary antibodies. 
 
Microscopy imaging 
Cells were seeded on gelatin/laminin and poly-D-lysine (Sigma) coated coverslips or chamber 
slides (Nunc, Thermo Fisher Scientific) and transfected with mammalian expression vectors for 
Halo-tagged viral proteins. After 16-24 hours, cells were incubated with TMR-HaloTag. 
Ligand (Promega) according to manufacturer’s instructions, washed with PBS and fixed in 4% 
Formaldehyde (Pierce, Thermo Fisher Scientific). Cells were subsequently incubated in DAPI 
for 10 min and washed with PBS. For chamber slides, samples were imaged directly. For 
coverslips, samples were washed with water and mounted with ProLong Gold + DAPI 
(Molecular Probes, Thermo Fisher Scientific). We acquired images on a Nikon TS100-F 
widefield microscope or a Zeiss LSM800 inverted confocal microscope, collecting in line-
scanning mode with 4x line averaging using a 63x oil objective. 
 
For staining of infected cells, cells were fixed and permeabilized in 8% formaldehyde 1% Triton, 
and subsequently labelled with primary antibodies raised in sheep to SARS-CoV-2 at 1/500 
dilution, followed by incubation with a rabbit anti-sheep Alexa 555 secondary antibody (Abcam, 
ab150182) at 1/1000 dilution and mounted with DAPI in the medium (Thermo Fisher Scientific, 
cat# P36395). Cells were imaged with a Zeiss LSM 880 confocal microscope, with 1 Airy unit 
pinhole for all primary antibody channel acquisitions and pixel size 0.07 µm x 0.07 µm. The 







NSP1 homology model. The predicted model of SARS-CoV-2 NSP1 was generated using the 
transform-restrained Rosetta (trRosetta) algorithm, a deep learning-based modeling method 
based on the Rosetta energy minimization pipeline with additional distance and interaction 
restraints generated from co-evolution108. All figures were generated using 
Pymol (www.pymol.org). 
 
NSP1-ribosome model. The model of NSP1 bound to the ribosome was generated using 
Modeller version 9.24109. The C-terminal sequence of NSP1 (KHSSGVTRELMRELNGG) was 
modeled using the structure of SERBP1 bound to the ribosome (PDB ID: 6MTE, chain w) as a 
template. The default Modeller parameters were used to create an alignment of NSP1 and 
SERBP1 and to generate the model, and all atoms within 6. of SERBP1 were included in the 
model to define the neighboring environment. Twenty models were generated and the model 
with the lowest DOPE score was selected to visualize with Pymol110. 
 
Structural analysis of protein-RNA interactions. X-ray crystal structures and cryo-electron 
microscopy structures were obtained from the Protein Data Bank (www.rcsb.org)111 and 
visualized with PyMOL110 . For U1 and U2 structural analysis, we used a cryo-EM structure of 
the pre-catalytic human spliceosome (PDB ID: 6QX9). For 7SL structural analysis, we used an 
X-ray crystal structure of the human signal recognition particle (PDB ID: 1MFQ). To examine 
human SRP in the context of the ribosome, we used a cryo-EM structure of the mammalian SRP-




superimposed a cryo-EM structure of the expansion segment (PDB ID: 6SXO) onto the complete 
ribosome structure (PDB ID: 3JAJ) using the PyMOL command “super.” Finally, for NSP1–18S 
rRNA structural analysis, we used multiple structures of the ribosome, including structures of the 
pre-40S subunit (PDB ID: 6G5H), 48S late-stage initiation complex (PDB ID: 6YAL), 80S in 
complex with SERBP1 (PDB ID: 6MTE), and 80S in complex with Stm1 (PDB ID: 4V88). 
 
Recombinant NSP1 production 
NSP1 was cloned into a bacterial expression vector resulting in N-terminally tagged Halo-6xHis-
tagged Nsp1. The NSP1 sequence was PCR amplified from Addgene Nsp1 entry vector to add a 
N-terminal 6X HIS tag and restriction enzyme sites for digestion and ligation into N-terminal 
Halo bacterial expression vector. This construct was transformed into BL21 DE3 E. coli 
(Agilent), expanded to a 500mL liquid culture, and grown until OD600 reached 1.0. IPTG was 
added to a final concentration of 1mM. After 3 hours of IPTG induction, bacteria was 
centrifuged for 15 min at 5000 X g. Pellet was lysed with binding buffer (50mM HEPES, pH 7.5, 
20mM MgCl2, 600mM NaCl, 2mM TCEP, 10mM Imidazole, 2mM ATP, 1% Triton X-100) 
supplemented with ATP (2mM), protease inhibitor cocktail (Promega), Benzonase (Sigma) and 
Triton-X 100 (Sigma) using 5mL of lysis mix per gram of wet cell paste. Cell suspension was 
rocked for 20 min at room temperature and then centrifuged at 16,000 X g for 20 min at 4C. 
Supernatant was incubated with washed iMAC resin (Bio-Rad) and rocked for 20 min at room 
temperature. We loaded the resin-lysate mixture into an appropriately-sized column and washed 
with 5 column volumes of binding buffer (50mM HEPES, pH 7.5, 20mM MgCl2, 600mM NaCl, 
2mM TCEP, 10mM Imidazole, 2mM ATP, 1% Triton X-100) followed by 10 column volumes 




Recombinant NSP1 (rNSP1) was eluted with 5 column volumes of elution buffer by adding 1 
column volume at a time with column flow stopped, collecting eluate after each addition, and 
waiting 15 min between each elution buffer addition. We dialyzed these eluates with a 10mL 
Spectra-Por. Float-A-Lyzer. G2 (Spectrum Laboratories) into storage buffer (50mM HEPES, 
pH 7.5, 150mM NaCl, 10% glycerol) at 4C using 2 exchanges, one after 2 hours and then 
overnight. 
 
In vitro translation assays 
Pierce 1-Step Human Coupled IVT-DNA (Thermo Fisher Scientific) in vitro translation kit was 
used to measure rNsp1-dependent translation inhibition. Bovine Serum Albumin (BSA), and 
buffer only controls were used to control for the addition of excess protein or changes in buffer 
composition. To measure translation inhibition, 5µL in vitro translation reactions were 
assembled, scaled according to manufacturer’s recommendations. The included control plasmid 
pCFE-GFP was used to measure translational output of the reactions. GFP fluorescence was 
measured on a BioTek Cytation3 plate reader using emission filters for GFP fluorescence. 1.5µM 
stock dilutions of rNsp1 and BSA were made in storage buffer (50mM HEPES, pH 7.5.,150mM 
NaCl,10% glycerol). Subsequent 10 fold dilutions were made in storage buffer to span a 
concentration range of 1000 nM to 1 nM for each protein in the final reaction. 10 µL of the 
diluted protein solution was added to the 5µL translation reactions, and incubated for 5 minutes 
at room temperature prior to the addition of the GFP reporter plasmid. Duplicate reactions were 
made to measure variability for each condition. In addition, a buffer only control was included to 
measure the effect of dilution of the translation reaction by the storage buffer. After the 5 minute 




4 hours prior to fluorescence detection. Two microliters from each reaction was measured in 
duplicate on a Biotek Cytation3 microplate reader using excitation and emission filters for GFP. 
Sample readings were blanked by subtracting values obtained from the buffer only control. 
Promega’s Rabbit Reticulocyte Lysate System was also used to assay translation inhibition. To 
measure translation inhibition, 10µL in vitro translation reactions were assembled, scaled 
according to manufacturer’s recommendations. For each translation reaction, either 10µL of 
recombinant protein storage buffer or rNSP1 was added, followed by 500ng of mRNA. After 4 
hours of incubation at 30C, luciferase was read out using the Bright-Glo luciferase assay 
(Promega) or GFP fluorescence was measured, both on a Biotek Cytation3 plate reader. 
 
In vivo translation assays 
We assayed translation in HEK293T cells transfected with mammalian expression vectors, 
mRNAs, or combinations of these. For mRNA transfections of fluorescence protein translation 
reporters (including unmodified, +SARS-CoV2 leader sequence, +SL1, +SL2-SL1, and +5nts), 
DNA templates for in vitro transcription were generated with sequences appended to the 5’ end 
of GFP and mCherry (see Tables S4 and S5 for primers and templates, respectively) and 
transcribed using HiScribe™ T7 ARCA mRNA Kit with tailing (New England Biolabs). For 
Nsp1 mRNA transfection, indicated primers from Table S4 were used to add restriction enzyme 
sites for cloning into pT7CFE1-CHis backbone provided in the Pierce Human 1-step Coupled 
IVT Kit and HiScribe™ T7 High Yield RNA Synthesis Kit (New England Biolabs) was used for 






Using BioT transfection reagent, mammalian expression vectors for a GFP reporter and for 
SARS-CoV-2 viral proteins were transfected into HEK293T cells seeded for imaging, as 
described above, or seeded in 24 well plate format. To transfect only mRNA, Lipofectamine 
messengerMax (Invitrogen, Thermo Fisher Scientific) or TransIT-mRNA Transfection Kit 
(Mirus Bio) was used. For transfections that included both mRNA and plasmid, Lipofectamine 
2000 (Invitrogen, Thermo Fisher Scientific) was used. 
 
To measure fluorescence at 24 hours (leader-mCherry, no leader-GFP) or 48 hours (leader GFP, 
no-leader mCherry) post-transfection, cells were trypsinized and processed for flow cytometry or 
transferred into black 96 well plates (Nunc) for fluorescence detection on a Biotek Cytation 3 
plate reader. For flow cytometry, lifted cells were washed with CBH buffer (10mM HEPES, pH 
7.4, 0.5% BSA, Hank’s Balanced Salt Solution (GIBCO, Thermo Fisher Scientific)), 
resuspended with a viability dye (7-AAD or DAPI) and analyzed on a MACSQuant Vyb. 
Acquisition files were analyzed with FlowJo analysis software. 
 
SUnSET assay 
To assay global protein translation, a SUnSET assay was performed as previously described77. 
Mammalian expression vectors were exchanged for versions that did not confer puromycin 
resistance and thus, for these experiments, LR reactions were carried out with destination vector 
pB-Halo-DEST-IRES-NGFR. Resulting expression vectors drive protein expression by a dox-
inducible promoter, contain the rtTA needed for dox induction, and produce an N-terminally-
tagged Halo fusion protein. Generation of this destination vector made use of the pB-TAG-ERN 




RRID:Addgene_80476)112 and the NGFR (Truncated Human Nerve Growth Factor Receptor) 
coding sequence from Addgene plasmid #27489 (a gift from Warren Pear; 
http://n2t.net/addgene:27489 ; RRID:Addgene_27489)88. 
 
We transfected these mammalian expression vectors for NSP1 and GFP into HEK293T using 
BioT transfection reagent. After 3 hours, doxycycline (Sigma) was added to a final concentration 
of 2µg/mL. After 24 hours, cells were incubated with puromycin (10µg/mL) for 10 min, then 
washed with fresh media, and harvested with cold PBS. Pelleted cells were lysed for 10 min on 
ice (mixing after 5 min) with 100uL RIPA buffer supplemented with protease inhibitor cocktail 
(Promega). Insoluble debris was pelleted by centrifuging at 12,500 X g for 2.5 minutes and 
supernatant was run on a Bolt™ 4-12% Bis-Tris Plus Gel (Thermo Fisher Scientific). Proteins 
were then transferred to nitrocellulose using the iBlot transfer system (Thermo Fisher Scientific) 
and Western blotting carried out using an anti-puro antibody (clone 12D10, EMD Millipore). 
 
SUnSET in SARS-CoV-2 infected cells 
SUnSET in SARS-CoV-2 infection was performed as above with the following modifications. 
Cells were infected or not (mock) with SARS-CoV-2, and 48 hpi cells were incubated with 
puromycin (10µg/mL) for 20 min. Media was aspirated and cells lysed directly in 2X Laemmli’s 
buffer (Biorad), heated at 95C for ten minutes and run on a 4-12% NuPAGE Gel (Thermo 
Fisher Scientific). Proteins were transferred to nitrocellulose using the iBlot transfer system and 






Membrane protein reporter experiments 
To assay SRP-dependent membrane protein transport to the cell surface, we monitored surface 
arrival of exogenously expressed Neuronal Growth Factor Receptor (NGFR) by flow cytometry 
in the presence of NSPs. Mammalian expression vectors were exchanged for versions that 
contained an IRES-NGFR to co-express a membrane reporter and thus, for these experiments, 
LR reactions were carried out with destination vector pB-6xHis-GFP-DEST-IRES-NGFR. 
Resulting expression vectors drive protein expression by a dox-inducible promoter, contain the 
rtTA needed for dox induction, and produce an N-terminally-tagged His-GFP fusion protein and 
a co-expressed NGFR. The GFP here is an enhanced GFP containing an amino acid substitution 
(A205K) to generate a monomeric variant based on previous literature113. 
 
We transfected these mammalian expression vectors for NSP8, NSP9, NSP1DRC mutant and 
EED into HEK293T using BioT transfection reagent, induced expression with 2µg/ml 
doxycycline 24 hours after transfection, and assessed surface arrival of NGFR 24 hours after 
induction. To carry out flow cytometric analysis, cells were lifted with 1mM EDTA, washed 
once with PBS and stained with PE-labeled anti-NGFR antibody (Biolegend; 1/600 dilution in 
PBS, 0.5%BSA) and analyzed on a MACSQuant Vyb. Fluorescence intensity measurements 
were taken for GFP and PE and analyzed using FloJo analysis software. 
 
siRNA experiments for SRP19 and SRP54 
To knockdown SRP19 and SRP54, siRNAs targeting each (Dharmacon cat# L-019729-01-0005 
and L-005122-01-0005, respectively) were transfected into HEK293T cells using Lipofectamine 




transfected cells were assayed by qPCR using primer sets (Table S2) to amplify each target as 
well as normalizer CALM3. Transfections were carried out 48 hours prior to assaying cells, 
either by qPCR, membrane reporter, or membrane SUnSET (see below) experiments. 
 
Leader-NGFR measurements 
Calu3 and Vero cells were transfected with mRNAs encoding leader-NGFR and leader-GFP 
using TransIT-mRNA Transfection Kit (Mirus) and subsequently infected with SARS-CoV-2 at 
an MOI of 0.1. After 24 hours, cells were washed with PBS, trypsinized and fixed in 4% PFA for 
20 minutes before staining with biotinylated anti-NGFR (BioLegend) and anti-SARS-Cov-2 
Spike Antibody (Sino) and subsequently stained with PE-labeled anti-Rabbit (Thermo, P- 
2771MP) and PacBlue-labeled streptavidin (Thermo, S1222). FACS was performed on a 
MACSquant Flow cytometer and analyzed using FloJo analysis software; FACS distributions 
were compared using a 2-tailed Kolmogorov-Smirnov test. For these experiments, RNA was 
transcribed from a PCR template (see Table S4) using the HiScribe T7 ARCA mRNA kit (with 
tailing). 
 
Membrane SUnSET assay 
To assay transport to the cell surface of all plasma membrane proteins, the SUnSET assay was 
adapted to puro-label surface proteins as previously described77, and read out by flow cytometry. 
Briefly, cells were incubated with puromycin as described above, followed by two quick washes 
and a chase with fresh complete media for 50 min. Cells were lifted with 1mM EDTA as 
described above and stained with an anti-puro antibody (clone 12D10, EMD Millipore) 




described above for membrane reporter assays. Fluorescence intensity measurements were taken 
for GFP and Alexa-647 on a MACSquant Flow cytometer and analyzed using FloJo analysis 
software; distributions were compared using a 2-tailed Kolmogov-Smirnov. 
 
Splicing assessment experiments 
 
IRF7-GFP splicing reporter. To assess splicing efficiency, exons 5-6 of mouse IRF7 
(ENMUST00000026571.10) containing its endogenous intron were fused upstream of 2A self-
cleaving peptide and eGFP and cloned into an MSCV vector (PIG, Addgene)118. This construct 
was co-transfected into HEK293Ts with NSP16 or GFP and measured 24 hours after transfection 
by flow cytometry (Macsquant) and analyzed using FloJo analysis software. 
 
5EU labeling of RNA. SARS-Cov2 or mock infected Calu3 cells and Nsp16- or GAPDH-
expressing HEK293Ts were labeled with 5-Ethynyl-uridine (5EU; Jena Bioscience) by adding 
5EU containing media to cells for 20 min at a final concentration of 1mM, as previously 
described114. After the pulse label, cells were washed with warm PBS and lysed in RLT buffer 
(Qiagen). Total RNA was isolated from cells using manufacturer’s protocols for Qiashredder and 
RNeasy RNA isolation (both Qiagen), followed by Turbo DNase treatment (Ambion, Thermo 
Scientific), and Zymo RNA Clean and Concentrate. For each sample, 2µg of RNA was used for 
ligation of a unique barcoded RNA adaptor, following the relevant steps in the protocol 
described above in Library Construction of RNA-seq libraries. Samples were then pooled before 





Biotinylation of 5EU labeled RNA. To biotinylate 5EU-labeled RNA, samples were first mixed, 
in order, with water, HEPES (100 mM), biotin picolyl azide (1 mM; Click Chemistry Tools) and 
Ribolock RNase inhibitor, then added to premixed CuSO4 (2 mM) and THPTA (10mM), and 
finally added to freshly prepared sodium ascorbate (12mM), as previously described115. The click 
reaction was incubated for 1 hour at 25C with 1000rpm shaking on an Eppendorf thermomixer 
followed by RNA purification using >17nt protocol for Zymo Clean and Concentrate. 
 
Sequential capture of biotinylated RNA. We completed three rounds of sequential capture on 
streptavidin beads to isolate nascent transcripts (see Figure 9B). To capture biotinylated RNA, 
MyOne Streptavidin C1 Dynabeads (ThermoFisher Scientific) were first washed three times in 
Urea buffer (10mM HEPES, pH 7.5, 10mM EDTA, 0.5M LiCl, 0.5% Triton X-100, 0.2% SDS, 
0.1% sodium deoxycholate, 2.5mM TCEP, 4M Urea) followed by three additional washes in M2 
buffer (20mM Tris, pH 7.5, 50mM NaCl, 0.2% Triton X-100, 0.2% sodium deoxycholate, 0.2% 
NP-40). Washed beads were mixed with 3 parts 4M Urea buffer and 1 part biotinylated RNA and 
incubated for 60 min with 900rpm thermomixer shaking at room temperature. 
 
After magnetic separation, beads were washed 3 times with M2 buffer followed by 3 washes 
with Urea buffer at 37C at 750rpm for 5 min. RNA was eluted from beads in 2 sequential 
elutions by incubating with elution buffer (5.7M guanidine thiocyanate , 1% N-lauroylsarcosine; 
both Sigma) at 65C for 2 minutes, repeating with more elution buffer for a second elution. 
The elutions were pooled, diluted with Urea buffer, incubated with pre-washed streptavidin 




sequential captures. Final elutions were pooled, cleaned with Zymo RNA Clean and Concentrate 
following manufacturer’s protocols, and carried through RNA-seq library preparation as 
described above starting with the reverse transcription step. 
 
Splicing analysis of 5EU data. Sequenced reads were demultiplexed according to barcoded 
RNA adaptor sequences ligated to each respective sample. Trimmomatic 
(https://github.com/timflutre/trimmomatic ) was used to remove any contaminating Illumina 
primer sequences in the reads and low quality reads. Demultiplexed and trimmed files were then 
aligned to a hg19 reference genome using the spliceaware STAR aligner 
(https://github.com/alexdobin/STAR). Alignments were then deduplicated 
for PCR duplicates using PICARD MarkDuplicates (https://broadinstitute.github.io/picard/). 
 
Aligned read-fragments were defined as read1 and read2 contained within a paired-end read 
fragment along with the insert between these two reads. We defined a set of high-quality 
represented isoforms per gene using the APPRIS database116. All read fragments that spanned 
any 3’ splice site within an isoform of one of these genes was retained. For each 3’ splice site 
spanning fragment, we classified the read-fragment as a spliced fragment if it spanned an exon-
exon junction (e.g. aligned entirely within 2 distinct exons) or an unspliced fragment if it 
spanned an intron-exon junction (e.g. one of the reads was contained, or partially contained, 
within the intron). For each isoform, we computed an unspliced ratio by counting the total 
number of reads that were classified as unspliced divided by the total number of read fragments 
spanning 3’ splice sites within that gene. To ensure that the splicing ratio that we measured is a 




contained at least 10 read-fragments in each sample and where the total number of reads in the 
control and sample conditions (when merged together) contained a significant number of reads to 
reliably measure a difference between the two groups as measured by a hypergeometric test 
(p<0.01). 
 
Because different genes contain different baseline splicing ratios due to gene length and 
coverage, we computed a change in the splicing ratio for each gene independently. To do this, 
we subtracted the unspliced ratio for each sample from the average unspliced ratio for that gene 
in all of the control samples. We plotted the overall distribution of these differences in splicing 
ratios as violin plots for each sample. If there is no change in splicing ratio, we would expect that 
some genes would have higher splicing ratios and others lower splicing ratios but that the overall 
distribution would be centered around 0. 
 
Total RNA analysis of infected samples. Total RNA-Seq libraries were generated from the same 
mock infected and SARS-CoV-2 virally infected Calu3 samples treated with 5EU. Prior to 5EU 
purification, total RNA was taken and an RNA-Seq library constructed as described above using 
barcoded RNA adapters. Cytoplasmic ribosomal RNAs (18S and 28S) were depleted using 
NEBNext ribosomal RNA depletion kit (NEB E6310L) per manufacturers recommendations. 
Demultiplexed reads were aligned using Bowtie2 (http://bowtie-
bio.sourceforge.net/bowtie2/index.shtml) to custom genomes encoding classical noncoding 
RNAs (ncRNAs) or human messenger RNAs (mRNAs). Expression levels were computed for 
each mRNA by counting the total number of sequencing reads aligned to the mature mRNA. To 




to non-spliced structural non-coding RNAs – excluding rRNA but including snRNAs, 7SL, 7SK, 
etc. We then divided each mRNA count by the sum of all ncRNA counts. This normalized value 
for each gene per sample was then converted into a fold-change by dividing this normalized 
value to the mean value for both mock infected samples. The fold change of each gene relative to 
mock was plotted across all mRNAs as a violin plot. 
 
Interferon stimulation experiments 
HEK-Blue™ ISG cells were seeded in 96 well plates, transfected with Nsp1 mammalian 
expression vectors using BioT and stimulated with 50 ng/ml human IFN-B (R&D Systems). 
Supernatants were assayed for alkaline phosphatase as per manufacturer instructions using 
QUANTI-Blue reagent (Invivogen). 
 
HEK-293T cells were seeded in 6 well plates, transfected with either Halo-tagged GapdH, Nsp1, 
NSP8 and NSP9 in combination, or NSP16 mammalian expression vectors using BioT. 24 hours 
later, the media was replaced with media containing 50 ng/ml human IFN-b (R&D Systems). 
Expression was assayed using live cell Halo-imaging. Halo-TMR ligand was diluted 1:200 in 
media and added to the culture for a 1:1000 final dilution. Samples were incubated 30 minutes at 
37C, 5% CO2 and then the media was aspirated. Wells were rinsed twice with PBS, then media 
was added back to the wells. Samples were incubated 30 minutes at 37C, 5% CO2 to allow 
uncoupled ligand to diffuse out of the cells. Media was then aspirated and replaced, and cells 
were imaged by widefield fluorescence microscopy. Cultures were ultimately harvested for RNA 





A549s were seeded in 6 well plates, transfected with NSP1 mammalian expression vectors using 
Lipofectamine 2000 and stimulated with 1 µg/ml HMW poly(I:C) (Invivogen) 24h after 
transfection. Supernatant was assayed for secreted IFN-b by ELISA (Human IFN Beta ELISA, 
High Sensitivity, PBL) 24 hours after stimulation, and RNA from cells was purified and assessed 
for ISG gene expression as normalized to GAPDH expression (SYBR Green Master Mix, Bio- 
Rad). Primers used for qPCR are listed in Table S2. 
 
5’ viral leader experiments 
Sars-CoV-2 Leader sequence was appended to the 5’ end of GFP and mCherry reporter 
templates via PCR. PCR templates were then transcribed using HiScribe T7 ARCA mRNA kit 
(with tailing). Leader mutants, including SL1 only, SL1/SL2 swap, and +5nts mutants were 
likewise appended to the 5’ end of fluorescent reporter templates via PCR and transcribed using 
Hiscribe T7 ARCA kit. mRNA reporters were transfected in HEK-293T cells with 
Lipofectamine MessengerMax. To measure fluorescence of mCherry and GFP reporters, 24 
hours post transfection cells were either lifted with PBS and transferred into black 96 well plates 
for fluorescence readout on a Biotek Cytation 3 or trypsinized and processed for flow cytometry. 
Alignments and phylogeny reconstructions 
 
Alignments were performed with MAFFTT (v7.407) using a local alignment (linsi --ep 0.123 -- 
reorder [in.fasta] > [out.aln.fasta]). Resulting alignments were visualized with Geneious. 
Pairwise distance matrices were visualized with Morpheus. Phylogeny reconstructions were 
performed with IQTREE multicore (v1.6.12), model selection with 1000 bootstrap 




were visualized with FigTree. 
 
Table S1: RNA binding map of SARS-CoV-2 proteins, Related to Figure 4B can be found 
online117 
 
Table S2: qPCR primers 
 
Target Forward Primer Reverse Primer 
GAPDH ATTCCACCCATGGCAAATTC TGGGATTTCCATTGATGACAAG 
IFNbeta TTCAGTGTCAGAAGCTCCTGTGG CTGCTTAATCTCCTCAGGGATGTCA 
ISG54 CTTCCCAGTCTATCATCAACCTT CCGTCGCTTCTAGCTATGTATCT 
18S_1 CATTCGAACGTCTGCCCTAT ACCCTGATTCCCCGTCAC 
18S_2 ATTGGAGGGCAAGTCTGGT CCAAGATCCAACTACGAGCTTT 
LBR AGTATAGCCTTCGTCCAAGAAGA CAAAGGTTCTCACTGCCAGTT 
CALM3 GACCATTGACTTCCCGGAGTT GATGTAGCCATTCCCATCCTTG 
SRP19 GCCGACCAGGACAGGTTTATT TCTCTGTAGCTGTAGGATTTTCAAC 
SRP54 TGGATTGCAAGGGAGTGGTAA GGTCAAAAGCCCCTGCTCT 
 
 
Table S3: Addgene ORFs, can be found online117. 
 
Table S4: Primers used in mRNA generation. 
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Figure 1. A human and mouse mixing experiment defines RNA-protein interactions that 
occur in solution after cell lysis. (A) A schematic overview of the human and mouse mixing 
experiment. An epitope-tagged protein is expressed in human cells (+tag) and UV-crosslinked, 
lysed, and mixed with UV-crosslinked cell lysate from mouse cells not expressing the tagged 
protein (-tag). The tagged protein is specifically enriched using an antibody against the epitope 
tag and its associated RNAs are sequenced and aligned to the human and mouse transcriptomes 




(B) Scatter plot of RNA abundance (log scale, x-axis) compared to CLIP enrichment (log scale, 
y-axis) for all the PRC2 components (EZH2,SUZ12,EED) components across all 100-nucleotide 
windows of all annotated human RNAs (+tag, left) and mouse RNAs (-tag, right). Windows with 
significant enrichment (binomial p<10-6) are shown in red.  (C) CLIP enrichments for each 
PRC2 protein in the +tag (red) or –tag (blue) samples are plotted across the human lncRNA 
MALAT1. (D) CLIP enrichment profiles for PRC2 components captured using endogenous 
antibodies in untagged cells plotted across human XIST. (E) CLIP enrichment profiles for V5-








Figure 2. CLAP removes RNA-protein interactions that do not occur in vivo. (A) A 
schematic illustrating several potential ways in which RNA-protein interactions that form in 
solution may still be detected by CLIP. (B) A schematic overview comparing the CLIP (left) and 
CLAP (right) methods. A protein is tagged with both a HaloTag and V5 epitope and expressed in 
human cells (+tag) which are then mixed with mouse cells not expressing the tagged protein (-
tag). After the human and mouse lysates are mixed, the sample is split and CLIP and CLAP are 
performed on each. CLIP is performed with an anti-V5 antibody followed by standard CLIP 




RNA sequencing. CLAP covalently binds the protein to a Halo capture resin and washes in fully 
denaturing conditions prior to RNA sequencing. (C) Cumulative Distribution Function (CDF) 
plots for all 100 nucleotide windows across -tag RNAs comparing CLIP and CLAP data for the 
same proteins. (D) Scatter plot of RNA abundance compared to the CLIP enrichment (left) or 
CLAP enrichment (right) for all the PRC2 (EZH2,SUZ12,EED) proteins across all 100-
nucleotide windows of annotated mouse RNAs (-tag). Windows with significant enrichment 








Figure 3. CLAP accurately identifies RNA-protein interactions that occur in vivo for well-
defined RNA binding proteins. (A) Read distribution profiles are shown for three distinct RNA 
binding proteins (FMR1, hnRNP C, and SRSF9) as well as the distribution of features in input. 
(B) Examples of CLAP enrichments are plotted for hnRNPH1 and hnRNPC over an intronic 
region of TOP2B gene (top). FMR1, IGF2BP1, and SRSF9 CLAP enrichment profiles over the 
entire length of ENAH gene are shown. (bottom) Exons are denoted by boxes and introns by 
connecting lines in the schematic. (C) Examples of CLIP (top) and CLAP (bottom) enrichments 
are plotted for PTBP1 over intronic region of ITGAD (+tag) human pre-mRNA. The locations of 




CLAP (bottom) enrichments are plotted for SAF-A over pre-mRNA of SESN2 (+tag). Exons are 
denoted by boxes and introns by connecting lines in the schematic. (D) A scatter plot for cells 
co-expressing GFP-λN and MBP-BoxB RNA. All 100 nucleotide windows from the GFP-λN 
CLAP experiment show that most windows are depleted, except for a few significant windows 
(red) that correspond to a co-expressed MBP-BoxB RNA control for which λN has known 
binding affinity. (E) Distribution of reads (gray) and crosslinked induced truncations (red) are 









Figure 4. Global RNA binding maps of SARS-CoV-2 proteins. (A) Schematic of our 
approach. (B) Enrichment heatmap of each SARS-CoV-2 protein (rows) by significantly 
enriched 100 nucleotide RNA bins (columns, p-value<0.001 and enrichment > 3-fold, Methods). 
Shared colored bars indicate multiple bins within the same mRNA. For spacing reasons, the 82 
mRNAs bound by N-protein are displayed separately. (C) Examples of sequencing reads over 
specific mRNAs for viral proteins (red) relative to input RNA coverage (gray) are shown. 
Coding regions (thick lines) and untranslated regions (thin lines) are shown for each mRNA. See 







Figure 5. Global RNA binding maps of SARS-CoV-2 proteins, Supplementary Material 
Related to Figure 4. (A) Protein expression gels of Halo-tagged SARS-CoV-2 proteins. 




(top) and Halo (bottom) enrichments are plotted for PTBP1 over intronic regions of ITGAD 
mRNA. The location of the corresponding PTBP1 recognition motif (blue boxes) are shown. (C) 
Density scatter plot of the enrichment levels of PTBP1 over all human RNA regions as measured 
by eCLIP (x-axis) compared to the enrichment levels as measured by Halo (y-axis) for all RNAs 
identified as significantly enriched by eCLIP. (D) Cartoon illustrating protein-adduct mediated 
reverse transcriptase read stops at binding motifs (top). PTBP1 crosslink-induced truncation 
frequency relative to known PTBP1 motif (HYUUUYU, shown in red). (E) Scatter plot of RNA 
abundance (log scale, x-axis) compared to Halo enrichment (log scale, y-axis) for the GAPDH 
protein across all 100-nucleotide windows of all annotated human RNAs (exon and introns) are 
plotted. Windows with significant enrichment are shown in red. (F) Representative tracks 
illustrating different mRNA binding patterns in Halo captures of NSP12 (red), NPS9 (blue), 







Figure 6. NSP16 binds to U1 and U2 at their mRNA recognition sites. (A) NSP16 enrichment 
of reverse transcription stop positions across each nucleotide of U1 (red) compared to a control 
protein (GAPDH - black). Red box (below the x-axis) represents most enriched nucleotide 
positions (U1:9-13 nts). Gray shaded box (overlay) outlines the position of the splice site 
recognition sequence. (B) Left: Structure of the pre-catalytic human spliceosome 
(PDB:6QX9)126 highlighting the location of NSP16 binding site (red spheres) relative to U1 
(yellow ribbon) and mRNA (purple ribbon). Right: Schematic of the structure. (C) Enrichment 




enriched nucleotide positions (U2:27-34 nts). Gray shaded box outlines the location of the 
branchpoint recognition sequence. (D) Structure of the pre-catalytic human spliceosome 
(PDB:6QX9)126 displaying NSP16 binding site (red spheres), U2 (orange), and mRNA (purple). 
(E) Mock (top) or SARS-CoV-2 infected (bottom) Vero E6 cells immunostained with a 
polyclonal antibody to NSP16 (left) or NSP1 (right). Imaris 3D reconstruction of DAPI (nucleus) 
and NSP16 or NSP1 signal are shown for each protein. Signal contained within the 3D nuclear 
volume (blue) is shown in yellow and cytoplasmic signal in purple. Size bars are 3µm. (F) 








Figure 7. NSP16 binds to the U1 and U2 components of the spliceosome at their mRNA 




enrichment across SARS-CoV-2 Halo capture datasets. (B) NSP16 binding traces along U1 RNA 
between two separate captures. Splice site recognition domain is highlighted in gray. (C) 
Comparison of U2 RNA enrichment across SARS-CoV-2 Halo capture datasets. (D) NSP16 
binding traces along U2 RNA between two separate captures. Branch point recognition domain 
is highlighted in gray. (E) NSP16 immunofluorescence in Vero E6 cells infected (or mock 
infected) with SARS-CoV-2 at an MOI of 0.1 for 48h. Four representative fields are displayed, 
with size bar indicating 10 microns. (F) Western blot confirmation of NSP16 and NSP1 
antibodies used to generate images in (E). Vero cells were infected (or mock infected) with 
SARS-CoV-2 at an MOI of 0.1 or 1; 72 hpi cells were lysed and probed by western blot with 
antibodies raised against NSP1 or NSP16. (G) Imaging of HEK 293T cells transfected with 
Halo-tagged NSP16, NSP1, and NSP1 Delta RC plasmids. Proteins are visualized using TMR-








Figure 8. NSP16 suppresses host mRNA splicing. (A) Schematic of fluorescence reporter used 
to assay mRNA splicing. (B) GFP density plot of HEK293T cells expressing the GFP splicing 
reporter and either GAPDH (gray) or NSP16 (red). (C) Schematic of nascent RNA purification 
method. (D) The % unspliced difference for each gene between HEK293T cells transfected with 




replicates; replicates plotted in Figure S4C. (E) Violin plot for SARS-CoV-2 infected human 
lung epithelial cells (MOI=0.01, 48 hours) compared to mock. Plot are merge of two biological 
replicates; replicates plotted in Figure S4E. (F) Model: NSP16 binding to U1 and U2 can reduce 
overall mRNA and protein levels. (G) Expression of an interferon stimulated gene (ISG) reporter 
upon transfection with GAPDH (gray) or NSP16 (red) after stimulation with IFN-β. Three 
independent biological replicates, ** indicates p-value<0.01. (H) Example of nascent RNA 









Figure 9. NSP16 suppresses host mRNA splicing, Related to Figure 3. (A) Median of raw 




either Halo-GAPDH (gray) or Halo-NSP16 (red). Two independent biological replicates per 
condition. (B) Overview of nascent RNA-sequencing method, including 5eU nucleotide feeding, 
biotin click chemistry conjugation, and biotin-streptavidin-based iterative capture methods. 
Human/mouse mixing experimental data illustrates selective enrichment of labeled material over 
unlabeled material after three sequential captures. (C1= capture 1 enrichment, C2= capture 2 
enrichment, etc.) (C) Violin plot depicting difference in unspliced reads per gene (defined as the 
difference between number of unspliced fragment divided by total fragments spanning the 3’ 
splice site between condition and median of all control samples) for HEK293T cells transfected 
with either GAPDH (gray) or NSP16 (red) for 48hrs. All four individual replicates are presented. 
(D) Violin plot depicting difference in unspliced reads per gene (relative to median of GAPDH) 
for HEK 293T cells transfected with either GAPDH, NSP9, or NSP16 (red) for 48hrs. (E) Violin 
plot depicting difference in unspliced reads per gene (relative to median of the mock condition) 
for Calu3 cells infected with SARS-CoV-2 virus at an MOI of 0.01 for 48 hrs (red) or uninfected 
(gray). Biological replicates are presented. (F) Violin plot depicting fold change in total steady-
state mRNA levels (mRNA initially normalized to ncRNA and ratio is fold normalized mock 
treatment) for SARS-CoV-2 infected (red) compared to mock infected (gray) samples. Data is 
presented for two biological replicates for each condition. (G) Normalized expression of an 
interferon signaling reporter upon stimulation with IFN-β and treatment with madrasin 
spliceosomal inhibitor (red) or DMSO vehicle (gray). Three independent biological replicates 
were measured for each condition. (H-I) Representative nascent RNA tracks from SARS-Cov-2 
infected (red) and mock-treated cells (gray) along Intron 11 and Intron 12 of interferon 










Figure 10. NSP1 binds to the 18S ribosomal RNA near the mRNA entry channel to 
suppress global mRNA translation in cells, Supplemental Material Related to Figure 11. 
(A) Comparison of 18S RNA enrichment across SARS-CoV-2 Halo capture datasets. (B) The 
location of NSP1 binding (orange spheres) relative to 18S binding site (cyan) upon known 
structure of the 80S ribosome (gray). (C) Predicted structure of NSP1 based on Robetta 
modeling. The critical C-terminal amino acids required for binding 18S (K164 and H165) are 
indicated as red spheres. The region of homology with SERBP1 is shown in green. The observed 
NSP1 binding sites on the 18S rRNA are demarcated in cyan on the structure of the human 40S 
ribosome (PDB: 6G5H; gray)127, relative to the mRNA path (purple; 6YAL)72 and known 
clogging factors (E) SERBP1 (green; 6MTE)74 and (F) Stm1 (orange; 4V88)75. (D) An mRNA 
encoding GFP was added to HeLa cell extracts along with different concentrations of purified 
NSP1 protein (x-axis). The amount of GFP protein measured relative to the median of replicates 
for a buffer only control is shown (y-axis). Two independent dose titrations were performed and 
are shown on top of each other. (E) Schematic illustrating puromycin tagging of newly translated 
proteins via the SuNSET method. If the level of ongoing translation is high, we expect to detect a 
large amount of newly generated proteins containing puromycin; if global translation is 
suppressed, we expect to observe a decrease in the amount of puromycin integrated into proteins. 
(F) Western blot of global puromycin incorporation into proteins of HEK293T cells transfected 
with either Halo-GFP (left) or Halo-NSP1 (right). GAPDH levels were measured in the same 
lysates to normalize for total protein in the sample (bottom). (-) puro lanes indicate transfected 
samples that were not treated with puromycin. (G) Quantification of puromycin intensity across 
each lane of the gel in Panel F. The ratio of puromycin signal over total GAPDH signal is plotted 




at an MOI of 0.01. 48hpi cells were labelled with media containing puromycin, and lysates were 
probed by western blot. (I) As a control for total protein levels, after samples in (G) were run on 
a SDS-PAGE gel, transferred to nitrocellulose, and total proteins were stained with PONCEAU 
before blocking/antibody detection of puromycin signal. (J) Normalized GFP fluorescence 
intensity of GFP reporter co-transfected in HEK293T cells in the presence of the NSP1DRC 
mutant that does not bind to 18S (gray) or NSP1 (cyan) proteins. Three independent biological 
replicates were measured for each sample.  
 
Note: This experiment was performed alongside the various controls displayed in Figure 4D and 
are plotted on the same scale. (K) mRNA levels of ISG54 and IFN-β following stimulation with 
poly(I:C) normalized to levels in unstimulated A549 cells. (L and M) mRNA and protein levels 
of IFN-β following stimulation with poly(I:C) normalized to levels in unstimulated A549 cells 
transfected with NSP1 Delta RC mutant (gray) or NSP1 (cyan). Two independent biological 
replicates were measured for each condition. In all panels, error bars represent standard deviation 
across replicates, and dots represent individual values for each replicate. * indicates p<0.05, ** 









Figure 11. NSP1 binds to 18S near the mRNA entry channel to suppress translation. (A) 
NSP1 enrichment across each nucleotide of 18S. Cyan box indicates the most enriched 
nucleotides of NSP1 binding (18S:607-644 nts). (B) The location of NSP1 binding (cyan 




Schematic illustrating structure127 and how NSP1 binding would block mRNA entry. (C) Images 
of HEK293T cells co-expressing GFP reporter and GAPDH (top) or NSP1 (bottom). (D) Flow 
cytometry quantification (mean intensity) of GFP in the presence of GAPDH, NSP8/9, M, or 
NSP1 proteins. Three independent biological replicates per condition. (E) Puromycin 
incorporation (top) or total actin levels (bottom) measured in Calu3 cells infected with SARS-
CoV-2 (MOI=0.01, 48h) or mock control (left 2 lanes). (F) The ratio of puromycin signal over 
total actin signal is plotted for each individual replicate. (G) Read enrichment on 18S for an 
independent replicate of NSP1 Wild Type, NSP1 R124A/K125A Mutant, and NSP1 
K164A/H165A (Delta RC) Mutant. (H) Flow cytometry analysis of HEK293T cells transfected 
with GFP and NSP1 Delta RC mutant (gray), wild-type NSP1, or NSP1 R124A/K125A (cyan). 
(I) Quantification of IFN-β response in the presence of GAPDH (gray) or NSP1 (cyan). (J) 
Schematic of how NSP1 acts to suppress mRNA translation. In all panels, error bars represent 
standard deviation across biological replicates, dots represent individual values for each 







Figure 12. The 5’ viral leader sequence protects mRNAs from NSP1-mediated translational 
inhibition, Supplemental Material Related to Figure 13. (A) A schematic of the experimental 
design containing two reporter RNAs encoding fluorescent proteins, without the viral leader 
(top) and with the viral leader sequence appended to the 5’ end of the mRNA (bottom). Viral 
leader represented by three stem-loops in red. (B) Representative images of HEK 293T cells co-
transfected with GAPDH or NSP1 along with mCherry RNA with or without SARS-CoV-2 
leader sequence. (C) Schematic illustrating the insertion of 5 nucleotides between the 5’ cap and 
the viral leader sequence. NSP1 protein represented in red. (D) Quantification of mCherry 
expression in HEK 293T cells transfected with mCherry RNAs, fused to different 5’ leader 




levels from control condition (GAPDH with + mCherry). At least 3 independent biological 
replicates per condition. Dots represent value for each independent replicate (e.g. NSP1 -L 
contains 6 independent replicates). (E) Quantification of mCherry expression from HEK 293T 
cells transfected with Halo-tagged NSP1 WT or NSP1 Delta RC mutant, along with leader-
mCherry expressing plasmids. Values are normalized to the median values of mCherry levels in 
control sample (NSP1 with + leader-mCherry). Two independent biological replicates were 
measured per condition. In all panels, error bars represent standard deviation across replicates, 








Figure 13. The 5’ viral leader protects mRNA from NSP1-mediated translational 
inhibition. (A) Images of cells co-transfected with NSP1 and mCherry alone (- leader, top) or 
mCherry fused to the SARS-CoV-2 leader (+ leader, bottom). (B) GFP (green) or mCherry (red) 
levels when fused to the viral leader (+leader, right) or lacking viral leader (-leader, left). (C) 
GFP reporter with no leader (left), full leader (middle), or stem loop 1 (SL1) upon NSP1 
expression. (D) Calu3 cells expressing SL1 fused to GFP. Cells were mock or SARS-CoV-2 
infected (MOI=0.1) and GFP expression was measured 24 hours post infection by flow 
cytometry. (E) GFP reporter containing SL1 (left), a swap of SL2 and SL1 (SL2-SL1), insertion 
of 5 nucleotides between the 5’ end and SL1 (+5nt-SL1), or no leader. GFP protein level was 
measured for each condition upon expression of NSP1. (F) Proposed model for how NSP1 




all panels, error bars represent standard deviation across biological replicates, dots represent 








Figure 14. NSP8 and NSP9 bind to 7SL RNA of the Signal Recognition Particle. (A) 
Enrichment of reverse transcription stop positions across each nucleotide of 7SL is shown for 
NSP8 (blue) and NSP9 (red). Red (7SL:142-143 and 7SL: 149-151 nts) and blue (7SL:193-194 
nts) boxes demarcate the most enriched nucleotide positions. (B) The locations of the NSP8 
(blue spheres) and NSP9 (red spheres) binding sites on the S domain of 7SL (yellow ribbon) 
structure relative to SRP54 and SRP19 (gray) (PDB:1MFQ)128. Right: Schematic of the structure 
and model of how NSP8/9 binding to 7SL could impact SRP protein binding. (C) Read 




location of the ES27 expansion sequence (28S:2889-3551 nts). Blue box indicates the most 
enriched nucleotide position on 28S rRNA (28S:3017-3529 nts). (D) The locations of the NSP8 
(blue) and NSP9 (red) binding sites relative to the structure of SRP ribosome complex 
(PDB:3JAJ)129 superimposed with the structure of the ES27 region of 28S (Ebp1-ribosome 
complex; PDB:6SXO)87. The observed NSP8 binding site within the ES27 region of 28S (gray) 
is demarcated in blue, and the NSP8 (blue) and NSP9 (red) binding sites on 7SL (yellow) are 











Particle, Supplemental Material Related to Figure 14. (A) Comparison of 7SL RNA second 
read enrichment across viral protein capture datasets (top) with region of highest enrichment for 
NSP8/9 boxed. Independent expression, purification, and sequencing experiments for NSP8 and 
NSP9 were performed and are shown. (B) Comparison of 28S RNA enrichment across SARS-
CoV-2 Halo capture datasets (top). Replicate representative tracks of NSP8 (blue) and NSP9 
(red) on 28S rRNA are presented below. (C) Full view of 80S ribosome structure, interfaced 
with SRP (7SL RNA, yellow line), NSP9 binding sites on 7SL (red circles), and NSP8 binding 
sites on 7SL (dark blue circles) and on ES27 expansion segment on the 28S ribosomal RNA 
(light blue line). (D) Imaging of HEK 293T cells transfected with Halo-NSP8 or Halo-NSP9 
plasmids. Proteins are visualized using TMR-conjugated Halo-ligand (orange) and 
counterstained with DAPI (blue) nuclear stain. Size bars indicate 10 microns. (E) Vero E6 cells 
were infected (or mock infected) with SARS-CoV-2 at an MOI of 0.1 for 48h, before fixing and 
staining with an antibody raised against NSP8 or NSP9. Cells are counter-stained with DAPI. 
Size bars indicate 10 microns. (F) Western blot confirmation of NSP8 and NSP9 antibodies used 
to generate images in (E). Vero cells were infected (or mock infected) with SARS-CoV-2 at an 
MOI of 0.1 or 1; 72 hpi cells were lysed and probed by western blot with antibodies raised 







Figure 16. NSP8 and NSP9 inhibit membrane and secretory protein function, 
Supplemental Material Related to Figure 17. (A) Schematic illustrating Signal Recognition 
Particle-mediated recognition and translocation of nascent membrane and secreted proteins (left). 
Upon SRP dysfunction, membrane and secreted proteins are predicted to be mis-localized and 




fluorescence normalized to eGFP fluorescence (NGFR:GFP) from HEK 293T cells transfected 
with control EED plasmid together with siRNAs targeting protein components of Signal 
Recognition Particle, SRP54 and SRP19. (C) Quantification of Membrane SuNSET puromycin 
staining fluorescence normalized to eGFP fluorescence (Puromycin:GFP) from HEK 293T cells 
transfected with control EED plasmid together with with siRNAs targeting protein components 
of Signal Recognition Particle, SRP54 and SRP19. Three independent replicates for control and 
one replicate for siRNA treatments within this experiment. (D) NGFR:GFP ratio from Calu3 
human lung epithelial cells infected with SARS-CoV-2 for 24 hrs at an MOI of 0.1. Density 
comparison between Spike positive cells in virally infected condition to Spike negative cells in 
virally infected condition. (E) Signal P analysis of open reading frames of SARS-CoV-2 
expressed proteins utilized in study. Proteins with greater than 0.95 predicted probability 
indicated Signal P algorithm are highlighted in green. (F) Top: Signal P analysis of open reading 
frames of various immunoregulatory cytokines and proteins, including Interferon Beta and Beta-
2-Microglobulin- Precursor. Bottom: Signal P analysis of NGFR (membrane reporter) amino 
acid sequence and plot of signal peptide probability along the first 70 amino acids of NGFR 
sequence. In all panels, error bars represent standard deviation across replicates, and dots 
represent individual values for each replicate. * indicates p<0.05 and ** p<0.01. (G) Expression 
of an interferon stimulated gene reporter upon transfection with GAPDH or NSP8 and NSP9 (in 
combination), followed by stimulation with IFN-β. We note that because this assay measures 
intensity across a population of cells, any cells that are not transfected by NSP8/9 would not 
show this effect and would lead to a smaller overall difference than might occur within 
individual cells. In contrast, NGFR and SUNSET flow cytometry measurements (B-C) represent 







Figure 17. NSP8 and NSP9 inhibit membrane and secretory protein trafficking. (A) 
Quantification of HEK293T cells transfected with plasmids co-expressing GFP-tagged NSPs and 




The ratio of puromycin-containing proteins at the cell membrane normalized to GFP expression 
for each condition. (C) Quantification of two mRNA reporters containing SL1 fused to either 
GFP (leader-GFP) or NGFR (leader-NGFR) in Vero cells infected with SARS-CoV-2 or mock 
for 24 hrs (MOI 0.1). Plotted is ratio of leader-NGFR to leader-GFP, binned by increasing 
amounts of Spike protein. (D) Density plot for leader-NGFR to leader-GFP ratios in virally 
infected Vero cells or mock treated controls. Replicate conditions were merged for display. (E) 
Model of how NSP8/9 act to suppress SRP-dependent protein trafficking upon viral infection. In 
all panels, error bars represent standard deviation across independent biological replicates, dots 
represent individual values for each replicate, * indicates p<0.05 and ** p<0.01. (F) A model of 
how SARS-CoV-2 suppresses host immune responses through multi-pronged inhibition of core 
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Through its abilities to recognize and hybridize to nucleic acid templates, spatially localize to 
different compartments within the cell, bind combinatorically to effector molecules, and in some 
cases directly catalyze chemical reactions, RNA is a widely utilized and integrated component of 
core cellular function. RNA has been reported to play key roles in many developmentally 
regulated processes, with one well-characterized example being the role of the Xist long non-
coding RNA (lncRNA) in the initiation of X-chromosome silencing in mammalian development. 
Xist-mediated silencing, in particular the recruitment of effector binding proteins including 
SMRT/HDAC1 Associated Repressor Protein (SHARP), is an established paradigm for RNA-
mediated gene regulation in cis. To explore how prevalent this paradigm is, we used Covalent 
Linkage Affinity Purification to identify additional SHARP-RNA interactions and revealed an 
interaction within a critical region of the Kcnq1ot1 lncRNA. Kcnq1ot1 lncRNA is responsible 
for paternal imprinting of a conserved one megabase domain in mouse and human. 
Dysregulation of this imprinting cluster has been linked to an overgrowth disorder called 
Beckwith-Wiedemann Syndrome, which presents with a variety of findings, including 
visceromegaly of intra-abdominal organs, abdominal wall defects, hemihyperplasia, and a 
predisposition for embryonal malignancies. Here we demonstrate that Kcnq1ot1 silencing of 
imprinting target genes is SHARP-dependent. Additionally, we identify several more SHARP-
lncRNA interactions and surprisingly, many SHARP/pre-mRNA interactions. Coupled with 
super resolution microscopy of full length and mutant forms of SHARP, our data reveals RNA-






2.1 RNA-MEDIATED REGULATION OF GENE EXPRESSION 
RNA is a widely utilized and integrated component of core cellular function because of its 
abilities to recognize and hybridize to nucleic acid templates, spatially localize to different 
compartments within the cell, bind combinatorically to effector molecules, and in some cases 
directly catalyze chemical reactions1-8. As discussed in Chapter 2 within the context of host cell 
takeover by SARS-CoV-2, nonstructural RNAs can be utilized as scaffolds for many integral 
complexes within the cell, including subunits of the eukaryotic ribosome as well as the Signal 
Recognition Particle8. RNA can also play a key role in regulating gene expression, with 
discovered mechanisms inspiring novel treatment modalities such as Antisense Oligonucleotides 
or Small Interfering RNA9-14. 
Eukaryotic genomes are pervasively transcribed, with clusters of genes coordinately regulated in 
cis15-21; this coordination is integral to cellular homeostasis as disruptions can lead to 
compromised viability and disease pathogenesis22-25. Despite the ever-expanding catalog of 
tissue- and cell-type specific gene expression profiles, we still do not completely understand how 
complex transcriptional programs are coordinately established and maintained, nor the complete 
molecular repertoire responsible for coordinated gene regulation in cis26. 
2.2 XIST-MEDIATED SILENCING AS A PARADIGM OF RNA-MEDIATED GENE 
REGULATION 
How can cells coordinate gene expression in cis? While DNA cis regulatory elements (promoters 




be encoded within each individual gene to allow trans acting factors (transcription factors) to 
recognize and coordinate a regulatory program27-28. Chromatin relaxation, in contrast, can result 
in deleterious upregulation of bystander genes17-18. Long non-coding RNAs (lncRNA) are an 
ideal answer; lncRNAs can leverage their preferential localization in the nucleus, spread in cis 
across local chromatin environments, and spatially concentrate effector chromatin effector 
molecules to seed defined regulatory compartments within the nucleus2,28-29. 
A well-established model for studying lncRNA-mediated gene regulation is X-chromosome 
inactivation (XCI), the process by which one of the two female X-chromosomes is 
transcriptionally silenced to establish dosage compensation in early mammalian development29. 
XCI is initiated through expression of a lncRNA called Xist, which was originally identified as 
the sole gene expressed from the inactive X-chromosome and later demonstrated to be both 
necessary and sufficient for this process30-35, 29. Xist-mediated silencing coordinates several 
different processes, including recruitment of chromatin-modifying proteins to the inactive X-
chromosome, chromosome-wide DNA compaction, and translocation of the entire chromosome 
to the nuclear lamina, to form a nuclear compartment called the Barr Body and ultimately 
establish stable and heritable chromosome-wide silencing across an organism’s lifetime3-6,36-46,34. 
2.3 SHARP AS A MODEL RNA-BINDING PROTEIN  
One RNA-binding protein required for Xist-mediated silencing is SMRT/HDAC1 Associated 
Repressor Protein (SHARP), also known as Split Ends Transcriptional Repressor (Spen) or 
Msx2-Interacting Nuclear Target Protein (Mint)3-6. SHARP is a member of the Split Ends 
Protein Family (which consists of SHARP, RBM15, and RBM15B) and is simultaneously the 




transduction (discussed further in Chapter 4)47-48. SHARP is an approximately 3600 amino acid 
protein which contains four N-terminal RNA-Recognition Motifs (RRM), a C-terminal Spen 
Paralog and Ortholog C-terminal (SPOC) domain (demonstrated to be responsible for 
recruitment of SMRT (Silencing Mediator for Retinoid or Thyroid-Hormone Receptor, also 
known as Nuclear Receptor Co-Repressor 2 or NCOR2) and transcriptional silencing), as well as 
a large intrinsically disordered region (Figure 1A)50,54,29. Despite its documented interaction with 
direct chromatin regulators, transcription factors and non-coding RNA, SHARP lacks a defined 
DNA-binding domain51-54,3. Interestingly, the RRM domains of SHARP have been shown to be 
both necessary for Xist-mediated silencing and recruitment to the inactive X-chromosome 
compartment, as well as sufficient for interactions with the Xist A-repeat55,50. Likewise, the 
SPOC domain has been shown to be necessary for Xist-mediated silencing and sufficient once 
localized to the compartment50. 
SHARP is a model RNA-binding protein for studying RNA-mediated chromatin remodeling and 
transcriptional regulation because of its ability to directly recognize and bind to RNA and its 
clear effector function when recruited to chromatin50,53-54. Despite the clear mechanistic 
dissection of SHARP’s role in XCI, it remains unclear if Xist-mediated recruitment of SHARP to 
regulate gene expression in cis is an anomaly or a more widely applied mechanism. That is, is 








3.1 RESULTS: COVALENT LINKAGE AFFINITY PURIFICATION REVEALS 
INTERACTION BETWEEN SHARP AND LNCRNA KCNQ1OT1 
To address this question, we performed Covalent Linkage Affinity Purification against SHARP 
in pSM33-derived mouse embryonic stem cells (mESC) expressing N-terminal Halo-epitope 
tagged SHARP protein56. We induced cells to express Xist lncRNA using doxycycline induction 
and were able to recover the SHARP/Xist-Repeat interaction using this method (Figure 1B). 
Surprisingly, we observed an interaction between SHARP and the Kcnq1ot1 lncRNA, which we 
subsequently verified using Immunostaining with RNA Fluorescence In Situ Hybridization (IF-
FISH) (Figure 1C and 1D).  
3.2 LNCRNA KCNQ1OT1 REGULATES IMPRINTING TARGET GENES IN TOPOLOGICAL 
ASSOCIATED DOMAIN 
Kcnq1ot1 lncRNA (also known as KCNQ1 Opposite Strand Transcript 1, KCNQ1 overlapping 
transcript 1, or Long QT Intronic Transcript 1) is expressed in antisense orientation from within 
an intronic region of the Kcnq1 protein coding gene on chromosome 7 in mouse and 
chromosome 11 in human respectively22,57. Kcnq1ot1 is responsible for paternal imprinting of 
the Kcnq1 gene cluster, which includes Cyclin-Dependent Kinase Inhibitor 1C (CDKN1C), 
Solute Carrier Family 22 Member 18 (Slc22a18), and Pleckstrin Homology Like Domain Family 
A Member 2 (Phlda2)58-61. Dysregulation of Kcnq1ot1-mediated imprinting is linked to a 
pediatric overgrowth syndrome called Beckwith Wiedemann Syndrome, which presents with 




hemihyperplasia, and a predisposition for embryonal malignancies, including Wilm’s Tumor and 
hepatoblastoma, among other sequelae22,62-63.  
Interestingly, Kcnq1ot1 lncRNA localizes to the same topologically associated domain on 
chromatin as its imprinting targets within the Kcnq1 gene cluster (Figure 2A). Given that 
lncRNAs may exert their function in an RNA-independent manner (that is, through the action of 
transcription or activity as a DNA cis regulatory element), we tested if Kcnq1ot1 is necessary 
and sufficient for transcriptional repression of its targets in vivo17,64. Using CRISPR-interference, 
we observed upregulation of imprint targets within the Kcnq1 gene cluster compared to control 
(Figure 2B). Moreover, using an mESC line engineered to express Kcnq1ot1 upon doxycycline 
administration, we observed specific repression of targets within the Kcnq1 gene cluster upon 
Kcnq1ot1 induction (Figure 2C). These data demonstrate that Kcnq1ot1 lncRNA is both 
necessary and sufficient for transcriptional repression in cis, consistent with findings from 
previous studies using deletion of the Kcnq1ot1 promoter, pre-mature transcriptional truncation, 
and RNA-destabilization58-59,65-68. 
3.3 KCNQ1OT1 REGULATES IMPRINTING GENES IN SHARP-DEPENDENT MANNER 
SHARP binds to Kcnq1ot1 lncRNA within a region previously demonstrated to be required for 
its silencing function, leading us to hypothesize that like Xist, Kcnq1ot1 transcriptionally 
silences genes in cis in a SHARP-dependent manner59,69. To test this hypothesis, we generated 
mESC lines harboring homozygous deletions of the SHARP binding site within Kcnq1ot1 and 
observed upregulation of imprint targets in this line compared to the control (Figure 3A). Given 
that SHARP interacts with SMRT to ultimately recruit histone de-acetylases, we independently 




presence of Trichostatin A70. We observed blunting of Kcnq1ot1-mediated silencing in the 
presence of Trichostatin A compared to control (Figure 3B). Finally, we generated SHARP-
knockout mESC lines using the CRISPR-Cas9 system and observed upregulation of CDKN1C in 
knockout lines compared to parent; this upregulation reverted upon re-introduction of Full 
Length SHARP (Figure 3C and D)71. These data demonstrate that Kcnq1ot1 lncRNA 
transcriptionally silences imprint target genes in cis in a SHARP-dependent manner, similar to 
Xist. (Figure 3E). It should be noted that unlike Xist, which is capable of establishing RNA-
independent transcriptional memory, Kcnq1ot1 is required for maintenance of transcriptional 
silencing, suggesting additional complexity during Barr Body formation60,65,46,34. 
3.4 EXAMINING SHARP-RNA INTERACTIONS ON A GLOBAL SCALE 
Beyond our identification of SHARP as a critical protein for Kcnq1ot1-mediated silencing, we 
asked if SHARP interacted with additional lncRNA targets. Using our SHARP CLAP-Seq 
dataset, we identified two additional lncRNA targets: Dleu2 and lncRNA 2610035D17Rik 
(named Embryonic stem cell SHARP-Associated Long Coding Transcript 1, eSalt1). We 
subsequently verified these interactions using IF-FISH (Figure 4A). 
We also identified several SHARP/pre-mRNA interactions, which actually outnumbered the 
number of lncRNA interactions (Figure 4B and 4C, Table 1). To test if these pre-mRNA 
interactions were conserved between mouse and human, we performed CLAP-Seq against 
SHARP in HEK293T cells and identified similar binding profiles in several pre-mRNA targets, 
including Zc3h11a, Jarid2, and SHARP’s mRNA transcript (Spen) (Figure 4D). Similar to 
SHARP-interacting lncRNAs, SHARP-interacting pre-mRNAs display broad localization in cis 




Given the number of SHARP-interacting RNAs and SHARP’s role in establishing repressive 
transcriptional compartments on both the inactive X-chromosome and within the Kcnq1 gene 
cluster, we wanted to examine RNA-mediated localization of the protein within the nucleus. 
Using 3-Dimensional Structural Illumination Microscopy, we observed punctate localization of 
Full Length SHARP protein, which was lost upon deletion of the RRM domain (Figure 5A). 
SHARP also contains an Intrinsically Disordered Region, which based on previous phase 
separation studies has been speculated to play a role in cooperative self-aggregation and RNA-
mediated super-stoichiometric silencing of the X-chromosome72-73,29. To test if the IDR domains 
are required for SHARP aggregation in the nucleus, we over-expressed mutant forms of the 
protein tagged monomeric eGFP-tagged SHARP in HEK 293T and performed live cell 
imaging74. In comparison to Full Length Protein or deletion of the SPOC domain, we observed 
loss of punctate localization upon deletion of the RRM and IDR domains (Figure 5B). 
4.0 DISCUSSION 
Here we demonstrate that Kcnq1ot1 recruits SHARP to a defined gene cluster to silence imprint 
target genes, which supports a broader model of RNA-mediated gene regulation in the nucleus, 
where RNA can recruit and concentrate proteins to defined chromatin territories to spatially 
amplify local regulatory signals in cis28-29. Kcnq1ot1 recruits SHARP to a defined gene cluster to 
silence target genes. Through its avidity to RNA and its intrinsically disordered domains, 
SHARP can then aggregate and compartmentalize over this chromatin territory. Control over the 
entire 1 megabase gene cluster and RNA-mediated compartment can therefore be coordinated 
from a single 3.6 kilobase cis regulatory DNA element: the Kcnq1ot1 promoter (also known as 




It is important to note that although SHARP acts in trans (being spatially recruited from a 
nucleoplasmic pool to given location on DNA) and synthetic recruitment of a 3kb Kcnq1ot1 
fragment (harboring the SHARP binding site) is sufficient to silence ectopic genes, endogenous 
Kcnq1ot1 is spatially limited in cis to a defined location on chromatin (Figure 3F and 2A). 
Therefore, Kcnq1ot1 lncRNA interacts with trans-acting factors to spatially amplify and 
coordinate gene regulation in cis28-29. 
What was most surprising to us from this dataset was the identification of SHARP/pre-mRNA 
interactions, which actually outnumber the SHARP/lncRNA interactions observed. Many of 
these pre-mRNAs localize broadly to chromatin in a similar manner to lncRNAs. Together, these 
data combined with our mechanistic dissection of Kcnq1ot1 suggest that SHARP-RNA 
interactions may be more pervasive than previously understood, and responsible for establishing 
repressive compartments across the nucleus to coordinate gene regulation in cis. 
5.0 MATERIALS AND METHODS 
Cell line generation, cell culture, and drug treatments 
Cell lines used in this study. We used the following cell lines in this study: (i) male ES cells 
(pSM33 ES cell line) previously engineered to express Xist lncRNA under the control of a 
tetracycline-inducible promoter and stably transfected with an episomally-maintained plasmid 
expressing Halo-tagged SHARP from a constitutive CAG promoter (Halo-SHARP pSM33)56. 
(ii) Female ES cells containing dCas9 fused to 4 copies of the SID transcriptional repression 
domain integrated into a single locus in the genome (dCas9-4XSID). (iii) Female ES cells where 
we replaced the endogenous Kcnq1ot1 promoter with a tetracycline-inducible promoter on both 




express Kcnq1ot1 from either allele, and in the presence of doxycycline they express Kcnq1ot1 
biallelically (Figure 2C). (iv) male e14-derived ES cells containing clonal insertions of PB-
3xUAS-PGK-tGFP reporter, Gal4-Lambda-N insertion into the Rosa locus, and BoxB-tagged 
RNA expressed by stable insertion via piggybac transposon89-92. (v) HEK293T, a female human 
embryonic kidney cell line obtained from ATCC. 
Cell culture conditions. All mouse ES cell lines were cultured in serum-free 2i/LIF medium as 
previously described76. Halo-SHARP pSM33 cells were additionally maintained in 0.5µg/ml 
puromycin to promote stable selection of the episomal plasmid. HEK293T cells were cultured in 
complete media consisting of DMEM (GIBCO, Life Technologies) supplemented with 10% FBS 
(Seradigm Premium Grade HI FBS, VWR), 1X penicillin-streptomycin (GIBCO, Life 
Technologies), 1X MEM non-essential amino acids (GIBCO, Life Technologies), 1 mM sodium 
pyruvate (GIBCO, Life Technologies) and maintained at 37C under 5% CO2. For maintenance, 
800,000 cells were seeded into 10 mL of complete media every 3-4 days in 10 cm dishes. 
Doxycycline Inducible Kcnq1ot1 lines. Female ES cells (F1 2-1 line, provided by K. Plath) were 
CRISPR-targeted (nicking gRNA pairs TGGGCGGGAGTCTTCTGGGCAGG and 
GGATTCTCCCAGGCCCAGGGCGG) to express the Tet transactivator (M2rtTA) from the 
Rosa26 locus using R26P-M2rtTA, a gift from Rudolf Jaenisch (Addgene plasmid #47381). The 
endogenous promoter of Kcnq1ot1 was CRISPR-targeted (nicking gRNA pairs 




minimal CMV promoter. Clones were screened for ablation of endogenous Kcnq1ot1 expression 
and biallelic upregulation of expression upon administration of doxycycline (Figure 2C).  
CRISPRi: dCas9-4XSID cell line generation. A catalytically dead Cas9 (dCas9) fused to 4 
copies of the SID repressive domain (4XSID) expressed from an Ef1a promoter was integrated 
into a single copy locus in the genome (mm10 - chr6:86,565,487-86,565,506; gRNA sequence 
AATCTTAGTACTACTGCTGC) using CRISPR (cells hereby referred to as dCas9-4XSID).  
Doxycycline induction. Expression of Xist and Kcnq1ot1 was induced in their respective cell 
lines by treating cells with 2 µg/ml doxycycline (Sigma). Xist was induced for 24 hours prior to 
crosslinking and analysis. Kcnq1ot1 was induced for 12-16hrs prior to harvesting RNA. 
Trichostatin (TSA) treatment. For HDAC inhibitor experiments, cells were treated cells with 
either DMSO (control) or 5µM TSA in fresh 2i media or 2µg/ml doxycycline in standard 2i.  
3D-SIM SHARP-Halo cell culture conditions. pSM33 cells were seeded in 4-well imaging 
chambers (ibidi) equipped with a high precision glass bottom and plasmids were transfected with 
lipofectamine 3000 24 hours prior to imaging according to the manufacturer’s instructions. 
SHARP expression was induced by the addition of doxycycline 8hrs prior to imaging. 1µM 
JF646 Halo ligand was introduced to the media for 30 min, washed off twice with PBS and 
exchanged with fresh media, following which cells were incubated for another 15 min. Live-cell 
3D-SIM imaging was performed at 37C and 5% CO2 in media without phenol red. 
Transfection of SHARP constructs in HEK293T. For those experiments that required high 
expression of proteins (CLAP, FRAP, live-cell imaging), we used human HEK293T cells instead 




transfected HEK293T cells using BioT transfection reagent (Bioland) according to 
manufacturer’s recommendations. We used ~10 µg of DNA when cells were grown on a 15 cm 
dish and ~1 ug of DNA when cells were grown on 3 cm glass-bottom dishes (Matek), adjusting 
DNA concentrations to match mole numbers across constructs. 48 hours post-transfection, cells 
were used for live-cell imaging (Figure 5B). 
 
Note: We observed that high and prolonged overexpression of SHARP and its mutants in 
HEK293T cells leads to rapid cell death. We found that processing cells 48 hours post-
transfection is an optimal time, providing both high protein expression and cell number.  
Another feature of the overexpression experiment that we had to take into consideration was 
heterogeneity in the level of protein expression between different cells and constructs. To correct 
for this and compare cells with similar levels of SHARP protein, we set laser powers and gains 
based on the lowest expressing samples (FL-SHARP) and used these settings for all other 
samples. As a consequence, some cells with extremely high overexpression levels (from Delta 
IDR-SHARP, Delta RRM-IDR, eGFP groups) were not imaged or analyzed. When lower laser 
powers and gains were used (too low to detect FL-SHARP), we observed the formation of 
condensates in Delta IDR-SHARP sample, but not in the eGFP control. This suggests that 
SHARP mutant proteins can form condensates; however, they require much higher concentration 









RNA-FISH and IF. For immunostaining combined with in situ RNA visualization, we used the 
ViewRNA Cell Plus (Thermo Fisher Scientific, 88-19000-99) kit per the manufacturer’s protocol 
with minor modifications. Cells were grown on coverslips and rinsed with 1xPBS, pre-extracted 
with 0.5% Triton X-100 in PBS for 5 minutes at room temperature, fixed in 4% 
paraformaldehyde in PBS for 15 minutes at room temperature, and rinsed in 1xPBS, and 
permeabilized with 0.5% Triton X-100 in 4% paraformaldehyde for 10 minutes at room 
temperature. Cells were either stored at -20C in 70% ethanol or used directly for immunostaining 
and incubated in blocking solution (0.2% BSA in PBS) for at least 1 h. If stored in 70% ethanol, 
cells were re-hydrated prior to staining by washing 3 times in 1xPBS and incubated in blocking 
solution (0.2% BSA in PBS) for at least 1 hour. Primary antibody against SHARP (Bethyl # 
A301-119A, Lot # 2) was diluted in blocking solution and added to coverslips for 3-5 hours at 
room temperature. Cells were washed three times with 0.01% Triton X-100 in PBS for 5 minutes 
each and then incubated in blocking solution containing corresponding secondary antibodies 
labeled with Alexa fluorophores (Invitrogen) for 1 hour at room temperature. Next, cells were 
washed 3 times in 1xPBS for 5 minutes at room temperature. After the last wash in 1xPBS, cells 
were subject to post-fixation for 10 min in 2% paraformaldehyde on 1xPBS at room temperature, 
washed 3 times in 1XPBS, and then RNA-FISH, based on the ViewRNA ISH (Thermo Fisher 
Scientific, QVC0001) protocol, was performed. Coverslips were mounted with ProLong Gold 
with DAPI (Invitrogen, P36935) and stored at 4C until acquisition. All probes used in the study 
were custom made by Thermofisher. To test their specificity, we either utilized RNAse treatment 
prior to RNA-FISH or two different probes targeting the same RNA. Images were acquired on a 




were taken every 0.3 µm. Image visualization and analysis were performed with Icy and ImageJ 
software respectively. 
3D-Structured Illumination Microscopy (3D-SIM): 3D-SIM 1000 super-resolution imaging was 
performed on a DeltaVision OMX-SR system (Cytiva, Marlborough, MA, USA) equipped with a 
60x/1.42 NA Plan Apo oil immersion objective (Olympus, Tokyo, Japan), sCMOS cameras 
(PCO, Kelheim, Germany) and 642 nm diode laser. Image stacks were acquired with z-steps of 
125 nm and with 15 raw images per plane. The raw data were computationally reconstructed 
with the soft-WoRx 7.0.0 software package (Cytiva, Marlborough, MA, USA) using a wiener 
filter set to 0.002 and channel-specifically measured optical transfer functions (OTFs) using an 
immersion oil with a 1.518 refractive index (RI). 32-bit raw datasets were imported to ImageJ 
and converted to 16-bit stacks. 
HEK 293T Live Cell Imaging: Live samples were imaged using the Leica Stellaris microscope 
with 63x water objective (~80nm xy, ~300nm z), and 16 Z-stacks were collected every 60 
seconds for 5 minutes. The microscope was equipped with a stage incubator to keep cells at 37ºC 
and 5% CO2. Image analysis was performed using ICY or FIJI (ImageJ v2.1.0/1.53c) software.   
Molecular Biology Protocols 
SHARP Covalent Linkage Affinity Purification. An expression vector containing full-length 
SHARP with an N-terminal Halo-FLAG (HF) fusion protein was transfected into mouse ES cells 
containing a doxycycline inducible Xist gene. Cells were washed once with PBS and then 
crosslinked on ice using 0.25 J cm−2 (UV2.5k) of UV at 254 nm in a Spectrolinker UV 
Crosslinker. Cells were then scraped from culture dishes, washed once with PBS, pelleted by 




lysed batches of 5 million cells by completely resuspending frozen cell pellets in 1 mL of ice 
cold iCLIP lysis buffer (50 mM Hepes, pH 7.4, 100 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% 
Sodium Deoxycholate) supplemented with 1X Protease Inhibitor Cocktail (Promega), 200 U of 
Murine RNase Inhibitor (New England Biolabs), 20 U Turbo DNase (Ambion), and 1X 
Manganese/Calcium Mix (0.5mM CaCl2, 2.5 mM MnCl2). Samples were incubated on ice for 
10 minutes to allow lysis to proceed. The lysates were then incubated at 37C for 10 minutes at 
1150 rpm shaking on a Thermomixer (Eppendorf). Lysates were cleared by centrifugation at 
15,000g for 2 minutes. The supernatant was collected and kept on ice until bound to the 
HaloLink Resin. 
We used 200 µL of 25% HaloLink Resin (50 µL of HaloLink Resin total) per 5 million cells. 
Resin was washed three times with 2 mL of 1X TBS (50 mM Tris pH 7.5, 150 mM NaCl) and 
incubated in 1X Blocking Buffer (50 mM HEPES, pH 7.5, 10 µg/mL Random 9-mer, 100 µg/mL 
BSA) for 20 minutes at room temperature with continuous rotation. After the incubation, resin 
was washed three times with 1X TBS. The cleared lysate was mixed with 50µl of HaloLink 
Resin and incubated at 4C for 3-16 hrs with continuous rotation. The captured protein bound to 
resin was washed three times with iCLIP lysis buffer at room temperature and then washed three 
times at 90C for 2 minutes while shaking at 1200 rpm with each of the following buffers: 1X 
ProK/NLS buffer (50 mM HEPES, pH 7.5, 2% NLS, 10 mM EDTA, 0.1% NP-40, 10 mM DTT), 
High Salt Buffer (50 mM HEPES, pH 7.5, 10 mM EDTA, 0.1% NP-40, 1M NaCl), 8M Urea 
Buffer (50 mM HEPES, pH 7.5, 10 mM EDTA, 0.1% NP-40, 8 M Urea), and Tween buffer (50 
mM HEPES, pH 7.5, 0.1% Tween 20, 10 mM EDTA). Finally, we adjusted the buffer by 
washing with Elution Buffer (50 mM HEPES, pH 7.5, 0.5 mM EDTA, 0.1% NP-40) three times 




elution) and 8 µL (TEV elution) reaction. 25 µL of 4X ProK/NLS Buffer and 10 µL of ProK 
were added to the ProK elution tube and the sample was incubated at 50C for 30 minutes while 
shaking at 1200 rpm. 2.3 µL of ProTEV Plus Protease (Promega) was added to the TEV Elution 
and the sample was incubated at 30C for 30 minutes while shaking at 1200 rpm.  
For each experiment, we ensured that we successfully purified the Halo-tagged protein. To do 
this, the TEV elution sample was mixed with 1X LDS Sample Buffer (Invitrogen) and 1X 
Reducing Agent (Invitrogen) and heated for 6 minutes at 70C. The sample was run on a 3-8% 
Tris Acetate Gel (Invitrogen) for 1 hour at 150 V. The gel was transferred to a nitrocellulose 
membrane using an iBlot Transfer Device (Invitrogen). The nitrocellulose membrane was 
blocked with Odyssey Blocking Buffer (LI-COR) for 30 minutes. We incubated the membrane in 
Anti-FLAG mouse monoclonal Antibody (Sigma, F3166) and V5 rabbit polyclonal antibody 
(Santa Cruz, sc-83849-R) at a 1:2500 dilution for 2 hours at room temperature to detect the 
protein. We visualized the protein by incubating the membrane in 1:17,500 dilution of both 
IRDye 800CW Goat anti-Rabbit IgG (LI-COR, 925-32210) and IRDYE 680DR Goat anti-Mouse 
IgG (LI-COR, 925-68070) for 1 hour at room temperature followed by imaging on a LICOR 
Odyssey. 
RNA was purified from the ProK elution sample and an RNA-Seq library was constructed as 
previously described77. Briefly, after proK elution, the RNA was dephosphorylated (Fast AP) 
and cyclic phosphates removed (T4 PNK) and then cleaned up on Silane beads as previously 
described77. The RNA was then ligated to an RNA adapter containing a RT primer binding site. 
The ligated RNA was reverse transcribed (RT) into cDNA, the RNA was degraded using NaOH, 
and a second adapter was ligated to the single stranded cDNA. The DNA was amplified and 




adapters. The molarity of PCR amplified libraries was measured by Agilent Tapestation High 
Sensitivity DNA screentapes and all samples were pooled at equal molarity. The pool was then 
purified and size selected on a 2% agarose gel and cut between 150-700 nts. The final libraries 
were measured by Agilent Bioanalyzer and Qubit high sensitivity DNA to determine the loading 
density of the final pooled sample. Pooled samples were paired-end sequenced on an Illumina 
HiSeq 2500 with read length 35 x 35nts. 
Sequencing reads were trimmed to remove adaptor sequences and any bases containing quality 
scores <10 using Trimmomatic78. Read-pairs where either read was trimmed to <25 nucleotides 
were filtered. PCR duplicates were excluded using the FastUniq tool83. The remaining reads 
were then aligned to Ribosomal RNAs (rRNAs) using the Tagdust program84 with a database of 
18S, 28S, 45S, 5S, 5.8S sequences. TagDust was chosen because it allowed more permissive 
alignments to rRNA reads that contained mismatches and indels due to RT errors induced by 
rRNA post-transcriptional modifications. The remaining reads were then aligned to the mouse 
(mm9) genomes using STAR aligner79. Only reads that mapped uniquely in the genome were 
kept for further analysis. SHARP CLAP performed from transiently transfected HEK293T cells 
was processed in a similar manner. Peaks and input-normalized enrichments were called using 
CLIPCLAPEnrichment javascript pipeline. Targets ultimately presented in Figure 4C were 
selected based on initial screen of peaks based on window-normalized p-value cut off of < e-5 
that were pooled between two biological replicates and additionally curated based on visual 
examination of pile-ups to remove repetitive element artifacts and comparisons between cell type 






SPRITE 2.0: RNA and DNA SPRITE  
SPRITE 2.0 is an adaptation of our initial SPRITE protocol with significant improvements to the 
RNA molecular biology steps that enable generation of higher complexity RNA libraries76,80. It 
was performed as follows: 
Crosslinking, chromatin isolation, and chromatin digestion. Cells were crosslinked at room 
temperature with 2mM disuccinimidyl glutarate (DSG) for 45 minutes followed by 3% 
formaldehyde for 10 minutes to preserve RNA and DNA interactions in situ. After crosslinking, 
the formaldehyde crosslinker was quenched with addition of 2.5M glycine for final concentration 
of 0.5M for 5 minutes, cells were spun down, and isolated in 1x PBS + 0.5% RNAse Free BSA 
(AmericanBio #AB01243-00050) and flash frozen at -80C for storage. When using BSA to 
isolate cells, we found that using RNAse-Free BSA was critical to avoid RNA degradation. 
RNase Inhibitor (1:40, NEB Murine RNAse Inhibitor or Thermofisher Ribolock) was added to 
all lysis buffers to avoid degradation. After lysis, cells were sonicated at 4-5W of power for 1 
minute (pulses 0.7 second on, 3.3 seconds off) using the Branson Sonicator and chromatin was 
fragmented using DNAse digestion to obtain DNA of approximately ~150-1kb in length. 
Estimating molarity. After DNase digestion, crosslinks were reversed on approximately 10 µl of 
lysate in 82 µL of 1X Proteinase K Buffer (20 mM Tris pH 7.5, 100 mM NaCl, 10 mM EDTA, 
10 mM EGTA, 0.5% Triton-X, 0.2% SDS) with 8 µL Proteinase K (NEB) at 65C for 1 hour. 
RNA and DNA were purified using Zymo RNA Clean and Concentrate columns per the 
manufacturer’s specifications (>17nt protocol) with minor adaptations, such as binding to the 
column with 2X volume RNA Binding Buffer combined with by 1X volume 100% EtOH to 




DNA concentration with the Qubit Fluorometer (HS RNA kit, HS dsDNA kit) and the average 
RNA and DNA sizes were estimated using the RNA High Sensitivity Tapestation and Agilent 
Bioanalyzer (High Sensitivity DNA kit). 
NHS bead coupling. RNA and DNA molarity estimated in the lysate was used to calculate the 
total number of RNA and DNA molecules per microliter of lysate. We coupled the lysate to 
NHS-activated magnetic beads (Pierce) in 1x PBS + 0.1% SDS combined with 1:40 dilution of 
NEB Murine RNase Inhibitor overnight at 4C as previously described76. We coupled at a ratio of 
0.5 molecules per bead to reduce the probability of simultaneously coupling multiple 
independent complexes to the same bead (which would lead to their association during the split-
pool barcoding process). Because multiple molecules of DNA and RNA can be crosslinked in a 
single complex, this estimate is a more conservative estimate of the number of molecules to 
avoid collisions on individual beads. After NHS coupling overnight, the reaction was quenched 
in 0.5M Tris pH 7.5 and beads were washed as previously described76. 
Because the crosslinked complexes are immobilized on NHS magnetic beads, several enzymatic 
steps can be performed by adding buffers and enzymes directly to the beads and performing 
rapid buffer exchange between each step on a magnet. All enzymatic steps were performed with 
shaking at 1200 rpm (Eppendorf Thermomixer) to avoid bead settling and aggregation, and all 
enzymatic steps were inactivated by adding 1 mL of SPRITE Wash buffer supplemented with 50 
mM EDTA and 50 mM EGTA to the NHS beads instead of Modified RLT buffer. 
DNA End Repair and dA-tailing. DNA ends are repaired to enable ligation of tags to each 
molecule. Specifically, we blunt end and phosphorylate the 5′ ends of double-stranded DNA 




hr, the enzyme is quenched using 1 mL Modified RLT buffer, and then buffer is exchanged with 
two washes of 1 mL SPRITE Detergent Buffer to beads at room temperature. Next, the 
NEBNext End Repair Enzyme cocktail (containing T4 DNA Polymerase and T4 PNK) and 1x 
NEBNext End Repair Reaction Buffer is added to beads and incubated at 20C for 1 hr, and 
inactivated and buffer exchanged as specified above. DNA was then dA-tailed using the Klenow 
fragment (5′-3′ exo-, NEBNext dA-tailing Module) at 37C for 1 hr, inactivated, and buffer 
exchanged as specified above. Note, we do not use the combined End Repair/dA tailing modules 
as the temperatures in the protocol are not compatible with SPRITE (the higher temperature will 
reverse crosslinks). To prevent degradation of RNA, each enzymatic step is performed with the 
addition of 1:40 NEB Murine RNAse Inhibitor or Thermofisher Ribolock. 
Ligation of the DNA Phosphate Modified (“DPM”) Tag. After end repair and dA-tailing of 
DNA, we performed a pooled ligation with “DNA Phosphate Modified” (DPM) tag that contains 
certain modifications that we found to be critical for the success of SPRITE 2.0. Specifically, (i) 
the phosphothiorate modification prevents enzymatic digestion by Exo1 in subsequent RNA 
steps and (ii) the internal biotin modification facilitates an on-bead library prep post reverse-
crosslinking. The DPM adaptor also contains a 5’phosphorylated sticky end overhang to ligate 
tags during split-pool barcoding. Ligation was performed as previously described using Instant 
Sticky End Mastermix (NEB) except that all ligations were supplemented with 1:40 RNAse 
inhibitor (ThermoFisher Ribolock or NEB Murine RNase Inhibitor) to prevent RNA degradation. 
Because the T4 DNA Ligase included in Instant Sticky End Mastermix ligates double-stranded 





Ligation of the RNA Phosphate Modified (“RPM”) Tag. To map RNA and DNA interactions 
simultaneously, we ligated an RNA adaptor containing the same 7nt 5’phosphorylated sticky end 
overhang as the DPM adaptor used to ligate tags to both RNA and DNA during split-pool 
barcoding. To do this, the 3’end of RNA is first modified to have a 3’OH for ligation of RPM. 
Specifically, RNA overhangs are repaired with T4 Polynucleoide Kinase (NEB) with no ATP at 
37C for 20 min. RNA is subsequently ligated with a “RNA Phosphate Modified” (RPM) as 
previously described using High Concentration T4 RNA Ligase I81. Because T4 RNA Ligase 1 
ligates single-stranded RNA, ligation of RNA with the unique RPM sequence enables 
identification between RNA and DNA molecules during sequencing. After RPM ligation, RNA 
was converted to cDNA using Superscript III at 42C for 1 hour using the “RPM bottom” RT 
primer that contains an internal biotin to facilitate on-bead library prep as above and a 5’end 
sticky end to ligate tags during SPRITE. Excess primer was digested with Exonuclease 1. All 
ligations were supplemented with 1:40 RNAse inhibitor (ThermoFisher Ribolock or NEB 
Murine RNase Inhibitor) to prevent RNA degradation. 
Split-and-pool barcoding to identify RNA and DNA interactions. The beads were then 
repeatedly split-and-pool ligated over four rounds with a set of “Odd,” “Even,” and “Terminal” 
tags (see SPRITE Tag Design in reference 76). Both DPM and RPM contain the same 7 
nucleotide sticky end that will ligate to all subsequent split-pool barcoding rounds. All split-pool 
ligation steps and reverse crosslinking were performed for 45min to 1 hour at 20C as previously 
described72. All ligations were supplemented with 1:40 RNAse inhibitor (ThermoFisher 
Ribolock or NEB Murine RNase Inhibitor) to prevent RNA degradation. 
Reverse crosslinking. After multiple rounds of SPRITE split-and-pool barcoding, the tagged 




13 hours) at 50C in NLS Elution Buffer (20mM Tris-HCl pH 7.5, 10mM EDTA, 2% N-
Lauroylsarcosine, 50mM NaCl) with added 5M NaCl to 288mM NaCl final combined with 5uL 
Proteinase K (NEB).   
Post reverse-crosslinking library preparation. AEBSF (Gold Biotechnology CAS#30827-99-7) 
is added to the Proteinase K (NEB Proteinase K #P8107S; ProK) reactions to inactive the ProK 
prior to coupling to streptavidin beads. Biotinylated barcoded RNA and DNA are bound to 
streptavidin beads. To improve recovery, the supernatant is bound again to 20 ul of streptavidin 
beads and combined with the first capture. Beads are washed in 1X PBS + RNase inhibitor and 
then resuspended in 1x First Strand buffer to prevent any melting of the RNA:cDNA hybrid. 
Beads were pre-incubated at 40C for 2 min to prevent any sticky barcodes from annealing. A 
second reverse transcription is performed by adding Superscript III (without primer) to extend 
the cDNA through the areas which were previously crosslinked. The second RT ensures that 
cDNA recovery is maximal, particularly if RT terminated at a crosslinked site prior to reverse 
crosslinking. After generating cDNA, the RNA is degraded by addition of RNaseH and RNase 
cocktail, and the 3’end of the resulting cDNA is ligated to attach an dsDNA oligo containing 
library amplification sequences for subsequent library amplification.  
Previously, we performed cDNA (ssDNA) to ssDNA primer ligation which relies on the two 
reactants coming together for conversion to a product that can then be amplified for library 
preparation. To improve the efficiency of cDNA molecules ligated with the Read1 Illumina 
priming sequence, here we performed a “splint” ligation, which involves a partially ssDNA 
partially dsDNA primer that contains a random 6mer annealing to the 3’ end of the cDNA and 




annealing. This ligation is performed with 1x NEB Instant Sticky End Master Mix at 20C for 1 
hour. This greatly improves the cDNA tagging and overall RNA yield. 
Libraries were amplified using Q5 Hot-Start Mastermix (NEB) with primers that add the full 
Illumina adaptor sequences. After amplification, the libraries are cleaned up using 0.8X SPRI 
(AMPure XP) and then gel cut using the Zymo Gel Extraction Kit selecting for sizes between 
280 bp - 1.3 kb. 
Sequencing. Sequencing was performed on an Illumina NovaSeq S4 paired-end 150x150 cycle 
run. For the mES RNA-DNA SPRITE 2.0 data in this experiment, 144 different SPRITE 
libraries generated from two replicate SPRITE experiments were sequenced. Each SPRITE 
library corresponds to a distinct aliquot during the Proteinase K reverse crosslinking step which 
is separately amplified with a different barcoded primer to provide an additional round of 
SPRITE barcoding. 
Primers Used for RPM, DPM, and Splint Ligation (IDT):  
1. RPM top: /5Phos/rArUrCrArGrCrACTTAGCG TCAG/3SpC3/ 
2. RPM bottom (internal biotin): /5Phos/TGACTTGC/iBiodT/GACGCTAAGTGCTGAT 
3. DPM Phosphorothioate top: /5Phos/AAGACCACCAGATCGGAAGAGCGTCGTG*T* 
A*G*G* /32MOErG/  *Denotes Phosphorothioate bonds 
4. DPM bottom (internal biotin): 
/5Phos/TGACTTGTCATGTCT/iBioT/CCGATCTGGTGGTCTT 
5. 2Puni splint top: TACACGACGCTCTTCCGATCT NNNNNN/3SpC3/ 





Annealing of adaptors. A double-stranded DPM oligo and 2P universal splint oligo were 
generated by annealing the complementary top and bottom strands at equimolar concentrations. 
Specifically, the oligos were annealed in 1x Annealing Buffer (0.2 M LiCl2, 10 mM Tris-HCl pH 
7.5) by heating to 95C and then slowly cooling to room temperature (-1C every 10 sec) using a 
thermocycler. 
Assessing molecule to bead ratio. First, we ensured that SPRITE clusters represent bona fide 
interactions that occur within a cell by mixing human and mouse cells and ensuring that virtually 
all SPRITE clusters (~99%) represent molecules exclusively from a single species. Specifically, 
we separately crosslinked HEK293T cells performed a human-mouse mixing SPRITE 2.0 
experiment and identified conditions with low interspecies mixing (molecules =  RNA+DNA 
instead of DNA). Specifically, for SPRITE clusters containing 2-1000 reads, the percent of 
interspecies contacts was: 2 beads:molecule = 0.9% interspecies contacts, 4 beads:molecule = 
1.1% interspecies contacts, 8 beads:molecule = 1.1% interspecies contacts. We used the 2 
beads:molecule ratio for the SPRITE 2.0 data set generated in this paper. 
SPRITE 2.0 processing pipeline 
Adapter trimming. Adapters were trimmed from raw paired-end fastq files using Trim Galore! 
v0.6.2 and assessed with Fastqc v0.11.9. Subsequently, the DPM (GATCGGAAGAG) and RPM 
(ATCAGCACTTA) sequences are trimmed using Cutadapt v2.5 from 5’ end of R1 along with 
the 3’ end DPM sequences that result from short reads being read through into the barcode 
(GGTGGTCTTT, GCCTCTTGTT, CCAGGTATTT, TAAGAGAGTT, TTCTCCTCTT, 
ACCCTCGATT)82. The additional trimming improves read mapping in the end-to-end alignment 




the ligation efficiency is assessed. Reads with an RPM or a DPM barcode are split into two 
separate files, to process RNA and DNA reads individually downstream, respectively. 
Processing RNA reads. RNA reads were aligned to GRCm38.p6 with the Ensembl GRCm38 
v95 gene model annotation using Hisat2 v2.1.0 with a high penalty for soft-clipping --sp 
1000,1000. Unmapped and reads with a low MapQ score (samtools view -bq 20) were filtered 
out for downstream realignment. Mapped reads were annotated for gene exons and introns with 
the featureCounts tool from the subread package v1.6.4 using Ensembl GRCm38 v95 gene 
model annotation and the Repeat and Transposable element annotation from the Hammel lab83. 
Filtered reads were subsequently realigned to our custom collection of repeat sequences using 
Bowtie v2.3.5, only keeping mapped and primary alignment reads84. 
Processing DNA reads. DNA reads were aligned to GRCm38.p6 using Bowtie2 v2.3.5, filtering 
out unmapped and reads with a low MapQ score (samtools view -bq 20). Data generated in F1 
hybrid cells (psm33 - C57BL and 129S1 or psm44 – CAST and 129S1) were assigned the allele 
of origin using SNPsplit v0.3.485. RepeatMasker regions with milliDev <= 140 and blacklisted 
v2 regions were filtered out using Bedtools v2.29.086-87. RNA and DNA reads were merged, and 
a cluster file was generated for all downstream analysis. MultiQC v1.6 was used to aggregate all 
reports88. 
Masked bins. In addition to known repeat containing bins, we manually masked the following 
bins (mm10 genomic regions: chr2:79490000-79500000, chr11:3119270-3192250, 
chr15:99734977-99736026, chr3:5173978-5175025, chr13:58176952-58178051) because we 





Kcnq1ot1 protein binding, perturbations, and gene expression measurements 
Kcnq1ot1 CRISPR interference. dCas9-4XSID cells were transfected using multiplexed gRNA 
vector constructs containing an episomal polyoma origin of replication, puromycin resistance 
driven by a PGK promoter and four tandem U6-gRNA cassettes (allowing for simultaneous 
expression of four sgRNAs). Negative control gRNA sequences recognizing the Saccharomyces 
cerevisiae Upstream Activation Sequence (UAS) and the Tetracycline Response Element (TRE) 
were multiplexed together (referred to as sgTUUT; gRNAs are follows:  
TCTCTATCACTGATAGGGAG, GAGGACAGTACTCCGCTCGG, 
GCGGAGTACTGTCCTCCGAG, and TCTCTATCACTGATAGGGAG). Four gRNA 
sequences targeting the Kcnq1ot1 promoter were multiplexed together (referred to as 
sgKcnq1ot1; gRNAs are as follows: GCCTAGCCGTTGTCGCTAGG, 
GCCCTGTACTGCATTGAGGT, GCCTGCACAGTAGGATTCCA, and 
GGAGGATGGGTCGAGTGGCT).  
dCas9-4XSID cells were transfected with either sgTUUT or sgKcnq1ot1 and selected for three 
days with 1µg/ml of puromycin in standard 2i culture conditions. Cells were subsequently 
passaged and maintained in 0.5µg/ml puromycin for an additional 7 days prior to RNA 
harvesting. Data presented are from two separate transfections and biological replicates. 
Genetic deletion of SHARP Binding Site. F1 2-1 line cells were CRISPR-targeted with gRNAs 
targeting the SHARP-Binding Site identified previously via Covalent Linkage Affinity 
Purification Sequencing (SHARP Binding Site Coordinates: mm10 – chr7:143,295,789-
143,296,455; gRNA sequences were ATGCACCATCATAGACCACG and 




culture conditions, transfected cells were allowed to recover in standard 2i media prior to sub-
cloning. Clone were subsequently screened using genomic DNA PCR with primers flanking the 
deletion region (CAGCATCTGTCCAATCAACAG and GCAAAATACGAGAACTGAGCC 
respectively). In contrast to the wild type 1048bp band, successfully targeted alleles produced a 
305bp band. Sub-clones homozygous for the targeted allele were subject to RT-qPCR and 
GAPDH-normalized gene expression was further normalized to the F1 parent line).  
SHARP Knockout Line Generation. Mouse ES cell lines with doxycycline-inducible Xist 
expression were CRISPR-targeted using pool of gRNAs selected against the Spen gene body. 
Subclones were screened using RT-qPCR using primer pairs selected against regions upstream, 
within, and downstream of gRNA targeting (gRNAs were GGAGACCGAGACCTCCGCA, 
TATGAGCGGAGACTCGATG, and GACTGGGAGAACTAACACA, 
TTCTGCCGATACGGACCTG). Subclones were identified based on the combination of 
absence of targeted region and upregulation of flanking upstream and downstream regions, 
matching the previously observed targeting signature observed by Montfort et al.6   
Primer pairs used for RT-qPCR screening were as follows: (SHARP Exon 1-2: 
CATTTCAAACGATATGGCCG and CTTTCTGTGCACTTTTGATGTC; SHARP Exon 3-5: 
CACTGACAGTAGCGACTCC and TAAGGCTTGTGTCTGTAGAGC; SHARP Exon 8-10: 
CTGTGGTAAAGGTGGTGTTTG and TGCAAAGTCCACCTTAATCTTATTC; and SHARP 
Exon 14-16: GAGAATGACAGTGGAAACCGA and GTAGGCAGGCTGATTGGAG.) 
Knockout subclones B1 and D5 were used for subsequent experiments. 
SHARP Rescue Experiments. Knockout subclones B1 and D5 were transfected with membrane-




CAG-Halo-SHARP, sorted for mCherry+ cells 48 hours post transfection, and harvested for 
RNA, PolyA-selection RNA-library preparation, and ultimately high-throughput sequencing. 
Transfection and sorting experiments were performed in biological duplicate, beginning at 
transfection. 
HDAC inhibitor treatment. The inducible Kcnq1ot1 cell line was treated with either DMSO 
(control) or 5µM TSA in fresh 2i media or 2µg/ml doxycycline in standard 2i. RNA was 
extracted, reverse transcribed, and qPCR was performed. CT values were normalized to GAPDH 
to compare gene expression differences between induced and non-induced samples within the 
same pharmacologic condition (i.e. GAPDH-normalized “Induced DMSO” to GAPDH-
normalized “Non-Induced DMSO Vehicle”) to generate fold gene expression ratios. RT-qPCR 
data presented is summarized from two separate replicate experiments. 
Kcnq1ot1 Synthetic Recruitment. Piggy-bac transposon modified e14 ES cells were analyzed 
using mean fluorescence intensity of tGFP reporter using flow cytometry. Mean fluorescence 
activity was normalized to mCherry control, with standard deviation representing inter-
experimental variability between two replicate experiments.  
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Figure 1: SHARP Covalent Linkage Affinity Purification reveals interaction with lncRNA 
Kcnq1ot1. (A) Diagram of the functional domains in full length (FL) SHARP (also referred to as 
Spen) protein. SHARP contains four RNA recognition motif (RRM, blue) domains and one Spen 
paralogue and orthologue C-terminal (SPOC, orange) domain. The region in between the RRM 
and SPOC domains are referred to as Intrinsically Disordered Domains (IDR). (B) SHARP 
preferentially binds to the 0-2kb region of the Xist lncRNA. (C) SHARP protein binding on the 
entire 84,000 nucleotide Kcnq1ot1 lncRNA (top), and a zoom in on the first 5,000 nucleotides of 
the lncRNA (bottom). We define a region called the SHARP binding site (SBS) shown as a black 
box. (D) Confocal 3D image reconstruction of mouse embryonic stem cell, visualized with 













Figure 2: Kcnq1ot1 is necessary and sufficient to seed an RNA-mediated compartment over 
its imprinted target genes. (A) Weighted DNA-DNA contacts within SPRITE clusters 
containing the Kcnq1ot1 RNA. Vertical dashed lines indicate the boundaries of the Kcnq1ot1-
enriched spatial compartment. (Zoom out) Genomic locations in this domain of the Kcnq1ot1 
gene (burgundy) and imprinted target genes Kcnq1, Slc22a18, Cdkn1c, and Phlda2 (black) and 
non-imprinted neighboring genes Nap1l4 and Cars (gray). (B) Changes in mean gene expression 
upon CRISPR inhibition (CRISPRi) of the Kcnq1ot1 lncRNA. Genes contained within the 
Kcnq1ot1-associated domain (e.g. Cdkn1c, Phlda2, Slc22a18) are shown in black and genes 
outside the domain (e.g. Cars, Nap1l4) are shown in gray. Error bars represent standard 
deviation. (C) Changes in mean gene expression upon doxycycline mediated induction (+Dox) 
of Kcnq1ot1 relative to cells with no doxycycline (-Dox). Genes contained within the Kcnq1ot1-







domain (e.g. Cars, Nap1l4) are shown in gray. Error bars represent standard deviation. RNA-
FISH of inducible line with or without addition of doxycycline; probes aligned against two 







Figure 3: Kcnq1ot1 transcriptionally silences imprint-target genes in a SHARP-dependent 
manner. (A) RT-qPCR analysis of two lines engineered to have homozygous deletions of the 
SHARP binding site (Delta SBS) within Kcnq1ot1. (B) Mean gene expression differences of 
Kcnq1ot1-regulated and Kcnq1ot1-non-regulated genes between induced (+Dox) and non-






































(right). Error bars represent standard deviation. (C and D) CDKN1C is repressed by SHARP in a 
SHARP-dependent manner. Data presented is GapdH-normalized gene expression to parent 
control line (SHARP Deletion) and relative fold change from sequencing data between control 
and rescue (SHARP Rescue). Primer targeting SHARP was designed against gRNA-targeted 
region (SHARP Exon 3-5). (E) Cartoon of Kcnq1ot1-mediated compartmentalization of SHARP 
in the Kcnq1 topological associated domain. (F) Flow cytometry analysis of synthetic 
recruitment of select RNAs to PGK-tGFP locus. Data is presented as normalized mean 
fluorescence intensity, with experimental conditions normalized to mCherry control. Standard 











Figure 4: SHARP-RNA interactions are pervasive throughout the nucleus. (A) Input 
normalized enrichment plot of SHARP CLAP-Seq to Dleu2 and 2610035D17Rik lncRNAs, 
along with confocal 3D image reconstruction of mouse embryonic stem cell, visualized with 
SHARP immunostaining and Dleu2 RNA-FISH. (B) Input-normalized enrichment plot of 
SHARP CLAP-Seq to Rbm25 and Eif4e mRNA. (C) Representation of SHARP-RNA 
interactions identified from mouse embryonic stem cell SHARP CLAP-Seq. (D) Input-
normalized enrichment plot of SHARP CLAP-Seq to Zc3h11a, Jarid2, and Spen (SHARP) 
mRNAs across mouse (blue) and human (red). (E and F) Genome-wide localization of 
individual (E) SHARP-interacting lncRNAs (blue) and (F) SHARP-interacting pre-mRNAs 
(red). Malat1, while not a SHARP-interacting lncRNA, is included to contrast cis versus trans 







Figure 5: SHARP aggregates in a RRM- and IDR-dependent Manner. (A) (Top) 3D-
Structural Illumination Microscopy 125 nm optical sections of FL-SHARP (left) and Delta 
RRM-SHARP (right) and z-projections (bottom) Halo-tagged FL- and Delta RRM- 
SHARPJF646. FL-SHARP localizes in foci throughout the nucleus (zoom in panels 1-2), while 
Delta RRM-SHARP leads to diffusive localization. Bar: 5µm, insets: 0.5µm (magnifications). 
Intensities are depicted in 16-color grading from black (minimum) to white (maximum). 
Diagram of the functional domains of the Delta RRM SHARP mutant, generated by deletion of 
the first 591 amino acids is shown above. B) Images representing localization of meGFP-tagged 
FL-SHARP, Delta RRM-SHARP, Delta IDR-SHARP, as well as controls, in transiently 







Table 1: List of High Confidence SHARP-Interacting RNAs 
 
RNA 
Class Gene Symbol Name 
mRNA Aebp2 AE binding Protein 2 
mRNA Alg13 Asparagine-Linked Glycosylation 13 
mRNA Arl15 ADP-Ribosylation Factor-like 15 
mRNA Eif4e Eukaryotic Translation Initiation Factor 4E 
mRNA Fkbp3 FK506 Binding Protein 3 
mRNA HnrnpC Heterogeneous Nuclear Ribonucleoprotein C 
mRNA Jarid2 Jumonji, AT- Rich Interactive Domain 2 
mRNA Luc7l2 Luc7-like 2 
mRNA Mbtd1 MBT Domain Containing 1 
mRNA Psme4 Proteasome Activator Subunit 4 
mRNA Rbm25 RNA Binding Motif Protein 25 
mRNA Serbp1 Serpine1 mRNA Binding Protein 1 
mRNA Smg1 SMG1 Homolog, Phosphatidylinositol 3-kinase related kinase 
mRNA Spen Split Ends Transcriptional Repressor (SHARP) 
mRNA Sumo2 Small Ubiquitin-like Modifier 2 
mRNA U2surp U2 snRNP-Associated SURP Domain Containing 
mRNA Ube2d3 Ubiquitin-conjugating enzyme E2D 
mRNA Ubxn2a UBX Domain Protein 2A 
mRNA Zc3h11a Zinc Finger CCCH Type Containing 11A 
mRNA Zfp42 Zinc Finger Protein 42, Rex-1 
lncRNA 2610035D17Rik 
Embryonic stem cell SHARP-Associated Long Coding 
Transcript 1, eSalt1 
lncRNA 1810026B05Rik Chaserr (CHD2 adjacent suppressive regulatory RNA) 
lncRNA Dleu2 Deleted In Lymphocytic Leukemia 2 
lncRNA Kcnq1ot1 KCNQ1 overlapping transcript 1 
lncRNA Pvt1 Pvt1 oncogene 





C h a p t e r  4  
THE SMRT/HDAC1-ASSOCIATED REPRESSOR PROTEIN POSITIVELY BUFFERS 
NOTCH SIGNALING IN EARLY T-CELL DEVELOPMENT 
 













During early T-cell development, multipotent hematopoietic progenitor cells systematically lose 
alternative cell fate potential and acquire components of the T-cell developmental program. 
Notch signaling is critical for early T-cell development and lineage commitment, however in 
spite of this essential role, the transcriptional regulation and downstream targets of Notch 
signaling remain unknown. One important regulator of Notch signaling is the SMRT/HDAC1 
Associated Repressor Protein (SHARP), which has been demonstrated to act as a transcriptional 
repressor and negative regulator of the pathway in other contexts. In contrast to Notch pathway 
gain of function (which results in ectopic T-cell differentiation and tumorigenesis), SHARP 
deficiency results in stage-specific developmental delay. This suggests that SHARP’s 
relationship to Notch activity may be more nuanced in early T-cell development. Here we 
demonstrate that SHARP acts to buffer a Notch-mediated Incoherent Feedforward Loop. By 
repressing a key negative regulator of Notch activity, Notch-Regulated Ankyrin Repeat Protein 
(Nrarp), SHARP exerts an overall positive influence on the circuit. SHARP is also a well-defined 
RNA-binding protein. We demonstrate that SHARP can recognize its own pre-mRNA and 
participate in RNA-mediated autofeedback, suggesting that RNA-binding may add an additional 
layer of regulatory complexity to developmentally sensitive circuits and processes. 
2.0 INTRODUCTION 
2.1 NOTCH SIGNAL TRANSDUCTION AND EARLY T-CELL DEVELOMPENT 
Early T-cell development is a highly stereotyped biological process, through which multipotent 




components of the T-cell developmental program1. Notch signaling is critical for early T-cell 
development and lineage commitment, and dysregulation of the pathway has been linked to a 
variety of hematologic and solid malignancies, including T-Acute lymphoblastic leukemia and 
pancreatic cancer etc..1-4 
At its core, Notch signaling relies on the interactions between Notch-family receptors and their 
cognate, transmembrane-bound Delta-like/Jagged family ligands. Upon ligand recognition and 
binding, Notch receptors undergo a series of proteolytic cleavage events. This results in the 
release and translocation of Notch intracellular domain (NotchICD) into the cell nucleus. Within 
the nucleus, NotchICD can then interact with its DNA-binding partner, Recombination Signal 
Binding Protein-Jk (RBPJk, also known as CSL or SuH), to activate expression of target genes 
(Figure 1)3-6. Despite the essential role for Notch signaling in early T-cell development, its 
transcriptional regulation and downstream targets remain critical mysteries in the field. 
2.2 THE RELATIONSHIP BETWEEN SHARP AND NOTCH PATHWAY REGULATION IS 
COMPLEX 
One important regulator of Notch signaling is SMRT/HDAC1 Associated Repressor Protein 
(SHARP), also known as Split Ends Transcriptional Repressor (Spen) or Msx2-Interacting 
Nuclear Target Protein (Mint)7-10.  SHARP is a member of the Split Ends protein family, which 
consists of SHARP, RBM15, and RBM15B11. It is an approximately 3600 amino acid protein 
and contains four N-terminal RNA-Recognition Motifs and a C-terminal Spen Paralog and 
Ortholog C-terminal (SPOC) domain, demonstrated to be responsible for recruitment of SMRT 
(Silencing Mediator for Retinoid or Thyroid-Hormone Receptor, also known as Nuclear 




SHARP has been shown to compete with NotchICD for RBPJk binding and suppress Notch-
mediated gene activation; it is thought to act as a transcriptional repressor, recruiting co-
repressive complexes to remodel chromatin and repress genomic loci9,14-16,12. Moreover, SHARP 
has been demonstrated to regulate several Notch-mediated processes, including marginal vs. 
follicular B-cell choice16. Despite evidence supporting SHARP’s role as a negative regulator of 
Notch in other developmental contexts, its relationship to Notch signaling is unclear in early T-
cell development. In contrast to Notch pathway gain of function which results in ectopic T-cell 
differentiation and tumorigenesis, SHARP deficiency results in stage-specific developmental 
delay15,17. What is the relationship between SHARP and Notch signaling in early T-cell 
development, and what are possible impacts of SHARP’s ability to recognize RNA? 
3.0 RESULTS 
3.1 RESULTS: SHARP DEFICIENCY DOES NOT STRICTLY PHENOCOPY NOTCH GAIN 
OF FUNCTION  
We first aimed to recapitulate the developmental phenotype associated with SHARP 
deficiency15. Cas9-expressing E13.5 fetal liver progenitors were retrovirally transduced with 
pools of guide RNA retroviruses targeting either Luciferase (SgControl), IL2r⍺ (CD25, 
SgIL2r⍺), or Spen, the gene body for SHARP (SgSpen). Transduced cells were sorted and later 
differentiated on OP9-Dl1 stromal layer with supportive cytokines for 4 and 7 days prior to 
analysis via flow cytometry (see Methods). We specifically looked for differences in the 
proportions of early pro-T cell progenitors (hereby referred to as DN1: CD44+CD25-; DN2: 
CD44+CD25+; DN3: CD44-CD25+; and DN4: CD44-CD25-)18-19. We observed an enriched 




development delay observed in Tsuji et al 2007 (Figure 2A)15. This trend continued on day 7 of 
analysis (Figure 2B). 
To complement our primary cell experiments, we repeated CRISPR/Cas9-based targeting in 
SCID.adh.2c2 cells, a DN3-like T-cell leukemia line originally isolated and subcloned from a 
Severe Combined Immunodeficiency T-cell lymphoma20. In comparison to ex vivo differentiated 
primary hematopoietic progenitors, SCID.adh.2c2 cells exhibit gamma-secretase-dependent, 
stromal-layer independent activation of Notch signaling. SCID.adh.2c2 cells are much more 
robust than primary cells and are more amenable to downstream genetic, pharmacologic, and 
biochemical manipulation.  
After transducing SCID.adh.2c2 cells with retroviruses encoding Cas9 and gRNAs as before, we 
performed flow cytometry against Il2r⍺ (CD25), an established Notch responsive cell-surface 
marker21-22. Surprisingly, we did not initially observe a change in CD25 cell-surface expression 
upon SHARP knockout. To rule out the possibility that phenotypes associated with SHARP 
deficiency were outside the sensitivity range of our system, we repeated CRISPR/Cas9 targeting, 
but additionally cultured cells in media supplemented with either DMSO vehicle or titrated 
amounts of Gamma Secretase Inhibitor (GSI) prior to flow cytometry analysis. We observed a 
modest decrease in CD25 signal in SHARP knockout cells compared to control, which became 
more pronounced with increasing concentration of GSI (Figure 2C). As with previous studies of 
Notch signaling and SHARP in early T-cell development, this GSI Hypersensitivity phenotype 
was in stark contrast to those observed upon over-expression of dominant active Notch 




3.2 SHARP NEGATIVELY REGULATES NRARP 
We wanted to better understand the genetic circuitry underlying SHARP deficiency and the 
observed GSI Hypersensitivity phenotype. To address this, we performed RNA-Sequencing in 
SHARP knockout and control cells, cultured with various concentrations of GSI. Among the 
most statistically significant, differentially expressed genes was Notch-Regulated Ankyrin 
Protein (Nrarp), a well-characterized negative regulator of Notch-mediated transactivation 
(Figure 2A)23. Nrarp has been shown to form a ternary complex with NotchICD and SuH, and it 
has been postulated to reduce NotchICD protein levels23-24. Interestingly, Tsuji et al also observed 
Nrarp up-regulation in SHARP knockout DN1 cells in their 2007 study, and Yun et al. 
demonstrated that Nrarp is sufficient to induce a DN1-DN2 developmental delay in early pro-T-
cells, similar to those observed by Tsuji et al. and by our group15,25. Given the strict requirement 
for Notch pathway signaling in early T-cell development and the regulatory relationship between 
Nrarp and Notch, this is an example of a Notch-mediated Incoherent Feedforward Loop, with 
SHARP-repression of Nrarp exerting an overall positive input on Notch signaling and 
developmental progression. In addition to Nrarp, several other SHARP-regulated genes appear to 
be Notch pathway-regulated, including Cpa3 (Carboxypeptidase A3, Mast Cell) and Sla (Src-like 
Adaptor) (Table 1 and 2). It should be noted that there are only 13 differentially expressed, 
statistically significant genes upon SHARP deficiency, which may reflect incomplete knockout 
or severe fitness deficits (Figure 2A). Therefore, the full expression overlap between SHARP 




3.3 NRARP IS SUFFICIENT FOR GSI HYPERSENSITIVITY 
Since Yun et al. demonstrated that Nrarp is sufficient to phenocopy the developmental delay 
observed with SHARP deficiency, we wanted to test if this were also true with respect to the GSI 
Hypersensitivity phenotypes observed25. To do this, we retrovirally transduced SCID.adh.2c2 
cells with either Empty Vector Control or an Nrarp over-expression vector and subjected cells to 
the GSI hypersensitivity assay. We observed downregulation of CD25 upon Nrarp over-
expression, mimicking the deficits observed upon SHARP knockout and demonstrating that 
Nrarp is sufficient to induce GSI Hypersensitivity (Figure 3B). 
3.4 SHARP ACTS IN AN NRARP-DEPENDENT MANNER 
To test if SHARP acts in an Nrarp-dependent manner, we isolated Cas9- and gRNA-expressing 
subclones (targeting either Luciferase or Spen) and additionally transduced subclones with 
retroviruses encoding gRNAs targeting Luciferase or Nrarp, along with an NGFR cell-surface 
receptor for gating. We subsequently repeated the GSI Hypersensitivity Assay in these cells and 
were able to effectively compare single knockout (Spen: SgSpen + SgControl ; Nrarp: 
SgControl + SgNrarp), double knockout (SgSpen + SgNrarp), and no knockout (SgControl + 
SgControl) conditions. Although we encountered slight baseline differences in Notch pathway 
activation between SgControl and SgSpen samples in the DMSO vehicle condition, we reasoned 
that this was due to genetic drift from subcloning. We focused instead on the 0.1µM GSI 
condition, since it had enabled us to look at more subtle differences in Notch-mediated gene 
expression previously (Figures 2C and 3B). We observed reversion of GSI Hypersensitivity in 




SHARP in this circuit and ultimately that SHARP acts to positively buffer Notch signaling in an 
Nrarp-dependent manner (Figure 3C). 
3.5 SHARP PARTICIPATES IN RNA-MEDIATED AUTOFEEDBACK 
SHARP is a well-characterized RNA-binding protein that has been studied extensively within the 
context of nuclear hormone signaling and X-chromosome inactivation12,26-29. Many RNA-
binding proteins exhibit autoregulation, including alternative splicing-coupled nonsense-
mediated decay, poison cassette exon inclusion, RNA destabilization, and control of 3’end 
processing, among other mechanisms30-35. Given its interaction with RNA in other contexts, we 
were interested in characterizing SHARP-RNA interactions within the context of early T-cell 
development. 
To do this, we performed Covalent Linkage Affinity Purification in SCID.adh.2c2 lines 
engineered to express Halo-epitope tagged SHARP and identified interactions between the 
protein and its own mRNA transcript (Spen) within intron 2. This binding interaction was 
conserved among cell types (mouse embryonic stem cell and SCID.adh.2c2) and species (mouse 
and human), leading us to hypothesize that SHARP negatively regulates its own production in 
early T-cell development (Figure 4A, Chapter 3 – Figure 4D). To test the significance of this 
interaction, we generated homozygous SHARP Binding Site deletion lines in mouse embryonic 
stem cells and measured Spen mRNA using RT-qPCR. We observed an increase in steady state 
Spen transcript levels compared to parent line control, demonstrating that SHARP participates in 
autofeedback (Figure 4B). We independently confirmed this finding by analyzing recently 
published RNA-Seq datasets from Dossin et al, who had generated mouse embryonic stem cells 




Based on SHARP’s interactions with SMRT and HDAC3 in Xist-mediated silencing, we 
reasoned that HDAC inhibition would also result in an increase of steady state Spen mRNA. To 
test this prediction, we exposed SCID.adh.2c2 cells to several histone de-acetylase inhibitors, 
including Suberoylanilide Hydroxamic Acid (SAHA), RGFP966 (an HDAC3-specific Inhibitor), 
and Trichostatin A (TSA), and observed an increase in steady state Spen levels compared to the 
DMSO vehicle (Figure 4C)36-38. While the effects of deleting the SHARP Binding Site within 
Spen in SCID.adh.2c2 cells or hematopoietic progenitors remain to be explicitly determined, 
these data support the claim that SHARP participates in RNA-mediated autofeedback and match 
previous reports of SHARP’s stable expression profile across T-cell development84. 
 
4.0 DISCUSSION: IMPLICATIONS FOR GENE REGULATORY NETWORKS 
Taken together, our data supports a gene circuit architecture whereby SHARP simultaneously 
buffers a Notch-mediated Incoherent Feedforward Loop and its own production (Figure 5). 
Incoherent Feedforward Loops are named because they contain two branches with opposing 
actions on a particular process. They are a commonly used regulatory architecture, documented 
in bacteria, mouse embryonic stem cells, hematopoietic stem cells, innate immune regulation, fly 
eye development, and downstream of Notch signaling, among other contexts39-49. Incoherent 
Feedforward Loops, like the circuit discussed above, can be used for several different purposes, 
including improving stability and dynamics of a conjoined negative feedback loop, increasing 
gene-regulatory network response time and expression pulsatility, biphasic expression responses, 
fold-change detection, and adaptive tuning of gene expression39,42,49-60. With respect to Notch 
signaling during early T-cell development, SHARP establishes a threshold for the repressor 




mediated inhibition, upregulated (Notch-induced) Nrarp causes loss of sustained Notch signal 
intensity, resulting in robust developmental delay15,25 (Figure 2A and 2B). 
RNA has already been implicated in Incoherent Feedforward Loops. Several studies examining 
the use of small inhibitory RNAs point towards their utility in establishing homeostatic 
robustness in response to change (rather than generation of expression pulses61-72,49). Through the 
ability to detect their respective mRNA, RNA-binding chromatin regulatory proteins can offer an 
additional layer of regulatory complexity to developmentally sensitive circuits and processes. As 
an example, Notch signal transduction can have variable transcriptional after-effects, based on 
degree of pulsatility73. Circuits stabilized by RNA-binding proteins could off-set 
environmentally variable inputs (as potentially observed with Delta-like ligand availability 
during progenitor migration within the thymic microenvironment) or establish a band-pass 
filtering for sustained effective signal over time. The specific consequences of SHARP’s 
interaction with its own mRNA for regulation of Notch signaling remain to be determined, as 
does the extent to which such a regulatory mechanism may occur in broader development. 
 
5.0 MATERIALS AND METHODS 
 
Experimental Animal Lines and Protocols 
 
Mice: C57BL/6 and B6.Gt(ROSA)26Sortm1.1(CAG-cas9*,- EGFP)Fezh/J (Cas9) mice were 
purchased from the Jackson Laboratory.  All animals were bred and maintained in the California 
Institute of Technology Laboratory Animal Facility under specific pathogen free conditions. The 




Animal Care and Use Committee of the California Institute of Technology (Protocol #1445, 
entitled “Conventional and Immunodeficient Mouse Breeding. Developmental Control of 
Transcription Factors”). 
For primary cell CRISPR knockout experiments, we used F1 progeny of B6 and Cas9 mice. 
Fetal mice were collected from pregnant females at embryonic day 13.5 for fetal liver cell 
collection. Fetal livers were dissected from E13.5 (day of plug, E0.5) C57BL/6 animals. Pooled 
suspensions of FL cells were stained for lineage markers using biotin-conjugated lineage 
antibodies (CD11c, Gr1, TER-119, NK1.1, CD19, F4/80), incubated with streptavidin-coated 
magnetic beads (Miltenyi Biotec), and passed through a magnetic column (Miltenyi Biotec) prior 
to freezedown in media containing 40% Serum and 10% DMSO; male and female embryos were 
pooled together and used in experiments74. 
 
Cell Culture Conditions 
 
SCID.adh.2c2: Scid.adh.2c2 cells were cultured in RPMI1640 with 10% fetal bovine serum 
(Sigma-Aldrich), sodium pyruvate, non-essential amino acids, Pen-Strep-Glutamine and 50 µM 
β-mercaptoethanol as previously described74.  
OP9-Dl1: OP9-Dl1 were cultured as previously described75.  
Mouse Embryonic Stem Cells (mESC): All mouse ES cell lines were cultured in serum-free 
2i/LIF medium as previously described83. SHARP-Binding Site targeting was performed in F1 2-
1 parent line, a F1 hybrid wild-type mouse ES cell line derived from a 129 × castaneous cross 




Retroviral Infection: Non-TC treated plates were coated overnight at 4C with 500µl of 50ug/ml 
Retronectin (Takara) in 1X Sterile Filtered PBS per well. On the following day, wells were 
briefly rinsed with 1ml of sterile-filtered 1X PBS, before being exposed to MCSV-based 
retroviral supernatants. Retroviral coated plates were centrifuged at 2000G X 2 hrs X 32C and 
excess unbound virus was rinsed away with 1ml of sterile-filtered 1X PBS. 250-500K 
SCID.adh.2c2 cells were then added to each respective well, centrifuged at 800 RPM X 20 
minutes X 32C, and then left to incubate with virus for 24hrs at 37C prior to further downstream 
experiments. For primary cell experiments, Lin- Fetal Liver Precursors (FLPs) were cultured in 
OP9 media supplemented with 5ng/ml Flt3, Il7, and SCF for 6-12 hours prior to retroviral 
infection. Cells were subsequently transferred to retrovirus-coated wells as previously described, 
centrifuged at 800 RPM X 20 minutes X 32C, and left to incubate with retrovirus for 48hrs at 
37C prior to fluorescence activated cell sorting (FACS). 
OP9-Dl1 Co-Culture and Pro-T Cell Ex vivo Differentiation: Following FACS for Lin-, 
mTurquoise2+, CD27+, cKIT+ precursors, cells were seeded onto prepared OP9-Dl1 stromal 
layers, with media supplemented with 5ng/ml Flt3 and Il7. Cells were analyzed on Day 4 of co-
culture and re-seeded to new OP9-Dl1 stromal layers with media supplemented with 1ng/ml Il7. 
Cells were subsequently analyzed on Day 7 of co-culture. Co-culture experiments were 
performed in replicate, starting from retroviral infection and sorting through Day 7 co-culture 
flow cytometry. Data presented in Figure 1 is representative of both co-culture series.  
Gamma Secretase Inhibition (GSI): GSI (InSolution γ-Secretase Inhibitor X - EMD Millipore) 
was administered to SCID.adh.2c2 cells as previously documented in Del Real, 201375. GSI 
dosages were titrated by diluting 2000X stock solutions with additional Dimethyl-sulfoxide 




SCID.adh.2c2 cells were resuspended and plated in SCID.adh.2c2 media containing working 
concentrations of GSI and allowed to culture for 48hrs prior to flow cytometry analysis or RNA 
harvesting post-FACS. 
Histone De-Acetylase Inhibitor Administration: RGFP966, SAHA, and TSA were diluted in 
DMSO solvent to generate stock concentrations and further diluted in SCID.adh.2c2 media for 
final working concentrations of 0.1µM SAHA, 5µM RGFP966, and 10nM TSA. Cells were 
grown in HDAC Inhibitor media for 48hrs prior to RNA harvesting for RT-qPCR. GapdH-
normalized gene expression was fold-normalized to DMSO Vehicle and averaged across three 
separate Spen-targeting primer pairs. 
Generation of Halo-tagged SHARP SCID.adh.2c2 Line: To generate an N-terminal Halo-
tagged SHARP mammalian expression construct, a LR-compatible pB-Halo-DEST-IRES-eGFP 
destination vector was first generated. Generation of this destination vector made use of the pB-
TAG-ERN backbone (a gift from Knut Woltjen; Addgene plasmid # 80476; 
http://n2t.net/addgene:80476 ; RRID:Addgene_80476) and the coding sequence for the Halo 
epitope (gift from Ward Walkup IV)76. Resulting expression vectors drive protein expression by 
a dox-inducible promoter, contain the rtTA needed for dox induction, and produce an N-
terminally-tagged Halo fusion protein. LR recombination was subsequently performed using the 
Full Length SHARP entry clone (Sp22, gift from Alexander Shiskin) to generate the pB-Halo-
SHARP,IRES-eGFP expression vector. SCID.adh.2c2 cells were transfected using the pB-Halo-
SHARP,IRES-eGFP, along with piggybac transposase (gift from Xun Wang), using a previously 
published Lonza/Amaxa Nucleofection (Solution-V, program D-19) method77. Cells with stable 
integration of the construct were selected using repeated cycles of 2µg/ml doxycycline 




SCID.adh.2c2 lines.  
Deletion of SHARP Binding Site in Spen: F1 2-1 line were CRISPR-targeted with gRNAs 
targeting the SHARP-Binding Site identified previously via Covalent Linkage Affinity 
Purification Sequencing (SHARP Binding Site Coordinates: mm10 - chr4:141,520,614-
141,521,890; gRNA sequences were TCTACCGGGAGATCACATGG and 
ACTGTGCCAGGTATCCACTG). Following selection using 1µg/ml of puromycin in standard 
2i culture conditions, transfected cells were allowed to recover in standard 2i media prior to sub-
cloning. Clone were subsequently screened by genomic DNA PCR using primers flanking the 
deletion region (GGAGACGGAAGTTATTTCTATCC and GTTTCTCACTTAACCTGGAGC 
respectively). In contrast to the wild type 1833bp band, successfully targeted alleles would 
produce a 215bp band. Sub-clones homozygous for the targeted allele were subject to RT-qPCR 
and GAPDH-normalized gene expression was further normalized to the F1 parent line. 
Flow Cytometry: Flow cytometry was performed as previously discussed75. More specifically 
for Day 4 and Day 7 Ex Vivo Differentiation studies, cells were stained against cKit, CD45, 
CD44, and CD25 cell-surface markers, as well as 7-AAD to assess viability. For GSI 
Hypersensitivity assays, SCID.adh.2c2 samples were stained against CD25 and NGFR cell-
surface marker and viability was assessed using 7-AAD. 
 
Molecular Biology Protocols 
 
Retroviral Cloning: The NRARP open reading frame was cloned into the pMX-IRES-eGFP 




vector was also a gift from H. Hosokawa. All retroviruses were packaged as previously 
described81. 
gRNA Retroviral Vector Cloning: gRNA sequences were cloned and packaged as discussed 
previously, with the following modifications74. To enable selection of SHARP and NRARP 
double knockouts, E42 dTet-CFP was modified to replace the CFP selection marker with 
Truncated Human Nerve Growth Factor Receptor (NFGR) (coding sequence from Addgene 
plasmid #27489, a gift from Warren Pear; http://n2t.net/addgene:27489 ; RRID:Addgene_27489) 
to generate E42 dTet-NGFR78. gRNA sequences targeting the Spen gene body were cloned into 
E42 dTet-CFP (GGAGACCGAGACCTCCGCA, TATGAGCGGAGACTCGATG, and 
GACTGGGAGAACTAACACA). Control gRNA sequence, as well as gRNA sequences 
targeting Nrarp gene body were cloned into E42 dTet-NGFR. Nrarp-targeting gRNAs were 
TACACCAGTCAGTCATCGA, GTGCGCAAGGGCAACACGC, and 
GTCTGTGGCGCCGAGCAGG). 
RT-qPCR: Total RNA was extracted from cultured SCID.adh.2c2 or mESCs with Silane beads 
(Sigma) according to manufacturer’s conditions and treated with Turbo DNase (Life 
Technologies) for 15min at 37C to remove genomic DNA. RT reactions were performed 
according to the Superscript II protocol (Thermo Fisher Scientific #18064022) with random 
9mers. qPCRs were performed in technical replicates using a Roche Lightcycler. Plots were 
generated using GraphPad software. ddCt values were calculated by normalizing to GAPDH and 
to samples transfected with control treatment or parent line to compare fold gene expression 
differences between samples82. 
mRNA and RNA-seq library preparation: RNA and RNA-Seq libraries were processed as 




to manufacturer’s recommendations. Libraries were constructed using NEBNext Ultra RNA 
Library Prep Kit for Illumina (NEB #E7530) from ~1 µg of total RNA following manufacturer’s 
instructions. Libraries were sequenced on an Illumina HiSeq2500 in single read mode with the 
read length of 50 nt according to manufacturer's instructions74. 
SHARP Covalent Linkage Affinity Purification (CLAP): CLAP and associated library-
preparation were performed as previously described (Chapters 2 and 3), with the following 
modifications for suspension SCID.adh.2c2 cells: Halo-SHARP SCID.adh.2c2 cells were 
resuspended in media supplemented with 2µg/ml doxycycline for 48 hours prior to harvesting. 
Cells were washed with 1X PBS, transferred to a 15cm plate and crosslinked on ice using 0.25 J 
cm−2 (UV2.5k) of UV at 254 nm in a Spectrolinker UV Crosslinker. Following UV-cross 
linking, cells were transferred from a culture dish to a 50ml conical vial, washed once with PBS, 
pelleted by centrifugation at 1,500g for 4 min and flash-frozen in liquid nitrogen for storage at     
-80C. 
 
Quantification and Statistical Analysis 
 
Flow cytometry Analysis: When available, median fluorescence intensities were averaged 
between replicate wells within a given experiment. Mean fluorescence intensities were then 
internally normalized to a reference control for fold normalized intensity (please see legend for 
respective reference control used for each experiment). Normalized intensity was then averaged 





Differential Gene Expression: Calls were made according to previously documented pipelines 
and software packages74. Use of the DeSeq2 package is denoted in respective figure legends, 
with false discovery rate set to 0.05. High Confidence Notch target genes were determined by 
comparing between two separate Notch pathway perturbations: GSI inhibition treatment (0.1µM 
GSI: CD25+ versus CD25- subsets) and over-expression of NotchICD (CD25+ subsets from 
NotchICD versus Empty Vector Control). Notch-dependent genes (GSI-repressed and NotchICD-
enhanced) and Notch-repressed genes (GSI-enhanced and NotchICD-repressed) are presented in 
Tables 1 and 2. Calls were made using DeSeq2 pipeline, with FDR set to 0.05. 
RNA-seq data used in Figure 4D was adapted from Dossin et al., where mouse-ES cells were 
engineered to express SHARP tagged with an auxin-inducible degron13. Fastq files were trimmed 
using skewer and pseudoaligned using Salmon to mm10 using the latest transcripts from 
Gencode (GRCm38_p6)85-86. TPM’s were calculated using Salmon for untreated and 28-hour 
auxin treated samples (3 replicates for each condition)85. TPMs were furthered averaged across 
aligned transcript isoforms and presented in Figure 4D.  
For analysis performed for Chapter 5 - Figure 1, comparing SHARP-mediated differential gene 
expression (log-2 fold change after auxin treatment against untreated control) versus Spen RNA 
localization on chromatin from RNA-DNA SPRITE, log-2 fold changes for each gene with a 1 
Mb window around SHARP, excluding genes that had a mean TPM of zero in either condition 
were plotted on the left y-axis. Weighted SHARP-RNA to DNA contacts from the RNA-DNA 
SPRITE data were counted in 50kb bins around the SHARP locus and plotted on the right y-axis.  
 
CLAP Peaks: Calls and input-normalized enrichments were made using CLIPCLAPEnrichment 
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Figure 1: Classic model of Notch signaling. Upon ligand-interaction between Notch receptor 
and its cognate cell-surface bound receptors, Notch Receptor undergoes proteolytic cleavage, 
releasing its intracellular domain to translocate to the nucleus and convert RBP-Jk from 








Figure 2: SHARP deficiency does not functionally phenocopy Notch gain of function. A and 
B) Flow cytometric analysis of ex vivo differentiated Cas9-targeted fetal liver progenitors (FLP). 
Cas9-eGFP expressing E13.5 FLPs were retrovirally transduced with pools of guide RNA 
retroviruses targeting either Luciferase (Control), IL2r⍺, and Spen. Transduced cells were 
differentiated on OP9-Dl1 stromal layer with supportive cytokines for (A) 4 and (B) 7 days prior 
to flow cytometry analysis. (C) Quantification of flow cytometry against Il2r⍺ (CD25) from 






Gamma Secretase Inhibitor Hypersensitivity Assay from SgControl and SgSpen SCID.adh.2c2 
experimental conditions. Internally normalized to SgControl DMSO vehicle condition (see 
methods) and average of two biological experimental series. (D) Quantification of CD25 flow 
cytometry in SCID.adh.2c2 cells retrovirally infected with Empty Vector Control or Dominant 
Active Notch (NotchICD). Internally normalized to Empty Vector Control DMSO vehicle 






Figure 3: SHARP regulates Notch-mediated gene expression in a NRARP-dependent 
manner. (A) Heat map representation of RNA-Sequencing data comparing DMSO exposed 
CD25+ subsets from SgControl and SgSpen transduced SCID.adh.2c2 cells. Average of two 
biological experimental series. Data is represented in log2 fold change. (B) Quantification of 
CD25 flow cytometry from Gamma Secretase Inhibitor Hypersensitivity Assay from Empty 
Vector Control or Nrarp Over-expression vector. Internally normalized to Empty Vector Control 
DMSO vehicle condition (see methods) and average of two biological experimental series. 
(C) Quantification of CD25 flow cytometry from Gamma Secretase Inhibitor Hypersensitivity 









































NGFR or SgNrarp, NGFR. Internally normalized to SgControl + SgControl, DMSO vehicle 








Figure 4: SHARP exhibits negative auto-regulation. (A) Input normalized enrichment plots of 
SHARP CLAP-Seq of Spen pre-mRNA transcript, performed in both mouse embryonic stem 
cells and in Halo-SHARP SCID.adh.2c2 lines. Comparison between mouse embryonic stem cell 
and Human Embryonic Kidney 293T SHARP CLAP-Seq is included in Figure 4D of Chapter 3 
of this dissertation. (B) RT-qPCR analysis of two different mouse embryonic stem cell clones, 
harboring homozygous deletion of the SHARP binding site (Delta SBS) within Spen. Expression 
normalized to WT, average of 3 separate primer pairs. (C) RT-qPCR analysis of SCID.adh.2c2 
















































































vehicle and average of two biological experimental series. (D) RNA-Seq analysis of published 
dataset from Dossin et al. 202013. Authors generated mouse embryonic stem cell harboring 
auxin-degron tagged-SHARP and compared differential gene expression between parent and 
auxin lines, with or without Auxin exposure. Presented are isoform-averaged TPM values of 








Figure 5: SHARP positively buffers a Notch-mediated Incoherent Feedforward Loop. In 
early T-cell development, Notch signaling promotes the DN1-DN2 developmental transition, as 
well as production of Nrarp, which simultaneously inhibits this developmental process. SHARP 
negatively regulates Nrarp production, exerting a net positive effect. SHARP negatively auto-









Table 1: List of High Confidence Notch-Dependent Target Genes in SCID.adh.2c2 
 
Gene Symbol Name 
2700054A10Rik Putative Non-Coding RNA 
Afdn Adherens Junction Formation Factor 
Agfg1 Arf-GAP Domain and FG Repeats-Containing Protein 
Agtr1a Angiotensin II Receptor, Type 1A 
Aldh1b1 Aldehyde Dehydrogenase 1 Family, member B1 
Alp1 Alkaline Phosphatase, Intestinal 
Arhgef10l Rho Guanine Nucleotide Exchange Factor 10-like 
Arsi Arylsulfatase i 
Capn5 Calpain 5 
Colq 
Collagen-like Tail Subunit (single strand of homotrimer) of 
asymmetric acetylcholinesterase 
Deptor DEP Domain Containing MTOR-interacting Protein 
Dlg1 Discs Large MAGUK Scaffold Protein 1 
Dsc2 Desmocollin 2 
Dtx1 Deltex 1, E3 Ubiquitin Ligase 
Fkbp5 FK506 Binding Protein 5 
Frmd4a FERM Domain Containing 4A 
Il2ra Interleukin 2 Receptor, Alpha Chain (CD25) 
Itga9 Integrin Alpha 9 
Nav2 Neuron Navigator 2 
Notch1 Notch 1 
Nrarp Notch-regulated Ankyrin Repeat Protein 
Shb SRC Homology 2 Domain-Containing Transforming Protein B 
Slc16a10 
Solute Carrier Family 16 (monocarboxylic acid transporters), 
member 10 
Svep1 
Sushi, von Willebrand factor Type A, EGF, and Pentraxin 
Domain Containing 1 
Tcof1 Treacle Ribosome Biogenesis Factor I 







Table 2: List of High Confidence Notch-Repressed Target Genes in SCID.adh.2c2 
 
Gene Symbol Name 
5830411N06Rik SCART 2 
Btg2 B cell translocation gene 2, anti-proliferative 
Cpa3 Carboxypeptidase A3, Mast Cell 
Ctsl Cathepsin L 
Dok2 Docking Protein 2 
Fam214a Family with Sequence Similarity 214, Member A 
Glcci1 Glucocorticoid Induced Transcript 1 
Il21r Interleukin 21 Receptor 
Lztfl1 Leucine Zipper Transcription Factor-like 1 
Minpp1 Multiple Inositol Polyphosphate Histidine Phosphatase 1 
Nr3c1 Nuclear Receptor Subfamily 3, Group C, Member 1 
Pdcd4 Programmed Cell Death 4 
Pik3r3 Phosphoinositide-3-kinase Regulatory Subunit 3 
Ptprc Protein Tyrosine Phosphatase, Receptor Type, C 
Rora RAR-Related Orphan Receptor Alpha 
Sdc4 Syndecan 4 
Sla Src-like Adaptor 
Slc22a3 Solute Carrier Family 22 (organic cation transporter), member 3 
Synpo2l Synaptopodin 2 like 
Sys1 
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1.0 DISCUSSIONS AND IMPLICATIONS 
 
RNA-binding interactions are critical to core cellular function. It is important then to be able to 
accurately identify bona fide RNA-protein interactions. In Chapter 2, we demonstrated that the 
current gold standard approach, Crosslinking Immunoprecipitation (CLIP), does not fully 
exclude interactions that occur in solution (in vitro associations). These artifacts can overshadow 
true interactions or lead to further inaccurate studies. In contrast, we showed that Covalent 
Linkage Affinity Purification (CLAP) can simultaneously identify true interactions while 
resolving in vitro association artifacts and provides a critical new framework for studying bona 
fide RNA-protein interactions in vivo. 
In response to the current COVID-19 pandemic, we used CLAP to ask if RNA is a central target 
of host cell takeover by SARS-CoV-2 and observed that the virus uses at least three RNA-
mediated mechanisms to blunt the innate immune system’s ability to engage the interferon 
pathway. More specifically, we identified interactions between SARS-CoV-2 NSP16 with the 
U1 and U2 snRNAs to inhibit pre-mRNA splicing, NSP1 with the 18S ribosomal RNA to inhibit 
mRNA translation, and NSP8/9 with 7SL RNA to inhibit protein trafficking. We expect that 
mechanistic insights gained from these three examples, as well as the comprehensive RNA 
binding maps of the SARS-CoV-2 proteins presented in Chapter 2, will be a critical resource for 
the larger scientific community working to develop therapeutic strategies and dissect 
mechanisms of viral protection. More generally, global mapping of RNA binding by viral 
proteins via CLAP could be a generally applicable strategy for rapidly characterizing 
mechanisms and potential therapeutic strategies for newly emerging pathogenic RNA viruses, as 




In Chapter 3, we examined the role of RNA-binding interactions in gene regulation. More 
specifically, we leveraged the CLAP method to study a key, RNA-binding, chromatin regulatory 
protein called SHARP. We demonstrated that the paternally imprinted long non-coding RNA 
(lncRNA) Kcnq1ot1 acts to transcriptionally repress targets in a SHARP-dependent manner, 
similar to the activity of Xist lncRNA during X-chromosome inactivation. This work supports a 
broader model of RNA-mediated gene regulation in the nucleus, where RNA can recruit and 
concentrate proteins to defined chromatin territories to spatially amplify local regulatory signals 
in cis1-2. Kcnq1ot1 recruits SHARP to a defined gene cluster to silence target genes. Through its 
avidity to RNA and its intrinsically disordered domains, SHARP can then aggregate and 
compartmentalize over this chromatin territory. Control over the entire gene cluster and RNA-
mediated compartment can therefore be coordinated from a single cis regulatory DNA element: 
the Kcnq1ot1 promoter (also known as the Kcnq1 Imprint Control Region)3-4. 
What was most surprising to us from this dataset was the identification of SHARP/pre-mRNA 
interactions, which actually outnumber the SHARP/lncRNA interactions observed. Many of 
these pre-mRNAs localize broadly to chromatin in a similar manner to lncRNAs. These data 
suggest that RNA-mediated compartmentalization of effector proteins may act more pervasively 
to coordinate gene regulation across the nucleus. While the reasons underlying SHARP’s 
interaction with chromatin-retained pre-mRNAs and possible gene regulation in cis are currently 
unknown, it is interesting to note that several pre-mRNA targets are documented to be 
haploinsufficient or have pathologies sensitive to dosage5-8. If these SHARP/pre-mRNA 
interactions are capable of seeding functional regulatory compartments within the nucleus (as 
suggested by preliminary data from SHARP’s interaction with Spen mRNA on expression of 




(that is regulatory RNA and coding RNA are mutually exclusive) and expands the field’s 
definition of functional regulatory RNAs (Figure 1). 
In Chapter 4, we dissected a SHARP-mediated transcriptional circuit in early T-cell 
development. Given previous evidence demonstrating SHARP to be a negative regulator of 
Notch signaling in other hematopoietic contexts, we were surprised to observe that SHARP loss 
of function does not functionally phenocopy Notch gain of function in this system9-10. Through a 
series of targeted perturbations, we demonstrated that SHARP negatively regulates a negative 
regulator of Notch (Nrarp) and in extension, positively buffers a Notch-mediated Incoherent 
Feedforward Loop11. We also identified an interaction between SHARP and its mRNA using 
CLAP and showed that SHARP autoregulates its own transcription. 
Incoherent Feedforward Loops, like the circuit discussed above, are commonly used regulatory 
circuits that can be used for several different purposes, including improving stability and 
dynamics of a conjoined negative feedback loop, increasing gene-regulatory network response 
time and expression pulsatility, biphasic expression responses, fold-change detection, and 
adaptive tuning of gene expression12-25. Although the specific consequences of SHARP’s 
interaction with its own mRNA on Notch signaling remains to be experimentally determined, 
circuits stabilized by RNA-binding proteins could off-set environmentally variable inputs (as 
potentially observed with Delta-like ligand availability for progenitors as they migrate within the 







2.0 FUTURE DIRECTIONS 
As stated very eloquently by Alan Chalmers regarding the progress of scientific understanding, 
“[w]e start off confused and end up confused on a higher level”26. While the three presented 
studies illustrate the diversity of roles played by RNA-interactions in development, cellular 
homeostasis, and disease, our data poses many additional questions for discussion and further 
investigation.  
To begin, what is the implication of an interaction between RNA and an RNA-binding protein? 
Important clues for tackling such questions include the function of the specific RNA or RNA-
binding protein in question (if available), localization of these components within the cell (if 
available), nucleotide resolution localization of the RNA-binding protein on its interacting RNA, 
and context of identification. For some interactions, interpretation may be clear. For example, in 
Chapter 2 we observed specific interactions between NSP16 and the U1 and U2 snRNAs, 
specifically at the splice site recognition sequence of U1 and adjacent to the branch point 
recognition sequence of U2; given the importance of these snRNAs in pre-mRNA splicing, it 
was straightforward to hypothesize the implications of such a viral protein/host RNA 
interaction27.  
While it is tempting to apply a reductionist framework to viral protein/host RNA interactions and 
assume that all interactions must promote viral fitness, such hypothesis may not be justified. For 
example, we do not understand the reasons underlying interactions between NSP12 and JUN 
mRNA, NSP9 and COPS5 mRNA, or those between the Nucleocapsid protein and a specific 
subset of 83 host mRNAs. Further study is required to determine the role, if any, that these 




There are many cases where cellular context is not as clear (Figure 2). For example, Lamin B 
Receptor (LBR) protein plays a key role in tethering the inactive X-chromosome to the nuclear 
lamina and also has annotated sterol reductase enzymatic activity28-29. Given the interaction 
between LBR and Dsg2 (Desmoglein 2) pre-mRNA or Ttc28 (Tetratricopeptide Repeat Domain 
28) pre-mRNA, it may or may not be reasonable to assume all LBR interactions act in a similar 
manner. While the CLAP method has enabled genome-wide, high-specificity identification of 
RNA-binding interactions, it is now equally (if not more) important to develop massively 
multiplexed, hypothesis-agnostic, experimental perturbation systems to dissect their significance 
without reliance on a priori knowledge. 
Historically, much has been learned by bootstrapping upon previously characterized biological 
mechanisms and using this approach to understand SHARP is no exception. The interactions of 
SHARP with RNA, as well as its role in gene regulatory networks and chromatin regulation are 
well known; SHARP is therefore amenable to carefully designed experiments with clear, logical 
and testable predictions9,30-37. Its functional interactions with the Kcnq1ot1 lncRNA, along with 
the identification of several more targets, point towards pervasive mechanisms of RNA-mediated 
gene regulation and compartment formation within the nucleus. However, this raises several new 
questions to be explored.  
First given the similarities between Xist- and Kcnq1ot1-mediated silencing, it remains to be 
determined why Xist is capable of establishing durable transcriptional memory, while Kcnq1ot1 
is not38-40. Second as discussed in Chapter 4 within the context of Incoherent Feedforward Loops, 
transcriptional circuits stabilized by RNA can promote robustness in response to change, 




SHARP autoregulates its transcription. Therefore, the role of SHARP autoregulation in 
compartment robustness and crosstalk remains to be explored (Figure 3).  
We began discussing the advantages of RNA as a flexible biomolecule with exclusive 
capabilities based on its unique attributes. We showed that RNA plays a key role in core cellular 
machinery, such as pre-mRNA splicing and translation, and as such, is the target of host-cell 
takeover by SARS-CoV-2. We showed that RNA can spatially amplify regulatory signals within 
the nucleus to coordinate gene regulation in cis and speculate that it has yet uncharacterized roles 
in nuclear compartment stabilization and crosstalk. It is therefore appropriate to conclude with a 
simple yet open-ended question: How deep does the RNA rabbit hole go? 
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Figure 1: Preliminary evidence of cis gene regulation by SHARP/pre-mRNAs. Comparison 
of SHARP-mediated differential gene expression, published in Dossin et al., with localization of 
Spen RNA on chromatin from RNA-DNA SPRITE (both datasets aligned to mm10)37,53. Data is 
presented along linear chromatin distance, with genes centered around Spen gene body 
(displayed in red). Differential gene expression for individual genes is plotted in black, while 
localization of Spen RNA on chromatin is plotted in blue. For quantification methods used, 







Figure 2: CLAP reveals a growing number of uncharacterized RNA-protein interactions. 
Input normalized enrichment plot of LBR CLAP-Seq to Dsg2 and Ttc28 pre-mRNAs, performed 
using mouse embryonic stem cell lines engineered with endogenous integrations of Spy-V5 tags 










Figure 3: Shared effector proteins enable compartment cross-talk. Upon Xist-mediated 
silencing, SHARP is dynamically recruited and concentrated to the inactive X-chromosome. 
Recruitment of SHARP away from its own locus would lead to de-repression and lack of 
autoregulation, resulting increased Spen transcription and SHARP protein production to re-
establish autoregulation. 
 
 
 
 
 
